{
    "testId": 390624099,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 63,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 26,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 1,
    "timeInSeconds": 924,
    "averageTimeSpentInSeconds": 157,
    "otherAverageTimeSpentInSeconds": 67,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 3597,
            "questionIndex": 3597,
            "questionText": "<p>A 66-year-old man comes to the emergency department with acute onset of severe chest pain and shortness of breath.&nbsp; The pain is in the right upper chest and is aggravated by deep breathing and coughing.&nbsp; Medical history is significant for hypertension and obstructive sleep apnea.&nbsp; The patient quit smoking 10 years ago and drinks beer on weekends.&nbsp; Blood pressure is 110/70 mm Hg, pulse is 116/min and regular, and respirations are 22/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Normal vesicular breath sounds are heard on auscultation of the chest.&nbsp; Cardiac auscultation reveals tachycardia and an accentuated S2.&nbsp; Chest x-ray is unremarkable.&nbsp; ECG shows sinus tachycardia.&nbsp; CT angiogram of the chest reveals an embolus in the right pulmonary artery.&nbsp; Which of the following is the most likely origin of this embolus?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4715\" src=\"https://www.uworld.com/media/L29406.jpg\" ></p><p>This patient&#39;s clinical presentation (eg, acute chest pain worse with inspiration, tachycardia, S2 suggestive of pulmonary hypertension) with CT angiogram findings of a thrombus in the right pulmonary artery is diagnostic of <strong>pulmonary embolus</strong> (PE).&nbsp; The deep veins of the lower extremities are the most frequent source.&nbsp; Lower extremity deep vein thrombosis (DVT) is divided into 2 categories:</p><ul><li><p><strong>Proximal</strong>/thigh (eg, iliac, <strong>femoral</strong>, <strong>popliteal</strong>):&nbsp; These DVTs are the source of <strong>&gt;90% of acute PEs</strong>, probably due to their large caliber and proximity to the lungs.</p></li><li><p>Distal/calf:&nbsp; Although most DVTs occur in the calf vein, distal/calf DVTs are less likely than proximal/thigh DVTs to embolize to the lungs and cause PE and they are more likely to spontaneously resolve <strong>(Choice A)</strong>.</p></li></ul><p><strong>(Choice C)</strong>&nbsp; Thrombi originating from the renal veins are most common in patients with nephrotic syndrome.&nbsp; The prevalence of PE in patients with nephrotic syndrome is 10%-30%.</p><p><strong>(Choice D)</strong>&nbsp; Thrombi originating in the right atrium are more common in patients with intracardiac devices (eg, pacemaker) and are less likely to occur spontaneously.</p><p><strong>(Choice E)</strong>&nbsp; Spontaneous upper extremity DVT is generally uncommon (1%-4%) and even less likely to cause PE.&nbsp; Common risk factors for upper extremity DVT include prothrombotic state, indwelling catheter, and anatomical venous obstruction (eg, cervical rib, bony overgrowth after clavicular fracture).</p><p><strong>Educational objective:</strong><br>The proximal deep leg veins are the most common source of symptomatic pulmonary embolism.&nbsp; Other less common sources of emboli include the calf veins, renal veins, pelvic veins, upper extremity veins, and right heart.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Calf vein",
                    "choiceNumber": 1,
                    "correctTaken": 7902,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Femoral vein",
                    "choiceNumber": 2,
                    "correctTaken": 12000,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal vein",
                    "choiceNumber": 3,
                    "correctTaken": 112,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Right atrium",
                    "choiceNumber": 4,
                    "correctTaken": 2063,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Upper extremity vein",
                    "choiceNumber": 5,
                    "correctTaken": 196,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "532,587,true,-1,1*992,1100,true,-1,1*1307,1445,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19793188",
                    "mediaDataId": 0,
                    "title": "Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19793188",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 122,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 22273,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1717,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 4383,
            "questionIndex": 4383,
            "questionText": "<p>A 17-year-old girl comes to the emergency department due to a nosebleed that began an hour ago after she was hit in the face by a basketball.&nbsp; She pinched the nostrils for about 20 minutes in an attempt to stop the bleeding, but the hemorrhage continued after pressure was removed.&nbsp; The patient has a history of heavy, painful menses and takes scheduled ibuprofen for the first few days of her period.&nbsp; Her last period was a week ago.&nbsp; Temperature is 37.2 C (99 F).&nbsp; Examination shows clear lung fields with normal S1 and S2.&nbsp; The liver span measures 8 cm along the midclavicular line, and the spleen is not palpable.&nbsp; Scattered ecchymoses are present on both legs and arms.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hematocrit</td><td>36%</td></tr><tr><td>Platelets</td><td>9,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>5,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td>60%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Eosinophils</td><td>1%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td>32%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td>7%</td></tr><tr><td>Fibrinogen</td><td>250 mg/dL (normal: 150-350 mg/dL)</td></tr><tr><td>PT</td><td>13 sec</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41094\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Immune thrombocytopenia </strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Platelet autoantibodies</li><li>Preceding viral infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Petechiae, ecchymosis</li><li>Mucosal bleeding (eg, epistaxis, hematuria)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Isolated thrombocytopenia &lt;100,000/mm<sup>3</sup></li><li>Few platelets (size normal to large) on peripheral smear</li></ul></td></tr><tr><td>&nbsp;<p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Children<ul style=\"list-style-type:circle;\"><li>Observe if cutaneous symptoms only</li><li>Glucocorticoids, IVIG, or anti-D if bleeding</li></ul></li><li>Adults<ul style=\"list-style-type:circle;\"><li>Observation if cutaneous symptoms AND platelets &ge;30,000/mm<sup>3</sup></li><li>Glucocorticoids, IVIG, or anti-D if bleeding or platelets &lt;30,000/mm<sup>3</sup></li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.25in;\"><strong>IVIG</strong> = intravenous immunoglobulin.</p></td></tr></tbody></table></div><p>This patient has bleeding episodes and <strong>isolated thrombocytopenia</strong>, likely due to <strong>immune thrombocytopenia</strong> (ITP).&nbsp; ITP is an autoimmune disorder in which IgG <strong>autoantibodies</strong> against platelet membrane glycoproteins cause increased platelet destruction and inhibition of platelet production.&nbsp; Presentation is most common in healthy children (age 2-5) or adolescents with petechiae, ecchymoses, and <strong>mucosal bleeding</strong> (eg, epistaxis, heavy menses).&nbsp; Other than bruising, physical examination is generally unremarkable.&nbsp; Patients have a <strong>normal liver span</strong> (eg, 6-12 cm at midclavicular line) and <strong>nonpalpable spleen</strong>.</p><p>Although ITP is a common cause of isolated thrombocytopenia (ie, normal hematocrit and leukocytes), it is a diagnosis of exclusion.&nbsp; Prolonged bleeding warrants workup with coagulation tests (PT, PTT, fibrinogen), which are normal in patients with ITP.&nbsp; Observation alone is sufficient for mild ITP (cutaneous manifestations) in children, whereas glucocorticoids, anti-D immune globulin (if Rh-positive and Coombs-negative), or intravenous immunoglobulin is the treatment for bleeding.&nbsp; Hormonal therapy may also be considered in patients with heavy menses.</p><p><strong>(Choice A)</strong>&nbsp; Nonsteroidal anti-inflammatories (eg, ibuprofen) block production of thromboxane A2, which can impair platelet function but would not result in the severe thrombocytopenia seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Malignant infiltration of the bone marrow, as seen in leukemia, typically results in pancytopenia.&nbsp; It is unlikely in this patient with isolated thrombocytopenia and no hepatosplenomegaly.</p><p><strong>(Choice C)</strong>&nbsp; Decreased von Willebrand factor can present in adolescent girls with heavy menstrual bleeding.&nbsp; Although platelet function is affected, platelet count is typically normal.</p><p><strong>(Choice D)</strong>&nbsp; ADAMTS13 is deficient in thrombocytopenic purpura, which is characterized by thrombocytopenia and microangiopathic hemolytic anemia (not seen in this patient).</p><p><strong>(Choice E)</strong>&nbsp; Disseminated intravascular coagulation is associated with hyperactivation of coagulation and fibrinolysis.&nbsp; Patients typically have thrombocytopenia, microangiopathic hemolytic anemia, low levels of clotting factors (fibrinogen, factors V and VIII), and prolonged PT and PTT.</p><p><strong>Educational objective:</strong><br>Immune thrombocytopenia is an autoimmune disorder with increased platelet destruction and inhibition of platelet production due to IgG autoantibodies against platelet membrane glycoproteins.&nbsp; Patients may have mucocutaneous bleeding with isolated thrombocytopenia and no hepatosplenomegaly.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16575,
            "topic": "ITP",
            "titleId": 16575,
            "title": "ITP",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Blocked production of thromboxane A2",
                    "choiceNumber": 1,
                    "correctTaken": 624,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow infiltration by malignant cells",
                    "choiceNumber": 2,
                    "correctTaken": 416,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased circulating von Willebrand protein",
                    "choiceNumber": 3,
                    "correctTaken": 4458,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Deficient ADAMTS13 activity",
                    "choiceNumber": 4,
                    "correctTaken": 2553,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperactivation of coagulation and fibrinolysis",
                    "choiceNumber": 5,
                    "correctTaken": 211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Platelet autoantibody production",
                    "choiceNumber": 6,
                    "correctTaken": 8924,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1539,1749,true,-1,1*219,255,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22753097",
                    "mediaDataId": 0,
                    "title": "Immune thrombocytopenia: pathophysiologic and clinical update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22753097",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 17263,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1334,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 4112,
            "questionIndex": 4112,
            "questionText": "<p>A 64-year-old man undergoes an emergency colonic resection for extensive ischemic colitis.&nbsp; He lives alone and consumes large amounts of alcohol.&nbsp; His family history is noncontributory.&nbsp; The patient is extubated on the 4th postoperative day.&nbsp; After extubation, he has episodes of confusion and agitation treated with lorazepam and haloperidol.&nbsp; He is also receiving piperacillin with tazobactam.&nbsp; The patient has had nothing by mouth since the surgery.&nbsp; On postoperative day 7, the nurse notices bleeding from a venipuncture site.&nbsp; His temperature is 36.7 C (98 F), blood pressure is 121/76 mm Hg, pulse is 80/min, and respirations are 16/min.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"425\"><tbody><tr><td>Hemoglobin</td><td>11.5 g/dL</td></tr><tr><td>Mean corpuscular volume</td><td>88 fL</td></tr><tr><td>Platelets</td><td>160,000/&micro;L</td></tr><tr><td>Leukocytes</td><td>7,500/&micro;L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Segmented neutrophils</td><td>68%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bands</td><td>1%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Eosinophils</td><td>1%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td>24%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td>6%</td></tr><tr><td>Prothrombin time</td><td>24 sec (INR 2.2)</td></tr><tr><td>Partial thromboplastin time</td><td>44 sec (normal 25-40)</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s clinical presentation suggests an acquired bleeding disorder, most likely due to <strong>vitamin K deficiency</strong>.&nbsp; Vitamin K is a fat-soluble vitamin that plays an important role in hemostasis by serving as a cofactor in the enzymatic carboxylation of glutamic acid residues on prothrombin complex proteins.&nbsp; The body obtains vitamin K exogenously from intestinal absorption of dietary Vitamin K and endogenously from bacterial production of vitamin K in the intestine.&nbsp; Vitamin K deficiency is most commonly due to inadequate dietary intake, intestinal malabsorption, or hepatocellular disease causing loss of storage sites.&nbsp; The liver can normally store a 30-day supply of vitamin K, but an acutely ill person with underlying liver disease can become vitamin K deficient in as little as 7-10 days.</p><p>This patient received no enteral nutrition postoperatively and was given a broad-spectrum antibiotic, and so both natural sources of vitamin K were compromised.&nbsp; In addition, he also likely has alcoholic liver disease, further limiting his vitamin K stores.&nbsp; Vitamin K deficiency decreases plasma levels of all the prothrombin complex proteins (factors 2, 7, 9, 10, and protein C and S).&nbsp; This initially increases the prothrombin time (PT), followed by prolongation of the partial thromboplastin time (PTT).&nbsp; Administration of vitamin K rapidly replenishes the stores in 8-10 hours, and fresh frozen plasma may be used for the management of acute hemorrhage in the interim.</p><p><strong>(Choice A)</strong>&nbsp; Disseminated intravascular coagulation causes depletion of clotting factors and secondary fibrinolysis.&nbsp; This causes bleeding, acute kidney and liver injury, hypotension, and tachycardia.&nbsp; Testing shows thrombocytopenia, prolonged PT and PTT, decreased fibrinogen, and schistocytes on peripheral smear.&nbsp; Although this patient&#39;s PT and PTT are prolonged, he is hemodynamically stable and has a normal platelet count.</p><p><strong>(Choices B and E)</strong>&nbsp; Lupus anticoagulant (LAC) is an antiphospholipid antibody that prolongs the PTT during diagnostic testing.&nbsp; However, patients with LAC are actually hypercoagulable with increased risk for venous thrombosis.&nbsp; Factor V Leiden causes a hypercoagulable state due to activated protein C resistance.&nbsp; This patient&#39;s increased bleeding makes these unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Factor VIII deficiency is an X-linked inherited plasma coagulation disorder that primarily prolongs the PTT.&nbsp; It would usually be apparent earlier in life.</p><p><strong>(Choice D)</strong>&nbsp; Hypersplenism can occur in patients with cirrhosis, portal hypertension, and splenomegaly.&nbsp; Splenic sequestration leads to thrombocytopenia, and patients rarely develop clinical bleeding or prolonged PT/PTT.</p><p><strong>(Choice F)</strong>&nbsp; Thrombotic thrombocytopenic purpura is a rare form of consumptive thrombocytopenia caused by widespread platelet thrombi that form in the microcirculation.&nbsp; It typically presents with thrombocytopenia, microangiopathic hemolytic anemia, fever, and neurologic findings (eg, altered mental status).</p><p><strong>(Choice H)</strong>&nbsp; von Willebrand disease is the most frequently diagnosed inherited bleeding disorder in adults.&nbsp; Laboratory testing usually shows increased bleeding time and PTT.&nbsp; However, the PT will be normal.</p><p><strong>Educational objective:</strong><br>Vitamin K deficiency is usually due to inadequate dietary intake, intestinal malabsorption, or hepatocellular disease.&nbsp; An acutely ill patient with underlying liver disease can become vitamin K deficient in 7-10 days.&nbsp; Laboratory studies usually show prolonged prothrombin time followed by prolonged partial thromboplastin time.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9108,
            "topic": "Vitamin k deficiency",
            "titleId": 9108,
            "title": "Vitamin k deficiency",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "7",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute disseminated intravascular coagulation",
                    "choiceNumber": 1,
                    "correctTaken": 33606,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factor V Leiden",
                    "choiceNumber": 2,
                    "correctTaken": 2492,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factor VIII deficiency",
                    "choiceNumber": 3,
                    "correctTaken": 2500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypersplenism",
                    "choiceNumber": 4,
                    "correctTaken": 752,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lupus anticoagulant",
                    "choiceNumber": 5,
                    "correctTaken": 420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thrombotic thrombocytopenic purpura",
                    "choiceNumber": 6,
                    "correctTaken": 2500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin K deficiency",
                    "choiceNumber": 7,
                    "correctTaken": 67654,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "von Willebrand disease",
                    "choiceNumber": 8,
                    "correctTaken": 2843,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "238,341,true,-1,1*658,832,true,-1,1*1343,1506,true,-1,1*1519,1935,true,-1,1*1953,2305,true,-1,1*3111,3209,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 278,
            "othersAvgTimeSpent": 87,
            "notes": null,
            "peopleTaken": 112767,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1389,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 11309,
            "questionIndex": 12461,
            "questionText": "<p>A 22-year-old woman comes to the emergency department due to continuous gum bleeding after a mouth injury a few hours ago.&nbsp; She was playing doubles tennis and was accidentally struck on her bottom lip by her partner&#39;s racquet.&nbsp; The patient has a history of bruising with minor trauma and of heavy menstruation with crampy pain.&nbsp; She has no other medical conditions and takes no medications other than occasional ibuprofen.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs; she eats a balanced diet.&nbsp; Her mother also had a history of &#x22;bleeding issues.&#x22;&nbsp; Blood pressure is 120/70 mm Hg and pulse is 80/min.&nbsp; Oropharyngeal examination shows blood oozing from a gum abrasion.&nbsp; A fading ecchymosis is present on the right calf, but there are no other skin abnormalities.&nbsp; The remainder of the physical examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">10.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td style=\"vertical-align:middle;\">76 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">150,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Coagulation studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;PT</td><td style=\"vertical-align:middle;\">12 sec</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;INR</td><td style=\"vertical-align:middle;\">1</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Activated PTT</td><td style=\"vertical-align:middle;\">44 sec</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s bleeding problem?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2707\" src=\"https://www.uworld.com/media/L23798.png\" ></p><p><strong>Von Willebrand disease</strong> (vWD) is the most common inherited bleeding disorder and is typically transmitted in an autosomal dominant fashion.&nbsp; Therefore, a family history of prolonged bleeding is an important diagnostic clue.&nbsp; Most patients are asymptomatic, but a minority (~1%) have easy bruising, skin bleeding, and mucosal bleeding (eg, menstruation), which can occasionally result in iron deficiency (microcytic anemia) due to chronic blood loss.</p><p>VWD is associated with impaired quantity/activity of <strong>von Willebrand factor</strong> (vWF), a glycoprotein produced by endothelial cells and platelets.&nbsp; VWF&nbsp;contributes to hemostasis by:</p><ol type=\"1\"><li><p>Binding platelets to subendothelial components at the site of vascular injury and aggregating platelets to each other, leading to the formation of a platelet plug.&nbsp; Therefore, patients with vWD have impaired <strong>platelet-endothelial binding</strong> and platelet aggregation, which prolongs bleeding times.</p></li><li><p>Acting as a carrier protein for factor VIII, which is part of the <a href=\"466\">intrinsic (contact activation) coagulation cascade</a> and contributes to fibrin clot formation.&nbsp; Because factor VIII degrades rapidly when not bound to vWF, patients with vWD generally have low factor VIII levels, which may <strong>prolong activated PTT</strong>.&nbsp; In contrast, <strong>PT is normal</strong> because the extrinsic coagulation pathway is unaffected.</p></li></ol><p><strong>(Choice A)</strong>&nbsp; Disseminated intravascular coagulation is marked by abnormal activation of coagulation and fibrinolysis, leading to thrombocytopenia and prolonged PT/PTT.&nbsp; It is triggered primarily by malignancy, infection, trauma, or obstetric complication.</p><p><strong>(Choice B) </strong> Hemophilia A, an X-linked recessive disorder that dramatically reduces factor VIII production, usually causes severe bleeding episodes (eg, soft tissue bleeding, hemarthrosis).&nbsp; VWD does not reduce factor VIII production (it increases factor VIII destruction).</p><p><strong>(Choice C)</strong>&nbsp; Factor VIII inhibitors are antibodies that prevent factor VIII function; they usually form due to medications, autoimmune disease, malignancy, or pregnancy (postpartum period).&nbsp; Factor VIII inhibitors are much less common than vWD and are not generally associated with a family history of bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Immune thrombocytopenia is associated with the autoimmune-mediated platelet destruction, leading to easy bleeding, petechiae, purpura, or epistaxis; laboratory examination reveals thrombocytopenia and normal PT/PTT.</p><p><strong>(Choice F)</strong>&nbsp; Vitamin K is a coenzyme necessary for the carboxylation of factors II, VII, IX, and X.&nbsp; Vitamin K deficiency/antagonists (eg, warfarin) prolong INR/PT, leading to increased bleeding risk.&nbsp; This patient&#39;s INR and PT are normal.</p><p><strong>Educational objective:</strong><br>Von Willebrand disease is a genetic disorder associated with impaired activity/quantity of von Willebrand factor, leading to poor platelet-endothelial binding and reduced factor VIII levels.&nbsp; Patients are usually asymptomatic but may have prolonged mucocutaneous bleeding, easy bruising, and prolonged PTT.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9145,
            "topic": "Von willebrand disease",
            "titleId": 9145,
            "title": "Von willebrand disease",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abnormal activation of coagulation and fibrinolysis",
                    "choiceNumber": 1,
                    "correctTaken": 395,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased factor VIII production",
                    "choiceNumber": 2,
                    "correctTaken": 4660,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factor VIII inhibitor production",
                    "choiceNumber": 3,
                    "correctTaken": 962,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immune-mediated platelet destruction",
                    "choiceNumber": 4,
                    "correctTaken": 344,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired platelet-endothelial binding",
                    "choiceNumber": 5,
                    "correctTaken": 9054,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduced gamma-carboxylation of vitamin K&ndash;dependent clotting factors",
                    "choiceNumber": 6,
                    "correctTaken": 425,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "313,385,true,-1,1*533,624,true,-1,1*1113,1264,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "255",
                    "mediaDataId": 0,
                    "title": "von Willebrand disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25712990",
                    "mediaDataId": 0,
                    "title": "Diagnostic approach to von Willebrand disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25712990",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 159,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 15840,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 924,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 3896,
            "questionIndex": 3896,
            "questionText": "<p>A 3-year-old boy is brought to the clinic by his father due to fatigue and pallor.&nbsp; The patient was seen in another clinic a week ago for abdominal pain and diarrhea.&nbsp; A medication was prescribed to help slow the diarrhea, which resolved, but the patient has been much less playful over the last day.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 110/70 mm Hg, pulse is 120/min, and respirations are 20/min.&nbsp; Physical examination shows an uncomfortable-appearing child with scleral icterus. &nbsp;Cardiac examination shows mild tachycardia with no murmurs. &nbsp;A few ecchymoses are noted along the upper and lower extremities.&nbsp; There is pitting edema along bilateral lower extremities to the knees.&nbsp; The remainder of the examination is unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">7.8 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td style=\"vertical-align:middle;\">84 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">40,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">13,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Coagulation studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;PT</td><td style=\"vertical-align:middle;\">12 sec</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;PTT</td><td style=\"vertical-align:middle;\">35 sec</td></tr></tbody></table><p>Peripheral blood smear results are shown in the image below:</p><p><img  draggable=\"false\" id=\"21799\" src=\"https://www.uworld.com/media/U17966.jpg\"  ></p><p>Which of the following is the most likely mechanism of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36652\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hemolytic uremic syndrome </strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis </strong></p></td><td><ul><li><em>E<em>scherichia</em> coli </em>serotype O157:H7 or <em>Shigella dysenteriae</em></li><li>Vascular damage &amp; microthrombi formation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features </strong></p></td><td><ul><li>Preceding bloody diarrhea</li><li>Fatigue, pallor</li><li>Bruising, petechiae</li><li>Oliguria, edema</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings </strong></p></td><td><ul><li>Hemolytic anemia (schistocytes, &#8593; bilirubin)</li><li>Thrombocytopenia</li><li>Acute kidney injury (&#8593; BUN, &#8593; creatinine)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Fluid &amp; electrolyte management</li><li>Blood transfusions</li><li>Dialysis</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>BUN</strong> = blood urea nitrogen.</p></td></tr></tbody></table></div><p>This patient has normocytic anemia, <strong>thrombocytopenia</strong>, and edema following a diarrheal illness, findings that are suggestive of <strong>hemolytic uremic syndrome</strong> (HUS).&nbsp; HUS most commonly occurs 5-10 days after an acute, often <strong>bloody</strong>, <strong>diarrheal</strong> illness caused by a Shiga toxin-producing strain of <em>Escherichia coli</em> (serotype O157:H7).</p><p>The Shiga toxin induces endothelial damage in renal glomeruli, leading to platelet activation, microthrombi formation, and <strong>microangiopathic hemolytic anemia</strong>.&nbsp; The mechanical <strong>intravascular shearing of red blood cells</strong> (RBCs) can result in jaundice or scleral icterus (from elevated indirect bilirubin) as well as <a href=\"21800\">schistocytes</a> (ie, fragmented RBCs) on peripheral smear, as seen in this patient.&nbsp; Patients may also have signs of thrombocytopenia (eg, bruising) and <strong>acute kidney injury</strong> (eg, edema, elevated blood urea nitrogen and creatinine).</p><p>Treatment of HUS is supportive and includes fluid and electrolyte management, blood transfusions, and dialysis.&nbsp; Treatment of the prodromal diarrhea with antibiotics or antimotility agents (eg, loperamide), as in this case, can increase the risk of developing HUS and is not recommended.</p><p><strong>(Choice A)</strong>&nbsp; Autoimmune hemolytic anemia results from antibody-mediated destruction of RBCs and usually presents after a respiratory illness or in the setting of systemic disease (eg, systemic lupus erythematosus).&nbsp; The platelet count is typically normal, and <a href=\"5764\">spherocytes</a> are seen on peripheral smear.</p><p><strong>(Choice B)</strong>&nbsp; Erythropoietin, a hormone produced by the kidneys and involved in RBC maturation, is decreased in patients with chronic kidney disease.&nbsp; This patient&#39;s illness is acute, with scleral icterus indicative of hemolytic anemia.&nbsp; <a href=\"942\">Burr cells (echinocytes)</a> would be seen on peripheral smear.</p><p><strong>(Choice C)</strong>&nbsp; Sickle cell anemia is a hemolytic anemia due to a missense mutation in the beta globin gene.&nbsp; Most patients have painful vasoocclusive crises in early childhood, and peripheral smear demonstrates <a href=\"2699\">sickled RBCs</a>.</p><p><strong>(Choice D)</strong>&nbsp; Deficiency of glucose-6-phosphate dehydrogenase, an enzyme that protects cells against oxidative damage, results in hemolysis after exposure to oxidative stress (eg, fava beans, sulfa drugs, infection).&nbsp; Thrombocytopenia is not associated with this condition, and <a href=\"5103\">bite cells</a> are present on peripheral smear.</p><p><strong>(Choice F)</strong>&nbsp; Disseminated intravascular coagulation results from systemic activation of the coagulation system due to an underlying disorder (eg, sepsis, trauma).&nbsp; It not only presents with thrombocytopenia and anemia but also with prolonged PT and activated PTT, not seen in this patient.</p><p><strong>Educational objective:</strong><br>Hemolytic uremic syndrome typically occurs in children who have recently recovered from a diarrheal illness and who have acute renal injury, thrombocytopenia, and microangiopathic hemolytic anemia with schistocytes on peripheral smear.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 4633,
            "topic": "Hemolytic uremic syndrome",
            "titleId": 4633,
            "title": "Hemolytic uremic syndrome",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoimmune-mediated erythrocyte hemolysis",
                    "choiceNumber": 1,
                    "correctTaken": 1636,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Erythropoietin deficiency due to kidney disease",
                    "choiceNumber": 2,
                    "correctTaken": 81,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital sickle cell disease",
                    "choiceNumber": 3,
                    "correctTaken": 851,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose-6-phosphate dehydrogenase deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 2749,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Microangiopathic hemolytic anemia",
                    "choiceNumber": 5,
                    "correctTaken": 10645,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic disseminated intravascular coagulation",
                    "choiceNumber": 6,
                    "correctTaken": 510,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "71,169,true,-1,1*649,813,true,-1,1*814,970,true,-1,1*1274,1352,true,-1,1*1464,1640,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28242109",
                    "mediaDataId": 0,
                    "title": "Haemolytic uraemic syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28242109",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 153,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16472,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 547,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 4736,
            "questionIndex": 4736,
            "questionText": "<p>A 42-year-old mildly overweight man is being evaluated for his second episode of deep vein thrombosis in 2 years.&nbsp; Both episodes appear to have been unprovoked.&nbsp; He has no recent prolonged immobility, long-distance travel, or lower-extremity trauma.&nbsp; The patient has no past medical history of diabetes, cancer, or liver disease.&nbsp; A thrombophilia workup is ordered.&nbsp; Use of which of the following drugs is most likely to lead to low protein S levels?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"672\"  src=\"https://www.uworld.com/media/L4326.jpg\" draggable=\"false\" ></p><p>Warfarin is a coumarin anticoagulant most commonly used in the setting of thrombophilia and cardiac conditions that predispose to intracardiac thrombus formation.&nbsp; Warfarin functions by inhibiting synthesis of the vitamin K-dependent clotting factors II, VII, IX, and X, as well as the vitamin K-dependent anticoagulant proteins C and S.&nbsp; As a result, it can cause a decrease in measured levels of protein S.&nbsp; This may lead to an incorrect diagnosis of inherited protein S deficiency.&nbsp; If possible, vitamin K antagonists such as warfarin should be discontinued for 2 weeks prior to evaluating protein S levels.</p><p><strong>(Choice A)</strong>&nbsp; Aspirin is an antiplatelet agent that inhibits cyclooxygenase-1, thereby inhibiting thromboxane A<font size=\"2\"><sub>2</sub></font> synthesis.</p><p><strong>(Choice B)</strong>&nbsp; Clopidogrel is an antiplatelet agent that prevents platelet activation by blocking adenosine diphosphate receptors on the surface of platelets.</p><p><strong>(Choice C)</strong>&nbsp; Heparin activates antithrombin III, which in turn inactivates factor IIa (thrombin), factor IXa, and factor Xa.</p><p><strong>(Choice D)</strong>&nbsp; Simvastatin is a lipid-lowering agent that functions by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme reductase.</p><p><strong>Educational objective:</strong><br>Warfarin is an anticoagulant agent that functions by inhibiting the synthesis of vitamin K-dependent factors II, VII, IX, and X, protein C, and protein S.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 23470,
            "topic": "Anticoagulants",
            "titleId": 23470,
            "title": "Anticoagulants",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aspirin",
                    "choiceNumber": 1,
                    "correctTaken": 1071,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clopidogrel",
                    "choiceNumber": 2,
                    "correctTaken": 2257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Heparin",
                    "choiceNumber": 3,
                    "correctTaken": 5646,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Simvastatin",
                    "choiceNumber": 4,
                    "correctTaken": 2594,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Warfarin",
                    "choiceNumber": 5,
                    "correctTaken": 109627,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "32,40,true,-1,1*386,642,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23480842",
                    "mediaDataId": 0,
                    "title": "Pitfalls in special coagulation testing: three illustrative case studies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23480842",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21523802",
                    "mediaDataId": 0,
                    "title": "Protein S abnormalities: a diagnostic nightmare.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21523802",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 56,
            "othersAvgTimeSpent": 28,
            "notes": null,
            "peopleTaken": 121195,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 90,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 749,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 4412,
            "questionIndex": 4412,
            "questionText": "<p>A 32-year-old woman comes to the emergency department due to chest pain and shortness of breath that woke her up this morning.&nbsp; The chest pain is sharp and worsens with inspiration.&nbsp; The patient has had no fever or cough but has had worsening right leg swelling over the past several days.&nbsp; Review of systems is positive for myalgias, joint pains, and facial rash brought on by sun exposure.&nbsp; Medical history includes 2 miscarriages at 12 and 16 weeks gestation.&nbsp; She takes no medications and does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 152/86 mm Hg, pulse is 98/min, and oxygen saturation is 95% on room air.&nbsp; Physical examination shows clear lungs, normal heart sounds, and no abdominal organomegaly.&nbsp; The right lower extremity is swollen and tender to touch.&nbsp; CT angiography of the chest reveals pulmonary emboli.&nbsp; Which of the following additional laboratory findings is most likely to be present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35373\"><table class=\"table-default-style\" style=\"width:510px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Diagnostic criteria for antiphospholipid-antibody syndrome</strong><br />(1 clinical &amp; 1 laboratory criterion must be met)</p></td></tr><tr><td><p align=\"center\"><strong>Clinical</strong></p></td><td><p><strong>Vascular thrombosis</strong></p><ul><li>Arterial or venous</li></ul><p><strong>Pregnancy morbidity</strong></p><ul><li>&ge;3 consecutive, unexplained fetal losses before 10th week</li><li>&ge;1 unexplained fetal losses after 10th week</li><li>&ge;1 premature births of normal neonates before 34th week due to preeclampsia, eclampsia, or placental insufficiency</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory</strong></p></td><td><ul><li>Lupus anticoagulant</li><li>Anticardiolipin antibody</li><li>Anti&ndash;&beta;2-glycoprotein I antibody</li></ul></td></tr></tbody></table></div><p>This patient has pulmonary emboli due to a right lower extremity <strong>deep venous thrombosis</strong> (DVT).&nbsp; Although risk of DVT is increased in several inherited and acquired conditions, this patient&#39;s history of fetal loss and signs of <strong>systemic lupus erythematosus</strong> (eg, myalgias, arthralgias, photosensitivity) suggest <strong>antiphospholipid-antibody syndrome</strong> (APS).</p><p>APS is characterized by the following:</p><ul><li>Venous, arterial, or small vessel <strong>thromboembolic disease</strong> and/or pregnancy complications such as <strong>fetal loss</strong></li><li>Laboratory evidence of an antiphospholipid antibody in the serum: lupus anticoagulant (LA), anticardiolipin antibody, and/or beta2-glycoprotein-I antibody</li></ul><p>Patients with antiphospholipid antibodies (particularly LA) generally have <strong>prolonged PTT</strong> because antiphospholipid antibodies bind the phospholipids used in most testing assays and prevent them from inducing coagulation.&nbsp; This laboratory artifact will not be fixed by a 1:1 mixing with normal plasma (unlike coagulation factor deficiency).&nbsp; However, adding phospholipids to the testing assay will eventually overcome the presence of the inhibitor and normalize the PTT.&nbsp; This is an indirect way of identifying LA antibodies; it is usually combined with other tests, such as the diluted Russell viper venom test or the kaolin clotting time test for diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; Patients with rheumatologic disease can develop autoantibodies to von Willebrand factor, leading to acquired von Willebrand disease (vWD).&nbsp; Acquired vWD is generally marked by easy bruising and mucosal bleeding (eg, epistaxis, gum bleeding, heavy menses), but fetal loss and thrombosis would be atypical.</p><p><strong>(Choice B)</strong>&nbsp; D-dimer is a product of cross-linked fibrin degradation.&nbsp; Therefore, almost all patients (&gt;95%) with ongoing thrombosis have elevated D-dimer levels.&nbsp; Low D-dimer would be highly unusual in the setting of pulmonary emboli and deep vein thrombosis.</p><p><strong>(Choice C)</strong>&nbsp; Factor V Leiden mutation is an altered form of coagulation factor V that renders it resistant to the anticoagulant effects of activated protein C.&nbsp; Risk of thromboembolism and fetal loss is significantly increased, but factor V Leiden mutation is not linked with systemic lupus erythematosus and would not explain this patient&#39;s arthralgias, myalgias, and photosensitivity.</p><p><strong>(Choice D)</strong>&nbsp; <em>JAK2</em> mutation is present in most cases of polycythemia vera, which is associated with increased risk of thromboembolism.&nbsp; However, most cases occur in older individuals; in addition, it would not explain photosensitivity, myalgias, or arthralgias.</p><p><strong>Educational objective:</strong><br>Antiphospholipid-antibody syndrome is common in patients with systemic lupus erythematosus.&nbsp; It generally presents with thromboembolism and/or recurrent fetal loss.&nbsp; Positive testing for lupus anticoagulant (LA), anticardiolipin antibody, and/or beta2-glycoprotein-I antibody is diagnostic.&nbsp; Those with LA have prolonged PTT that does not improve with 1:1 dilution with normal serum (mixing test).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15843,
            "topic": "Antiphospholipid syndrome",
            "titleId": 15843,
            "title": "Antiphospholipid syndrome",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Absent von Willebrand factor",
                    "choiceNumber": 1,
                    "correctTaken": 163,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased D-dimer level",
                    "choiceNumber": 2,
                    "correctTaken": 546,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Positive factor V Leiden mutation",
                    "choiceNumber": 3,
                    "correctTaken": 5017,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Presence of <em>JAK2</em> mutation",
                    "choiceNumber": 4,
                    "correctTaken": 1347,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prolonged PTT",
                    "choiceNumber": 5,
                    "correctTaken": 8604,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1164,1500,true,-1,1*1503,1633,true,-1,1*207,423,true,-1,1*1833,1970,true,-1,1*2410,2557,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22160568",
                    "mediaDataId": 0,
                    "title": "Drug-induced lupus anticoagulants and antiphospholipid antibodies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22160568",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 15677,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 922,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 3438,
            "questionIndex": 3438,
            "questionText": "<p>A 6-year-old boy is brought to the office due to pallor and decreased energy.&nbsp; For the past 2 days, the patient has been less active, uninterested in playing, and sleeping throughout the day.&nbsp; On review of systems, the parents note that he developed a fever, emesis, and diarrhea 10 days ago, but his symptoms resolved without intervention after a few days.&nbsp; His older sister had a sore throat a few days ago, but no other family members have been ill.&nbsp; The patient has no chronic medical conditions.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 120/70 mm Hg, and pulse is 145/min.&nbsp; Physical examination shows a tired-appearing boy with pale lips.&nbsp; A grade 2/6 systolic murmur is present.&nbsp; The lungs are clear to auscultation.&nbsp; The abdomen is soft, nontender, and nondistended.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">8.4 g/dL</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">30,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">15,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">32 mg/dL</td></tr><tr><td style=\"padding-left: 2em; vertical-align: middle;\">Creatinine</td><td>2.4 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of kidney injury in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"46426\" src=\"https://www.uworld.com/media/L72950.png\" ></p><p>This patient&#39;s prodromal diarrheal illness, followed by anemia (likely hemolytic), thrombocytopenia, and acute kidney injury (AKI), is consistent with <strong>hemolytic uremic syndrome</strong> (HUS).&nbsp; HUS is typically seen in children and usually occurs due to <strong>Shiga toxin</strong>&ndash;producing diarrheagenic pathogens such as <em>Escherichia coli</em> O157:H7 or, less commonly, <em>Shigella</em>.&nbsp; The production and systemic circulation of the Shiga toxin cause injury to small blood vessel endothelium, leading to a <strong>thrombotic microangiopathy</strong> and resultant:</p><ul><li><p><strong>renal vascular occlusion</strong> (eg, afferent arteriole, glomerular capillaries) by microthrombi; this blockage increases pressure within glomerular capillaries, leading to <strong>intrinsic acute kidney injury</strong> (eg, BUN/creatinine ratio of &lt;20:1, oliguria, hypertension, hematuria, proteinuria).</p></li><li><p>platelet consumption within microthrombi, resulting in <strong>thrombocytopenia</strong>.</p></li><li><p>red blood cell (RBC) destruction due to physical RBC shearing from passage through blood vessels occluded by systemic microthrombi, resulting in a <strong>hemolytic anemia</strong> (eg, fatigue, pallor).</p></li></ul><p>Treatment of HUS is supportive (eg, fluid management, transfusions) because most children (60%-70%) recover completely.</p><p><strong>(Choice A)</strong>&nbsp; This patient&#39;s murmur and tachycardia could be indications of heart failure, possibly related to recent illness (eg, viral myocarditis, bacterial endocarditis), and decreased cardiac function can cause tubular injury from prolonged renal ischemia.&nbsp; However, this patient&#39;s acute anemia, thrombocytopenia, and AKI are most consistent with HUS, and his systolic flow murmur is likely due to severe anemia.</p><p><strong>(Choice B)</strong>&nbsp; Although IgA vasculitis (Henoch-Schonlein purpura), a disease of the renal vasculature, can cause abdominal pain and AKI, patients typically have associated purpura (&gt;75%) and joint pain (&gt;80%); thrombocytopenia is unusual.</p><p><strong>(Choice C)</strong>&nbsp; Poststreptococcal glomerulonephritis is a common cause of intrinsic renal injury in children but typically presents several weeks after group A streptococcal pharyngitis or impetigo with edema, hypertension, and hematuria.&nbsp; Anemia and thrombocytopenia are uncommon.</p><p><strong>(Choice E)</strong>&nbsp; Acute renal vasoconstriction typically presents with prerenal AKI, which can occur in children who take nonsteroidal anti-inflammatory drugs during periods of hypovolemia (eg, gastroenteritis).&nbsp; However, patients typically have a normal complete blood count and a BUN/creatinine ratio of &gt;20:1, making this diagnosis less likely.</p><p><strong>Educational objective:</strong><br>Hemolytic uremic syndrome (HUS) is characterized by the triad of hemolytic anemia, thrombocytopenia, and acute kidney injury (typically following a prodromal diarrheal illness caused by <em>Escherichia coli</em> O157:H7).&nbsp; The mechanism of intrinsic renal injury in HUS is renal vascular occlusion caused by capillary microthrombi.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 4633,
            "topic": "Hemolytic uremic syndrome",
            "titleId": 4633,
            "title": "Hemolytic uremic syndrome",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased cardiac function",
                    "choiceNumber": 1,
                    "correctTaken": 440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "IgA vasculitis",
                    "choiceNumber": 2,
                    "correctTaken": 3611,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Poststreptococcal glomerulonephritis",
                    "choiceNumber": 3,
                    "correctTaken": 3883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal vascular occlusion",
                    "choiceNumber": 4,
                    "correctTaken": 6782,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal vasoconstriction",
                    "choiceNumber": 5,
                    "correctTaken": 1657,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2152,2482,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "665",
                    "mediaDataId": 0,
                    "title": "Thrombotic microangiopathies: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24237985",
                    "mediaDataId": 0,
                    "title": "HUS and TTP in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24237985",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23202315",
                    "mediaDataId": 0,
                    "title": "Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23202315",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 149,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 16373,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 554,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 2251,
            "questionIndex": 2251,
            "questionText": "<p>A 25-year-old woman comes to the office due to heavy menses.&nbsp; Over the past few months, the patient&#39;s menstrual periods have lasted 7 days rather than the usual 3 days.&nbsp; In addition, her menstruation has been unusually heavy and has, at times, bled through her clothing while at work.&nbsp; The patient is an active volleyball player but has not been able to play recently due to increasing fatigue; frequent, diffuse myalgias; and bilateral pain in her wrists that requires icing after practice.&nbsp; She has also noticed that her forearms become easily bruised in areas where the ball hits.&nbsp; The patient takes no medications and does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 116/76 mm Hg, pulse is 76/min, and respirations are 16/min.&nbsp; There are scattered petechiae across the body with a few large ecchymoses on the forearms.&nbsp; The remainder of the physical examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; &nbsp; Hematocrit</td><td style=\"vertical-align:middle;\">37%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; &nbsp; Platelets</td><td style=\"vertical-align:middle;\">24,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; &nbsp; Leukocytes</td><td style=\"vertical-align:middle;\">11,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Coagulation studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; &nbsp; PT</td><td style=\"vertical-align:middle;\">12 sec</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; &nbsp; Activated PTT</td><td style=\"vertical-align:middle;\">38 sec</td></tr></tbody></table><p>Peripheral blood smear shows normal and large platelets.&nbsp; Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31852\"><table class=\"table-default-style table-header-footer-style\" style=\"width:91.42%\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%;\"><p align=\"center\"><strong>Immune thrombocytopenic purpura</strong></p></td></tr><tr><td style=\"width:16.32%;\"><p align=\"center\"><strong>Epidemiology</strong></p></td><td style=\"width:83.68%;\"><ul><li>Commonly acquired form of thrombocytopenia</li><li>Autoantibody formation</li><li>Often recent viral infection or comorbidity (eg, HIV, HCV, CLL)</li></ul></td></tr><tr><td style=\"width:16.32%;\"><p align=\"center\"><strong>Manifestations</strong></p></td><td style=\"width:83.68%;\"><ul><li>Frequently asymptomatic</li><li>Mucocutaneous bleeding (eg, menorrhagia, epistaxis)</li><li>Ecchymoses, petechiae, purpura</li><li>Severe hemorrhage is rare</li></ul></td></tr><tr><td style=\"width:16.32%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:83.68%;\"><ul><li>Diagnosis of exclusion</li><li>Normal coagulation tests, platelet morphology (peripheral smear)</li><li>HIV, HCV testing (commonly induces ITP)</li></ul></td></tr><tr><td style=\"width:16.32%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width:83.68%;\"><ul><li>Observation if no bleeding &amp; platelets &gt;30,000/mm<sup>3</sup></li><li>Corticosteroids if platelets &lt;30,000/mm<sup>3</sup></li><li>IVIG &amp; platelet transfusion if hemorrhage</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:100.0%;\"><p><strong>CLL</strong>&nbsp;=&nbsp;chronic lymphocytic leukemia; <strong>HCV</strong>&nbsp;=&nbsp;hepatitis C virus; <strong>ITP</strong>&nbsp;=&nbsp;immune thrombocytopenic purpura; <strong>IVIG</strong>&nbsp;=&nbsp;intravenous immunoglobulin.</p></td></tr></tbody></table></div><p><strong>Immune thrombocytopenia</strong> (ITP) is an acquired disorder marked by the formation of autoantibodies to platelet surface glycoproteins, which increases platelet clearance in the spleen and inhibits megakaryocytosis.&nbsp; In ITP, platelet counts fall to <strong>&lt;100,000/mm</strong><font size=\"2\"><sup><strong>3</strong></sup></font>, leading to prolonged skin/mucosal bleeding (eg, menstrual, nasal), ecchymosis, and petechiae.</p><p>ITP is a <strong>diagnosis of exclusion</strong>; therefore, other causes of thrombocytopenia (eg, drug-induced thrombocytopenia, liver disease, hypersplenism, microangiopathic disorders, bone marrow abnormalities) must be ruled out.&nbsp; In ITP, leukocyte count, erythrocyte count, and <strong>coagulation studies are normal</strong>; peripheral blood smear usually shows normal platelet morphology (both normal-sized and&nbsp;<a href=\"19935\">large platelets</a>&nbsp;may be seen&nbsp;due to increased platelet turnover).</p><p>ITP is categorized as either primary (no discernible cause) or secondary (due to an underlying condition).&nbsp; HIV and hepatitis C are the most common secondary causes, so testing for these 2 conditions is generally performed.&nbsp; Additional testing is warranted when specific signs or symptoms of another disorder are present.&nbsp; This patient&#39;s myalgias and arthralgias raise concern for an autoimmune disease (eg, systemic lupus erythematosus); therefore, <strong>antinuclear antibody testing</strong> is advisable.</p><p><strong>(Choice B)</strong>&nbsp; Ascorbic acid (vitamin C) deficiency causes impaired collagen synthesis and can lead to ecchymosis and palpable purpura.&nbsp; However, most cases occur in severely malnourished individuals or those who use alcohol or illicit drugs.</p><p><strong>(Choice C)</strong>&nbsp; Factor VIII deficiency can cause similar bleeding symptoms but is associated with prolonged PTT.&nbsp; Hemophilia A, an X-linked disorder (seen only in males), causes severe factor VIII deficiency.</p><p><strong>(Choice D)</strong>&nbsp; Hemoglobin electrophoresis is used to diagnose thalassemia, a genetic hemoglobin disorder associated with anemia, microcytosis, and target cells.&nbsp; Hemoglobin disorders do not usually cause thrombocytopenia.</p><p><strong>(Choice E)</strong>&nbsp; Platelet aggregation testing evaluates for rare disorders of platelet function and is generally indicated in those who have normal platelet count and prolonged bleeding times.&nbsp; This patient&#39;s thrombocytopenia makes ITP far more likely; platelet aggregation testing would not be indicated.</p><p><strong>(Choice F)</strong>&nbsp; Von Willebrand disease (vWD) is associated with impaired platelet aggregation, which occasionally causes bruising and prolonged mucosal bleeding.&nbsp; However, platelet count and PT are normal; PTT is sometimes prolonged&nbsp;due to increased destruction of factor VIII.</p><p><strong>Educational objective:</strong><br>Immune thrombocytopenia (ITP) is an autoimmune disorder associated with isolated thrombocytopenia.&nbsp; Although most cases are primary, a minority of individuals have ITP due to an underlying condition (eg, HIV, hepatitis C).&nbsp; Testing for HIV and hepatitis C virus is recommended for all patients with ITP; additional testing is needed when signs and symptoms of other disorders (eg, systemic lupus erythematosus) are present.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16575,
            "topic": "ITP",
            "titleId": 16575,
            "title": "ITP",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody screen",
                    "choiceNumber": 1,
                    "correctTaken": 5182,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ascorbic acid level test",
                    "choiceNumber": 2,
                    "correctTaken": 472,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factor VIII assay",
                    "choiceNumber": 3,
                    "correctTaken": 484,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 4,
                    "correctTaken": 219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Platelet aggregation test",
                    "choiceNumber": 5,
                    "correctTaken": 5809,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Von Willebrand antigen level test",
                    "choiceNumber": 6,
                    "correctTaken": 3591,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "141,204,true,-1,1*451,490,true,-1,1*501,634,true,-1,1*2740,3029,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28416506",
                    "mediaDataId": 0,
                    "title": "Clinical updates in adult immune thrombocytopenia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28416506",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 15757,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 33,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 553,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 3440,
            "questionIndex": 3440,
            "questionText": "<p>A 4-year-old boy is brought to the office for evaluation of a rash.&nbsp; His mother states that &#x22;pinpoint&#x22; bruises have appeared all over his body during the past 24 hours.&nbsp; The patient has had no bleeding or recent trauma.&nbsp; Three weeks ago, he had an upper respiratory tract infection that resolved uneventfully.&nbsp; The patient takes no medications, he has no allergies, and his immunizations are up to date.&nbsp; There is no family history of bleeding or clotting disorders.&nbsp; Vital signs are normal for age.&nbsp; Physical examination shows a cooperative, well-appearing child with scattered petechiae on the trunk and extremities.&nbsp; Oral mucosa appears normal.&nbsp; There is no lymphadenopathy or splenomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>13.5 g/dL</td></tr><tr><td>Platelets</td><td>40,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>7,000/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Peripheral smear shows few platelets; the platelets are&nbsp;of normal size and morphology.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41094\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Immune thrombocytopenia </strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Platelet autoantibodies</li><li>Preceding viral infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Petechiae, ecchymosis</li><li>Mucosal bleeding (eg, epistaxis, hematuria)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Isolated thrombocytopenia &lt;100,000/mm<sup>3</sup></li><li>Few platelets (size normal to large) on peripheral smear</li></ul></td></tr><tr><td>&nbsp;<p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Children<ul style=\"list-style-type:circle;\"><li>Observe if cutaneous symptoms only</li><li>Glucocorticoids, IVIG, or anti-D if bleeding</li></ul></li><li>Adults<ul style=\"list-style-type:circle;\"><li>Observation if cutaneous symptoms AND platelets &ge;30,000/mm<sup>3</sup></li><li>Glucocorticoids, IVIG, or anti-D if bleeding or platelets &lt;30,000/mm<sup>3</sup></li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.25in;\"><strong>IVIG</strong> = intravenous immunoglobulin.</p></td></tr></tbody></table></div><p><strong>Immune thrombocytopenia</strong> (ITP), most common in children age 2-5, is characterized by an abnormally low platelet count (&lt;100,000/mm<font size=\"2\"><sup>3</sup></font>) that results in an increased propensity for bruising and bleeding.&nbsp; In ITP, autoantibodies are directed against platelet membrane antigens, leading to destruction of antibody-platelet complexes in the spleen.</p><p>ITP is usually <strong>preceded</strong> by a <strong>viral infection</strong>, as in this case, and presents with <strong>petechiae</strong> and <strong>purpura</strong>.&nbsp; In severe cases, patients may experience mucosal bleeding (eg, epistaxis, hematuria, gastrointestinal bleeding).&nbsp; Laboratory studies show isolated thrombocytopenia, and a few variably sized (normal to large) platelets may be present on peripheral smear due to increased platelet turnover.</p><p><strong>Observation</strong> alone is recommended for children with <strong>only cutaneous symptoms</strong> (eg, petechiae), regardless of platelet count.&nbsp; The course is usually self-limited with <strong>spontaneous recovery</strong> within 3 months.&nbsp; <strong>Glucocorticoids</strong>, anti-D immune globulin (if Rh-positive and Coombs-negative), or <strong>intravenous immunoglobulin</strong> is first-line treatment in children with mucosal bleeding <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Bone marrow evaluation is performed if the presentation is concerning for leukemia (eg, fever, leukopenia/leukocytosis, anemia).&nbsp; Biopsy is not typically indicated for isolated thrombocytopenia.</p><p><strong>(Choice B)</strong>&nbsp; Antibiotics treat sepsis, which can lead to bleeding and thrombocytopenia from disseminated intravascular coagulation (DIC).&nbsp; However, patients with DIC are ill-appearing and often have schistocytes on peripheral smear.&nbsp; Antibiotics are not indicated for ITP.</p><p><strong>(Choice E)</strong>&nbsp; Platelet transfusion is the treatment for congenital platelet abnormalities, such as Bernard-Soulier syndrome, which presents with very large platelets on peripheral smear.&nbsp; Platelet transfusion is considered in severe cases of ITP (eg, intracranial bleeding) but is typically avoided as it can lead to further platelet destruction.</p><p><strong>(Choice F)</strong>&nbsp; Splenectomy can increase the life span and quantity of platelets because the spleen is the site of platelet destruction.&nbsp; Splenectomy is a last resort, reserved for catastrophic bleeding or chronic ITP refractory to intravenous immunoglobulin and glucocorticoids.</p><p><strong>Educational objective:</strong><br>Immune thrombocytopenia typically presents with isolated thrombocytopenia after a viral infection.&nbsp; Children with isolated cutaneous symptoms (eg, petechiae) usually recover spontaneously and require observation alone, regardless of platelet count.&nbsp; Those with bleeding should receive glucocorticoids, anti-D, or intravenous immunoglobulin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16575,
            "topic": "ITP",
            "titleId": 16575,
            "title": "ITP",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone marrow evaluation",
                    "choiceNumber": 1,
                    "correctTaken": 985,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous antibiotics",
                    "choiceNumber": 2,
                    "correctTaken": 203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous immunoglobulin",
                    "choiceNumber": 3,
                    "correctTaken": 4470,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation",
                    "choiceNumber": 4,
                    "correctTaken": 8704,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Platelet transfusion",
                    "choiceNumber": 5,
                    "correctTaken": 1804,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenectomy",
                    "choiceNumber": 6,
                    "correctTaken": 269,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21325604",
                    "mediaDataId": 0,
                    "title": "The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21325604",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 127,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16435,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 453,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 14091,
            "questionIndex": 15494,
            "questionText": "<p>A 15-year-old boy is admitted to the hospital for management of right elbow pain and swelling.&nbsp; The symptoms began 5 days ago while he was watching television at home.&nbsp; The patient has factor VIII deficiency and has been receiving prophylactic recombinant factor VIII infusions through a subcutaneous port 3 times weekly since he was 11 months old.&nbsp; When this episode began, the frequency of his infusions was increased to daily, but the swelling and pain remain.&nbsp; Temperature is 37.6 C (99.7 F).&nbsp; The right elbow has edema, is tender to palpation, and has limited range of motion relative to the left elbow.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>13.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>150,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>8,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Coagulation studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;PT</td><td>14 sec</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Activated PTT</td><td>112 sec</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4730\" src=\"https://www.uworld.com/media/L9709.jpg\" ></p><p><strong>Factor VIII deficiency</strong> (hemophilia A) is an X-linked recessive bleeding disorder associated with recurrent hemarthrosis (bleeding into joints), as seen in this patient.&nbsp; Treatment is factor VIII replacement therapy (eg, recombinant factor VIII infusions through a port).&nbsp; However, <strong>inhibitor development</strong> occurs in approximately 25% of patients with severe hemophilia A (ie, frequent, spontaneous bleeds) as a complication of treatment.&nbsp; The immune system&nbsp;recognizes the infused factor&nbsp;as foreign,&nbsp;forming antibodies that interfere&nbsp;with factor function.</p><p>Therefore, an inhibitor should be suspected when a patient with hemophilia A on factor replacement therapy develops <strong>increased bleeding frequency</strong> or has hemorrhage <strong>refractory</strong> to treatment.&nbsp; In addition, because factor VIII belongs to the intrinsic coagulation pathway, <strong>prolonged PTT</strong>, but <strong>normal PT</strong>, occurs if factor VIII is inhibited.&nbsp; Regular screening for inhibitor development is performed when patients with severe hemophilia receive factor infusions as well as when an inhibitor is clinically suspected.</p><p>Treatment of an acute bleed in a patient with inhibitor development often involves bypassing products (eg, &nbsp;recombinant activated factor VII,&nbsp;activated prothrombin complex concentrates); such agents&nbsp;work&nbsp;downstream in the coagulation cascade to promote clotting without the need for factor VIII.</p><p><strong>(Choices A and E)</strong>&nbsp; Acquired von Willebrand disease and disorders of platelet function present with bruising and mucosal bleeding rather than with hemarthrosis.</p><p><strong>(Choice B)</strong>&nbsp; Fibrinogen (factor I) is in the common final coagulation pathway, and dysfunction causes prolonged PT and PTT.&nbsp; This patient&#39;s PT is normal.</p><p><strong>(Choice C)</strong>&nbsp; Heparin-induced thrombocytopenia is due to an autoantibody against heparin and typically presents with thrombosis and decreased platelet count, which are not seen in this patient.</p><p><strong>Educational objective:</strong><br>Inhibitor development occurs in 25% of patients with severe factor VIII deficiency.&nbsp; It should be considered in a patient with bleeding refractory to replacement therapy or with increased bleeding frequency.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16524,
            "topic": "Hemophilias",
            "titleId": 16524,
            "title": "Hemophilias",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acquired von Willebrand disease",
                    "choiceNumber": 1,
                    "correctTaken": 3244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fibrinogen dysfunction",
                    "choiceNumber": 2,
                    "correctTaken": 1289,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Heparin-induced thrombocytopenia",
                    "choiceNumber": 3,
                    "correctTaken": 261,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inhibitor development",
                    "choiceNumber": 4,
                    "correctTaken": 10955,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Platelet dysfunction",
                    "choiceNumber": 5,
                    "correctTaken": 839,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1092,1387,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "254",
                    "mediaDataId": 0,
                    "title": "Hemophilia A and B",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27367203",
                    "mediaDataId": 0,
                    "title": "A close insight to factor VIII inhibitor in the congenital hemophilia A.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27367203",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 128,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 16588,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1333,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 15121,
            "questionIndex": 16545,
            "questionText": "<p>A 22-year-old man comes to the office due to 2 days of right arm pain, swelling, and heaviness.&nbsp; The symptoms are worse with activity and improve when the arm is propped up on pillows.&nbsp; The patient is an avid weight lifter and plays recreational baseball.&nbsp; Several hours prior to the onset of symptoms, he pitched 6 innings in a baseball game.&nbsp; He has no prior medical conditions and takes no medications.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; Vital signs are normal.&nbsp; Examination shows diffuse swelling and mild erythema of the entire right arm.&nbsp; Prominent superficial veins are present over the proximal right arm and shoulder.&nbsp; Radial pulses are symmetric.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T51065\" style=\"overflow-x:auto;\" tid=\"24769\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Upper extremity deep vein thrombosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Central venous catheters</li><li>Repetitive arm motions (eg, baseball pitching)</li><li>Weight lifting</li><li>Malignancy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Acute arm edema, heaviness, pain &amp; erythema</li><li>Dilated subcutaneous collateral veins in chest/upper extremity</li><li>Pulmonary embolism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Duplex or Doppler ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>3 months of anticoagulation</li><li>Thrombolysis (non&ndash;catheter-related)</li></ul></td></tr></tbody></table></div><p>This young patient with acute pain, heaviness, swelling, and erythema of the right arm likely has <strong>upper extremity deep vein thrombosis (DVT)</strong>.&nbsp; Although most upper extremity DVTs arise in the setting of central catheters (eg, peripherally inserted central catheter), otherwise healthy patients can occasionally develop <strong>spontaneous</strong> DVT due to thoracic outlet abnormalities that compress or injure the axillosubclavian vein.</p><p>Young, <strong>athletic men</strong> are at greatest risk.&nbsp; Most cases are linked to hypertrophy of the scalene/subclavius muscles from <strong>weight lifting</strong> or damage to the vein from repetitive overhead arm motions (eg, <strong>baseball</strong> throwing).&nbsp; Congenital abnormalities of the thorax (eg, <a href=\"3638\">cervical rib</a>) can also occasionally lead to spontaneous DVT.</p><p>Manifestations tend to arise in the dominant arm within hours of strenuous activity (eg, pitching a baseball game).&nbsp; Patients usually have <strong>generalized acute swelling, heaviness, and pain</strong> in the upper extremity.&nbsp; The pain often improves with rest and elevation of the arm to the level of the heart, as in this patient; elevation above the head typically worsens symptoms.&nbsp; Nearby <strong>superficial veins</strong> (eg, proximal arm, shoulder) may become&nbsp;dilated&nbsp;as collaterals that allow bypass of the venous obstruction (Urschel sign).&nbsp; The diagnosis is generally made with venous <strong>Doppler</strong> or duplex <strong>ultrasonography</strong>.</p><p><strong>(Choices A and B)</strong>&nbsp; Cellulitis (often empirically treated with cephalexin) or soft tissue injury/infection (which MRI can help diagnose) can cause arm pain, erythema, and swelling.&nbsp; However, this patient&#39;s diffuse arm swelling and prominent superficial veins, coupled with an onset immediately following repetitive overhead movement, are most concerning for DVT.&nbsp; Upper extremity venous ultrasonography should be performed first in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Rest, ice, compression, and elevation are typically recommended in the treatment of medial epicondylitis (&#x22;golfer&#39;s elbow&#x22;), which sometimes occurs in pitchers.&nbsp; Although medial epicondylitis often results in arm pain, the pain is localized to the medial elbow; it would not cause edema and erythema of the entire arm.</p><p><strong>(Choice D)</strong>&nbsp; Acute exertional compartment syndrome (associated with an elevated serum creatine kinase level due to muscle breakdown) can occur after strenuous physical activity.&nbsp; However, associated pain is typically excruciating, and other neurologic findings (eg, paresthesia, weakness) are often present.&nbsp; In addition, the diagnosis is made clinically (in some cases aided by compartment pressure measurement), not by measuring the creatine kinase level.</p><p><strong>Educational objective:</strong><br>Spontaneous upper extremity deep vein thrombosis most often occurs in young athletic men who lift weights or engage in activities with repetitive overhead arm motions (eg, pitching a baseball game).&nbsp; The diagnosis is generally made with venous Doppler or duplex ultrasonography.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Empiric oral cephalexin",
                    "choiceNumber": 1,
                    "correctTaken": 46,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the right upper extremity",
                    "choiceNumber": 2,
                    "correctTaken": 531,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rest, ice, compression, and elevation",
                    "choiceNumber": 3,
                    "correctTaken": 1270,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum creatine kinase level",
                    "choiceNumber": 4,
                    "correctTaken": 298,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venous Doppler ultrasonography",
                    "choiceNumber": 5,
                    "correctTaken": 2861,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "373,436,true,-1,1*300,318,true,-1,1*105,166,true,-1,1*579,858,true,-1,1*1395,1554,true,-1,1*1555,1703,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "447",
                    "mediaDataId": 0,
                    "title": "Venous thromboembolism (VTE):  Deep venous thrombosis (DVT) and pulmonary embolism (PE)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36874699",
                    "mediaDataId": 0,
                    "title": "Anatomy and pathogenesis of vascular thoracic outlet syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36874699",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 173,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 5006,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1568,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 4316,
            "questionIndex": 4316,
            "questionText": "<p>A 59-year-old woman comes to the emergency department due to right leg swelling and pain for 3 days.&nbsp; The patient was started on hemodialysis 2 months ago for end-stage renal disease from poorly controlled hypertension and type 2 diabetes mellitus.&nbsp; Duplex ultrasound shows a right popliteal vein thrombosis.&nbsp; The patient is started on intravenous heparin infusion and admitted to the medical floor.&nbsp; On the third day of hospitalization, the right leg is more swollen and painful.&nbsp; Repeat ultrasound shows an extension of thrombus to the right femoral vein.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">14.0 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">50,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Activated partial<br>thromboplastin time</td><td style=\"vertical-align:middle;\">70 seconds</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s worsening condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"17492\" src=\"https://www.uworld.com/media/highresdefault/L42334.jpg\"  ></p><p>This patient with thrombocytopenia and thrombus progression 3 days into heparin therapy likely has <strong>type 2 heparin-induced thrombocytopenia</strong> (HIT).&nbsp; Heparin induces a conformational change to a platelet surface protein (platelet factor 4 [PF4]), which exposes a neoantigen.&nbsp; In patients with type 2 HIT, the immune system responds by forming an IgG autoantibody (<strong>HIT antibody</strong>) that then coats the surface of platelets and forms complexes (heparin-PF4-HIT antibody), resulting in:</p><ul><li><p><strong>Thrombocytopenia</strong> - the reticuloendothelial system (largely the spleen) removes antibody-coated platelets, causing a mild to moderate thrombocytopenia (rarely &lt;20,000/mm<font size=\"2\"><sup>3</sup></font>).</p></li><li><strong>Arterial and venous thrombus</strong> - HIT antibodies <strong>activate platelets</strong>, resulting in platelet aggregation and the release of procoagulant factors.&nbsp; The risk of thrombus is as high as 50% in untreated HIT.</li></ul><p>Although type 2 HIT usually manifests with a &gt;50% drop in platelets <strong>5-10 days</strong> after the initiation of heparin, it can occur <strong>earlier</strong> (sometimes &lt;1 day) in patients <strong>previously exposed</strong>.&nbsp; Patients with end-stage renal disease typically receive unfractionated heparin with hemodialysis to prevent blood clots in the dialysis tubing and dialyzer; therefore, this patient who recently started hemodialysis has likely had heparin exposure.&nbsp; If HIT is suspected, all heparin products should be discontinued immediately, and an alternate anticoagulant (eg, argatroban, fondaparinux) should be initiated.</p><p>Heparin works by binding antithrombin, which inactivates factor Xa; this <strong>prolongs activated partial thromboplastin time</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Impaired bone marrow platelet production is seen with malignant infiltration or myelodysplastic syndrome.&nbsp; Typically, the other cell lines are also affected (eg, leukocytosis, pancytopenia).</p><p><strong>(Choice C)</strong>&nbsp; Acute disseminated intravascular coagulation is usually characterized by bleeding, end-organ dysfunction (renal, pulmonary, liver), and shock.&nbsp; Trauma, infection, and malignancy are the most common causes, and patients tend to be acutely ill.&nbsp; In this patient on heparin with thrombocytopenia and thrombus progression alone, HIT is far more likely.</p><p><strong>(Choice D)</strong>&nbsp; Type 1 HIT is marked by nonimmune-mediated platelet aggregation.&nbsp; It results in mild thrombocytopenia (platelets rarely &lt;100,000/mm<font size=\"2\"><sup>3</sup></font>), usually within 2 days of heparin initiation.&nbsp; Type 1 HIT does not cause thrombosis or ill effects.&nbsp; Therefore, no intervention is required for type 1 HIT; the thrombocytopenia resolves without cessation of heparin.</p><p><strong>(Choice E)</strong>&nbsp; Splenomegaly may cause platelet sequestration and redistribution.&nbsp; It is associated with thrombocytopenia but does not increase thrombus risk.</p><p><strong>Educational objective:</strong><br>In type 2 heparin-induced thrombocytopenia (HIT), heparin induces a conformational change in a platelet surface protein which exposes a neoantigen.&nbsp; Antibodies are formed and bind to the surface of platelets, resulting in platelet activation, thrombocytopenia, and a prothrombotic state.&nbsp; Type 2 HIT typically occurs 5-10 days after heparin initiation but may occur sooner in patients previously exposed to heparin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7111,
            "topic": "Heparin induced thrombocytopenia",
            "titleId": 7111,
            "title": "Heparin induced thrombocytopenia",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antibody-mediated platelet activation",
                    "choiceNumber": 1,
                    "correctTaken": 8551,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased bone marrow platelet production",
                    "choiceNumber": 2,
                    "correctTaken": 179,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disseminated intravascular coagulation",
                    "choiceNumber": 3,
                    "correctTaken": 1479,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonimmune platelet aggregation",
                    "choiceNumber": 4,
                    "correctTaken": 2110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Platelet sequestration and redistribution",
                    "choiceNumber": 5,
                    "correctTaken": 892,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1476,1596,true,-1,1*2172,2522,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "480",
                    "mediaDataId": 0,
                    "title": "Heparin-induced thrombocytopenia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15071388",
                    "mediaDataId": 0,
                    "title": "Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15071388",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 13211,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 971,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 4249,
            "questionIndex": 4249,
            "questionText": "<p>A 16-year-old boy is brought to the office for pain and limited motion of the right knee.&nbsp; The patient has had previous episodes of sudden, severe swelling in his right knee and does not recall them being associated with injury.&nbsp; This current episode of knee pain began 6 months ago.&nbsp; Initially the pain was controlled with heating pads and acetaminophen, but it has gradually worsened over the last 2-3 months.&nbsp; The patient now has difficulty walking.&nbsp; He is worried that he will be unable to go on his annual camping trip with his family.&nbsp; The patient had an episode of prolonged bleeding after a tooth extraction several years ago.&nbsp; He is sexually active, has 2 lifetime partners, and uses condoms intermittently.&nbsp; Temperature is 36.7 C (98 F).&nbsp; On examination, the patient is alert and in no distress.&nbsp; The right knee is swollen and boggy with a small effusion present.&nbsp; The knee is not fully extendable with either active or passive motion.&nbsp; Which of the following is the most likely cause of this patient&#39;s knee joint findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41222\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hemophilia A &amp; B</strong></p></td></tr><tr><td><p align=\"center\"><strong>Inheritance</strong></p></td><td><ul><li>X-linked recessive</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Delayed/prolonged bleeding after mild trauma<ul style=\"list-style-type:circle;\"><li>Hemarthrosis, intramuscular hematomas</li><li>Gastrointestinal or genitourinary tract bleeding</li><li>Intracranial hemorrhage</li></ul></li><li>Complications: hemophilic arthropathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>&uarr; Activated PTT</li><li>Normal platelet count &amp; PT</li><li>Absent or &darr; factor VIII (hemophilia A) or factor IX<br />(hemophilia B) activity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Factor replacement</li><li>Desmopressin for mild hemophilia A</li></ul></td></tr></tbody></table></div><p>This patient&#39;s history of excessive bleeding after a dental procedure is concerning for <strong>hemophilia</strong>, an X-linked recessive bleeding disorder caused by deficiency of Factor VIII (hemophilia A) or Factor IX (hemophilia B).&nbsp; Disease severity varies based on degree of factor activity.&nbsp; Often, patients present with severe joint swelling and pain following little or no trauma due to spontaneous bleeding into a joint (hemarthrosis).&nbsp; <strong>Recurrent hemarthroses</strong>, as seen in this patient, can result in long-term complications such as hemophilic arthropathy.</p><p><strong>Hemophilic arthropathy</strong> refers to joint damage caused by intra-articular bleeding.&nbsp; <strong>Hemosiderin deposition</strong> within the joint triggers synovial inflammation, which leads to <strong>fibrosis</strong> and destruction of cartilage and bone.&nbsp; Chronic, worsening joint pain and swelling are accompanied by limited mobility on examination.&nbsp; Although severe hemophilic arthropathy may be visible on <a href=\"51201\">x-ray</a>, <a href=\"871\">MRI</a> allows for earlier detection and characterization of the degree of joint damage.&nbsp; <strong>Early prophylaxis</strong> with factor concentrates can significantly reduce the risk of developing arthropathy.</p><p><strong>(Choice A)</strong>&nbsp; Autoimmune cartilage destruction occurs in conditions such as rheumatoid arthritis and juvenile idiopathic arthritis.&nbsp; Although inflammatory arthritis may cause joint pain and swelling, it would not explain the patient&#39;s bleeding symptoms.</p><p><strong>(Choice B)</strong>&nbsp; Avascular necrosis of the femoral head is seen in sickle cell disease (SCD) and Legg-Calv&eacute;-Perthes disease (LCP).&nbsp; LCP typically presents with hip pain and limp in children age 4-12.&nbsp; SCD can cause recurrent vaso-occlusive episodes affecting the joints but is not associated with excessive bleeding.</p><p><strong>(Choice C)</strong>&nbsp; Lyme arthritis is caused by <em>Borrelia burgdorferi</em> infection and can present with large joint (eg, knee) swelling and limited range of motion.&nbsp; However, Lyme arthritis does not account for this patient&#39;s bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Disseminated gonococcal infection can lead to acute arthritis, which presents with abrupt onset of joint pain and swelling.&nbsp; Infection is unlikely in this patient with 6 months of symptoms.</p><p><strong>(Choice F)</strong>&nbsp; Urate and calcium pyrophosphate deposition cause gout and pseudogout, respectively.&nbsp; Both conditions are uncommon in children and not associated with abnormal bleeding.</p><p><strong>Educational objective:</strong><br>Hemophilic arthropathy is a consequence of recurrent hemarthroses and is associated with hemosiderin deposition leading to synovitis and fibrosis within the joint.&nbsp; The risk of hemophilic arthropathy is reduced by prophylactic treatment with factor concentrates.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16524,
            "topic": "Hemophilias",
            "titleId": 16524,
            "title": "Hemophilias",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoimmune cartilage destruction",
                    "choiceNumber": 1,
                    "correctTaken": 1376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Avascular necrosis",
                    "choiceNumber": 2,
                    "correctTaken": 839,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic <em>Borrelia burgdorferi</em> infection",
                    "choiceNumber": 3,
                    "correctTaken": 1036,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disseminated gonococcal infection",
                    "choiceNumber": 4,
                    "correctTaken": 2886,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemosiderin deposition and fibrosis",
                    "choiceNumber": 5,
                    "correctTaken": 9380,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraarticular crystal deposition",
                    "choiceNumber": 6,
                    "correctTaken": 828,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "254",
                    "mediaDataId": 0,
                    "title": "Hemophilia A and B",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28672826",
                    "mediaDataId": 0,
                    "title": "Pathophysiology of hemophilic arthropathy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28672826",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27890816",
                    "mediaDataId": 0,
                    "title": "Pathophysiology of hemophilic arthropathy and potential targets for therapy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27890816",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 179,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16345,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1093,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 6993,
            "questionIndex": 6993,
            "questionText": "<p>A 62-year-old hospitalized woman is evaluated for worsening skin lesions.&nbsp; She was admitted 6 days ago for elective coronary artery bypass grafting due to extensive coronary artery disease.&nbsp; The surgery was uncomplicated, and the patient was extubated on hospital day 2.&nbsp; She has recovered well, but yesterday she noticed red patches on her abdomen that progressed to purple lesions today.&nbsp; The patient has a history of non-ST elevation myocardial infarction, type 2 diabetes mellitus, hypertension, and hyperlipidemia.&nbsp; She is receiving low-dose subcutaneous heparin for prophylaxis of deep venous thrombosis and has not received any oral anticoagulation.&nbsp; Temperature is 37.1 C (98.7 F), blood pressure is 130/82 mm Hg, and heart rate is 90/min.&nbsp; Cardiopulmonary examination reveals patchy rales and normal heart sounds.&nbsp; The sternal surgical site is healing well.&nbsp; Several large purple/black patches are seen in the periumbilical area, surrounded by erythema.&nbsp; Peripheral pulses are normal.&nbsp; Neurologic examination is unremarkable.&nbsp; Which of the following is the most likely cause of this patient&#39;s skin lesions?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t79879\"><table class=\"table-default-style\" style=\"width:505px\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features of type 2 heparin-induced thrombocytopenia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical signs</strong></p></td><td><p>Suspected with heparin exposure &gt;5 days &amp; any of the following:</p><ul><li>Platelet count reduction &gt;50% from baseline</li><li>Arterial or venous thrombosis</li><li>Necrotic skin lesions at heparin injection sites</li><li>Acute systemic (anaphylactoid) reactions after heparin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic evaluation</strong></p></td><td><ul><li>Serotonin release assay: gold standard confirmatory test</li><li>Start treatment in suspected cases prior to confirmatory tests</li></ul></td></tr><tr><td><p align=\"center\"><strong>Therapy</strong></p></td><td><ul><li>Stop all heparin products</li><li>Start a direct thrombin inhibitor (eg, argatroban) or fondaparinux (synthetic pentasaccharide)</li></ul></td></tr></tbody></table></div></p><p><strong>Heparin-induced thrombocytopenia</strong> (HIT) is a life-threatening complication of heparin therapy.&nbsp; Heparin induces a conformational change in a platelet surface protein (platelet factor 4), which exposes a neoantigen.&nbsp; In patients with HIT, <strong>HIT antibodies</strong> form in response to the neoantigen and bind to the surface of platelets, causing platelet aggregation, <strong>thrombocytopenia</strong> (or drop in platelets &gt;50%), and a <strong>prothrombotic</strong> state.&nbsp; In patients receiving heparin subcutaneously (eg, enoxaparin), a classic thrombotic complication of HIT is <a href=\"4771\">skin necrosis</a> at the abdominal injection site.</p><p>HIT is diagnosed by immunoassay (only if high titer) or functional assay (eg, serotonin release assay [gold standard]).&nbsp; Treatment involves immediately discontinuing all heparin products (including heparin flushes) and initiating an alternate anticoagulant (eg, argatroban, fondaparinux).&nbsp; If HIT is suspected, treatment should not be delayed for laboratory confirmation as the risk of venous and arterial thrombosis is as high as 50% in untreated HIT.</p><p><strong>(Choice A)</strong>&nbsp; Warfarin is an oral anticoagulant that can cause an acquired protein C deficiency, which may manifest as skin necrosis.&nbsp; However, this patient has not received any oral anticoagulation.&nbsp; Warfarin is often used for chronic anticoagulation maintenance in HIT but not until argatroban or fondaparinux are initiated and platelets are &gt;150,000/mm<font size=\"2\"><sup>3</sup></font>.</p><p><strong>(Choice C)</strong>&nbsp; Delayed hypersensitivity reactions typically cause skin erythema, vesicles, or bullae.&nbsp; More severe reactions are associated with systemic symptoms, such as fever.&nbsp; This patient has necrotic lesions likely at the site of her low-molecular-weight heparin injections, making HIT much more likely.</p><p><strong>(Choice D)</strong>&nbsp; Cholesterol embolization can occur due to plaque embolization into small arteries following coronary angiography.&nbsp; Cholesterol embolization classically causes skin findings (eg, livedo reticularis [mottled erythema], gangrene, cyanosis) that most commonly affect the lower extremities.&nbsp; With necrotic lesions on the abdominal wall, HIT is much more likely.</p><p><strong>(Choice E)</strong>&nbsp; Viral reactivation is common with herpes zoster.&nbsp; Lesions are typically unilateral, in a single dermatome, and quite painful.&nbsp; They tend to be vesicular, not necrotic.</p><p><strong>Educational objective:</strong><br>Heparin-induced thrombocytopenia (HIT) should be suspected in patients on heparin who develop thrombocytopenia or thrombotic complications.&nbsp; In patients receiving heparin subcutaneously (eg, enoxaparin), a classic thrombotic complication is skin necrosis at the abdominal injection site.&nbsp; HIT is treated by discontinuing all heparin products and initiating an alternate anticoagulant (eg, argatroban, fondaparinux).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7111,
            "topic": "Heparin induced thrombocytopenia",
            "titleId": 7111,
            "title": "Heparin induced thrombocytopenia",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acquired deficiency of protein C",
                    "choiceNumber": 1,
                    "correctTaken": 2983,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antibodies against a platelet component",
                    "choiceNumber": 2,
                    "correctTaken": 15298,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Delayed-type hypersensitivity reaction",
                    "choiceNumber": 3,
                    "correctTaken": 2488,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Embolization of cholesterol",
                    "choiceNumber": 4,
                    "correctTaken": 4544,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactivation of a latent virus",
                    "choiceNumber": 5,
                    "correctTaken": 340,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "245,348,true,-1,1*371,427,true,-1,1*525,619,true,-1,1*1856,2011,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 25653,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 658,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 3608,
            "questionIndex": 3608,
            "questionText": "<p>A 70-year-old woman is brought to the emergency department after she experienced several episodes of large-volume melena and maroon hematochezia over the previous 2 days.&nbsp; The patient was hospitalized 2 weeks ago for an acute exacerbation of chronic obstructive pulmonary disease and acute thrombosis of the right popliteal vein.&nbsp; She has been taking rivaroxaban since discharge.&nbsp; The patient is mostly sedentary due to dyspnea and deconditioning.&nbsp; Blood pressure is 86/62 mm Hg and pulse is 115/min and regular.&nbsp; Mucous membranes are pale.&nbsp; The abdomen is soft and nontender.&nbsp; Right calf circumference is increased compared to the left.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td>5.9 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td>380,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td>1.2 mg/dL</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Coagulation studies</td></tr><tr><td style=\"padding-left: 2em;\">INR</td><td>2.8 (normal: 0.8-1.1)</td></tr></tbody></table><p>Rivaroxaban is discontinued.&nbsp; Rapid transfusion of several units of red blood cells is required.&nbsp; Endoscopy reveals numerous bleeding angiodysplasias of the gastric wall and small bowel.&nbsp; Only some of the lesions can be successfully coagulated.&nbsp; Which of the following is the best management for this patient&#39;s venous thromboembolic disease?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"59552\" src=\"https://www.uworld.com/media/highresdefault/L87575.png\"  ></p><p>This patient with recent acute deep vein thrombosis (DVT) has life-threatening gastrointestinal bleeding (ie, hypotension, major transfusion requirement) soon after anticoagulation was initiated.&nbsp; Anticoagulation therapy can unmask sources of bleeding.&nbsp; Given the patient&#39;s active/uncontrolled bleeding sources (small bowel angiodysplasias not accessible by endoscopy), resumption of anticoagulation would lead to potentially severe rebleeding.</p><p>However, lack of anticoagulation in this patient with recent acute DVT increases her risk for pulmonary embolism (PE).&nbsp; <strong>Inferior vena cava (IVC) filters</strong>&nbsp;<a href=\"5582\">trap clots in transit</a> from the legs to the lungs.&nbsp; They are an option for patients with acute DVT and absolute <strong>contraindications to anticoagulation</strong> (eg, intracranial hemorrhage, <strong>active/uncontrollable bleeding source</strong>).</p><p>Although IVC filters protect against PE (relative risk ~0.5), they increase the long-term risk of recurrent DVT (relative risk ~2).&nbsp; <strong>Prevention of PE</strong> is considered the more pressing clinical priority, especially in this patient with decreased cardiopulmonary reserve (ie, severe chronic lung disease).&nbsp; Short-term complications of IVC filters include bleeding and infection at the puncture site.</p><p><strong>(Choice A)</strong>&nbsp; Due to its quickly titratable and reversible kinetics, unfractionated heparin is an attractive short-term strategy for patients requiring anticoagulation who have non&ndash;life-threatening bleeding sources that are under control and accessible for intervention in the event of rebleeding (eg, surgical site).&nbsp; It would not be appropriate for this patient who just experienced life-threatening hemorrhage and has ongoing, inaccessible, active bleeding.</p><p><strong>(Choice C)</strong>&nbsp; Although the patient&#39;s existing popliteal DVT may spontaneously dissolve after several weeks, the clot itself is a thrombogenic nidus, tending to stimulate its own propagation.&nbsp; Furthermore, the risk of PE is very high (&gt;50%) with unprotected DVT.&nbsp; Therefore, observation without intervention would be unsafe.&nbsp; The option of an IVC filter should be discussed with the patient.</p><p><strong>(Choice D)</strong>&nbsp; Compression stockings are used for <a href=\"37871\">post-thrombotic syndrome</a>, which can produce pain, swelling, and lower extremity ulceration from chronic venous insufficiency following DVT.&nbsp; However, they are not effective in preventing or treating existing acute DVT.</p><p><strong>(Choice E)</strong>&nbsp; Aspirin is sometimes offered for secondary prevention of DVT after a patient completes a full course of anticoagulation.&nbsp; In contrast, aspirin monotherapy has a trivial therapeutic effect as primary treatment for acute DVT and may increase the risk of gastrointestinal rebleeding.</p><p><strong>Educational objective:</strong><br>Inferior vena cava filters are an option for patients with acute deep vein thrombosis and absolute contraindications to anticoagulation (eg, intracranial hemorrhage, active and difficult-to-treat source of major bleeding).&nbsp; They trap clots in transit, reducing the risk of clinically significant pulmonary embolism.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Infusion of unfractionated heparin",
                    "choiceNumber": 1,
                    "correctTaken": 1684,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insertion of an inferior vena cava filter",
                    "choiceNumber": 2,
                    "correctTaken": 12401,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation with no further intervention",
                    "choiceNumber": 3,
                    "correctTaken": 555,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placement of compression stockings",
                    "choiceNumber": 4,
                    "correctTaken": 1285,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substitution of aspirin for rivaroxaban",
                    "choiceNumber": 5,
                    "correctTaken": 625,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "979,1243,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "447",
                    "mediaDataId": 0,
                    "title": "Venous thromboembolism (VTE):  Deep venous thrombosis (DVT) and pulmonary embolism (PE)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24195920",
                    "mediaDataId": 0,
                    "title": "The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24195920",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23552968",
                    "mediaDataId": 0,
                    "title": "Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23552968",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 140,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 16554,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1199,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 3437,
            "questionIndex": 3437,
            "questionText": "<p>A 7-year-old boy is brought to the emergency department due to fatigue.&nbsp; One week ago, he developed abdominal pain, vomiting, and diarrhea.&nbsp; A few days later, he noticed significant blood in his stool, which has since resolved.&nbsp; The patient had been feeling better until today, when his mother noticed that he did not want to get out of bed.&nbsp; Despite drinking a normal amount of fluids, the patient has not urinated in 24 hours.&nbsp; Multiple family members had similar initial gastrointestinal symptoms after attending a family cookout last week, but they have all recovered.&nbsp; On physical examination, there is scleral icterus and 2+ pedal edema.&nbsp; Which of the following laboratory abnormalities is most likely associated with this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36652\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hemolytic uremic syndrome </strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis </strong></p></td><td><ul><li><em>E<em>scherichia</em> coli </em>serotype O157:H7 or <em>Shigella dysenteriae</em></li><li>Vascular damage &amp; microthrombi formation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features </strong></p></td><td><ul><li>Preceding bloody diarrhea</li><li>Fatigue, pallor</li><li>Bruising, petechiae</li><li>Oliguria, edema</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings </strong></p></td><td><ul><li>Hemolytic anemia (schistocytes, &uarr; bilirubin)</li><li>Thrombocytopenia</li><li>Acute kidney injury (&uarr; BUN, &uarr; creatinine)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Fluid &amp; electrolyte management</li><li>Blood transfusions</li><li>Dialysis</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>BUN</strong> = blood urea nitrogen.</p></td></tr></tbody></table></div><p>This patient has fatigue, edema, and anuria after a bloody diarrheal illness; these findings raise concern for <strong>hemolytic uremic syndrome</strong> (HUS).&nbsp; HUS most commonly occurs after infection due to a Shiga toxin-producing strain of <em>Escherichia coli</em> (serotype O157:H7).&nbsp; This toxin invades and destroys the colonic epithelial lining, producing abdominal pain and bloody diarrhea, as seen in this patient.</p><p>HUS typically presents about a week after the diarrheal illness with signs of anemia (eg, fatigue, pallor), <strong>thrombocytopenia</strong> (eg, bruising), and <strong>acute kidney injury</strong> (eg, oliguria, edema).&nbsp; The shearing of red blood cells by platelet microthrombi leads to <strong>microangiopathic hemolytic anemia</strong> with <a href=\"4944\">schistocytes</a> on peripheral smear.&nbsp; Hemolysis is evidenced by decreased haptoglobin and increased indirect bilirubin, which can cause scleral icterus (as in this case) as well as jaundice <strong>(Choice E)</strong>.</p><p>Treatment of HUS is supportive (eg, fluid/electrolyte management, blood transfusions, dialysis).&nbsp; Most patients improve within a few weeks.</p><p><strong>(Choice A)</strong>&nbsp; A decreased ferritin level is seen in iron deficiency anemia (eg, chronic gastrointestinal bleeding), which is unlikely in this patient with acute bloody diarrhea that is now resolved.&nbsp; Patients with HUS have normal or increased ferritin levels because ferritin is an acute-phase reactant that rises with inflammation.</p><p><strong>(Choice C)</strong>&nbsp; A decreased reticulocyte count in the setting of anemia indicates defective bone marrow (eg, viral suppression, aplastic anemia, malignancy).&nbsp; Reticulocyte counts are increased with hemolytic anemia.</p><p><strong>(Choice D)</strong>&nbsp; Disseminated intravascular coagulation occurs in severely ill patients (eg, sepsis) and is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and abnormal coagulation studies (ie, increased PT).&nbsp; HUS is more likely in this child with a preceding bloody diarrheal illness; PT is normal in HUS.</p><p><strong>(Choice F)</strong>&nbsp; The direct Coombs test is positive in patients with autoimmune hemolytic anemia, which can present with fatigue and indirect hyperbilirubinemia.&nbsp; However, signs of acute renal injury (eg, edema, anuria) would not be seen.&nbsp; Direct Coombs test is negative in HUS because red blood cells are mechanically destroyed.</p><p><strong>Educational objective:</strong><br>Hemolytic uremic syndrome, which is most commonly caused by a Shiga toxin-producing strain of <em>Escherichia coli</em> (serotype O157:H7), is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 4633,
            "topic": "Hemolytic uremic syndrome",
            "titleId": 4633,
            "title": "Hemolytic uremic syndrome",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased ferritin level",
                    "choiceNumber": 1,
                    "correctTaken": 814,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased platelet count",
                    "choiceNumber": 2,
                    "correctTaken": 9643,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased reticulocyte count",
                    "choiceNumber": 3,
                    "correctTaken": 381,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased PT",
                    "choiceNumber": 4,
                    "correctTaken": 730,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased serum haptoglobin",
                    "choiceNumber": 5,
                    "correctTaken": 2464,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Positive direct Coombs test",
                    "choiceNumber": 6,
                    "correctTaken": 2458,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "753,887,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28242109",
                    "mediaDataId": 0,
                    "title": "Haemolytic uraemic syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28242109",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 939,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16490,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 235,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 15013,
            "questionIndex": 16437,
            "questionText": "<p>A 26-year-old man is brought to the hospital after a motor vehicle collision.&nbsp; The patient was found unconscious at the scene and was intubated on the way to the hospital.&nbsp; Initial imaging showed left-sided epidural hematoma, multiple rib fractures, and a pelvic fracture.&nbsp; He was immediately taken to the operating room for epidural hematoma evacuation.&nbsp; During resuscitation and in the postoperative period, the patient received 4 L of intravenous fluids and 3 units of packed red blood cells.&nbsp; Although he was hemodynamically stable on day 1 of hospitalization, the nursing report on day 2 notes reduced urine output.&nbsp; In addition, there is persistent oozing from the patient&#39;s venipuncture sites and around the surgical wound.&nbsp; Which of the following is the most likely cause of this patient&#39;s bleeding?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50322\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Disseminated intravascular coagulation</strong></p></td></tr><tr><td><p align=\"center\"><strong>Major causes</strong></p></td><td><ul><li>Sepsis</li><li>Severe traumatic injury</li><li>Malignancy</li><li>Obstetric complications</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Procoagulant excessively triggers coagulation cascade &rarr;</li><li>Formation of fibrin-/platelet-rich thrombi &amp; fibrinolysis &rarr;</li><li>Bleeding &amp; organ damage (eg, kidneys, lungs)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Thrombocytopenia</li><li>Prolonged PT &amp; PTT</li><li>&darr; Fibrinogen</li><li>&uarr; D-dimer</li><li>Microangiopathic hemolytic anemia (schistocytes)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s oozing from venipuncture and surgical sites and reduced urine output after a serious traumatic injury raises strong suspicion for <strong>disseminated intravascular coagulation</strong> (DIC), a <strong>consumptive coagulopathy</strong>.&nbsp; <strong>Traumatic injury</strong> increases the risk of DIC due to endothelial (exposes tissue factor) and tissue damage (releases procoagulant proteins and phospholipids); other common causes of DIC include sepsis, malignancy, and obstetrical complications.</p><p>DIC is marked by:</p><ul><li>Overactivation of the coagulation cascade, leading to the formation of fibrin- and platelet-rich <strong>thrombi</strong> and the consumption of coagulation factors (prolonged PT/PTT), platelets (thrombocytopenia), and fibrinogen.</li><li>Subsequent fibrinolysis (to break up the clots), which increases fibrin degradation products (eg, D-dimer).&nbsp; Anticoagulation proteins (eg, protein C/S) are also consumed.</li></ul><p>Patients with acute DIC usually develop <strong>bleeding from venipuncture/surgical sites</strong>, ecchymosis, and petechiae.&nbsp; Organ damage (eg, renal insufficiency [reduced urine output in the setting of intravascular fluids]) is also commonly seen.</p><p><strong>(Choice A)</strong>&nbsp; ABO incompatibility can cause DIC, but severe symptoms (eg, fever, chills, respiratory difficulty) typically develop within seconds or a few minutes of transfusion initiation; manifestations a day later would be atypical.</p><p><strong>(Choice B)</strong>&nbsp; Acute liver failure can cause prolonged PT/PTT and mild thrombocytopenia.&nbsp; Although patients are sometimes mildly hypocoaguable (eg, easy bruising), clinically significant bleeding and oozing from venipuncture sites is atypical.&nbsp; Most cases of acute liver failure are caused by viral hepatitis or drugs (eg, acetaminophen), not motor vehicle collisions.</p><p><strong>(Choice C)</strong>&nbsp; Complement-mediated microangiopathy (also called nondiarrheal hemolytic-uremic syndrome) is a hereditary disorder marked by unregulated complement activation and the formation of platelet-rich thrombi.&nbsp; Although renal insufficiency is common, it does not typically cause oozing from venipuncture sites.&nbsp; In addition, it is not typically associated with trauma (unlike DIC).</p><p><strong>(Choice E)</strong>&nbsp; Drug-induced thrombocytopenia is usually due to the formation of antibodies against platelets or the suppression of platelet production in the bone marrow.&nbsp; Most cases manifest several days (~1 week) after drug exposure (not within a day).</p><p><strong>(Choice F)</strong>&nbsp; Vitamin K is necessary for the formation of several clotting factors (eg, factors II, VII, IX, and X).&nbsp; Deficiency is rare in healthy individuals and takes several weeks or months (not a day) to develop.&nbsp; Most cases arise in patients with disorders of the pancreas/biliary system (because vitamin K is fat-soluble) or in those who take prolonged courses of antibiotics.</p><p><strong>Educational objective:</strong><br>Severe trauma increases the risk of disseminated intravascular coagulation, a consumptive coagulopathy, due to the exposure of tissue factor and the release of procoagulant proteins and phospholipids.&nbsp; Laboratory evaluation will reveal prolonged PT/PTT and thrombocytopenia.&nbsp; Patients usually develop signs of bleeding (eg, oozing from venipuncture/surgical sites) and organ damage (eg, renal insufficiency).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16440,
            "topic": "DIC",
            "titleId": 16440,
            "title": "DIC",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "ABO incompatibility",
                    "choiceNumber": 1,
                    "correctTaken": 642,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute liver failure",
                    "choiceNumber": 2,
                    "correctTaken": 346,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Complement-mediated microangiopathy",
                    "choiceNumber": 3,
                    "correctTaken": 1119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Consumptive coagulopathy",
                    "choiceNumber": 4,
                    "correctTaken": 14003,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Drug-induced thrombocytopenia",
                    "choiceNumber": 5,
                    "correctTaken": 494,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin K deficiency",
                    "choiceNumber": 6,
                    "correctTaken": 798,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 40,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 17402,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 578,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 13722,
            "questionIndex": 15112,
            "questionText": "<p>A 17-year-old girl is brought to the emergency department due to acute abdominal pain, nausea, and vomiting.&nbsp; She has no chronic medical conditions and has had no surgery.&nbsp; The patient has had irregular menstruation and is not sexually active.&nbsp; Family history is significant for deep venous thrombosis following knee replacement in her mother, who takes apixaban.&nbsp; Temperature is 38.3 C (101 F).&nbsp; BMI is 18 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows right lower quadrant abdominal tenderness.&nbsp; CT scan of the abdomen reveals acute appendicitis, and laparoscopic appendectomy is planned.&nbsp; Preoperative laboratory studies demonstrate a platelet count of 400,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Coagulation study results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Prothrombin time</td><td style=\"vertical-align:middle;\">12 sec</td></tr><tr><td style=\"vertical-align:middle;\">International Normalized Ratio (INR)</td><td style=\"vertical-align:middle;\">1.2 (normal: 0.8-1.2)</td></tr><tr><td style=\"vertical-align:middle;\">Activated partial thromboplastin time</td><td style=\"vertical-align:middle;\">52 sec</td></tr><tr><td style=\"vertical-align:middle;\">Thrombin time</td><td style=\"vertical-align:middle;\">15 sec (normal: 14-19 sec)</td></tr></tbody></table><p>Mixing the patient&#39;s plasma sample with normal plasma fails to correct the coagulation abnormalities.&nbsp; Which of the following best explains this patient&#39;s coagulation study results?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7665\" src=\"https://www.uworld.com/media/L8787.png\" ></p><p>This patient&#39;s prolonged activated PTT does not correct when mixed with normal plasma.&nbsp; Normal plasma provides coagulation factors; therefore, it corrects prolonged PTT in the setting of coagulation factor deficiency but fails to correct prolonged PTT in the setting of a <strong>coagulation inhibitor</strong>.</p><p>One of the most common coagulation inhibitors is <strong>lupus anticoagulant</strong> (LA), a type of an <strong>antiphospholipid antibody</strong>.&nbsp; LA binds to the phospholipids used in most PTT tests and prevents them from inducing coagulation (thereby prolonging PTT).&nbsp; This laboratory artifact is not improved with the addition of plasma <strong>(mixing test)</strong> but is resolved with the addition of phospholipids (which eventually overwhelm all the antibody binding sites).</p><p>Patients with antiphospholipid antibodies may remain asymptomatic but are at increased risk for antiphospholipid-antibody syndrome, which is associated with thromboembolism and fetal loss.&nbsp; Most cases occur sporadically; this patient&#39;s mother&#39;s deep venous thrombus likely was related to her orthopedic surgery rather than a clotting disorder.&nbsp; Furthermore, the patient&#39;s thrombophilia is likely a byproduct of her infection rather than of a platelet disorder.</p><p><strong>(Choice B)</strong>&nbsp; Most patients with von Willebrand deficiency are asymptomatic, but a minority develop easy bruising or mucocutaneous bleeding.&nbsp; PTT is sometimes prolonged because von Willebrand factor acts as a carrier for clotting factor VIII (degradation is increased in the setting of reduced von Willebrand factor).&nbsp; However, a mixing study would correct PTT.</p><p><strong>(Choice C)</strong>&nbsp; Hemophilia B is an inherited deficiency of clotting factor IX.&nbsp; Although it causes prolonged PTT, it corrects with mixing studies.&nbsp; Furthermore, almost all cases present in early childhood and occur in male children (because it is X-linked recessive).</p><p><strong>(Choice D)</strong>&nbsp; Vitamin K is found in green, leafy vegetables and is required to generate clotting factors VII, IX, X, and prothrombin.&nbsp; Although deficiency is rare in healthy individuals, it usually manifests with prolonged PT because of clotting factor VII deficiency.&nbsp; In severe cases, PTT can be prolonged, but both PT and PTT would correct with mixing studies.</p><p><strong>(Choice E)</strong>&nbsp; Infections can sometimes cause disseminated intravascular coagulation, which is marked by the excessive consumption of clotting factors.&nbsp; However, most patients have thrombocytopenia (due to the formation of intravascular microthrombi) and prolonged PT and PTT.&nbsp; Furthermore, signs of bleeding (eg, oozing at venipuncture sites) and thrombosis are often present.</p><p><strong>Educational objective:</strong><br>Patients with antiphospholipid antibodies (eg, lupus anticoagulant) have prolonged PTT that fail to correct with a mixing test (combination with normal plasma).&nbsp; Most patients with antiphospholipid antibodies are asymptomatic, but a minority develop antiphospholipid-antibody syndrome (thromboembolism, fetal loss).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15843,
            "topic": "Antiphospholipid syndrome",
            "titleId": 15843,
            "title": "Antiphospholipid syndrome",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "1",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoantibodies against phospholipids",
                    "choiceNumber": 1,
                    "correctTaken": 9280,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased von Willebrand factor level",
                    "choiceNumber": 2,
                    "correctTaken": 3893,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inherited deficiency of factor IX",
                    "choiceNumber": 3,
                    "correctTaken": 1351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nutritional deficiency of vitamin K",
                    "choiceNumber": 4,
                    "correctTaken": 589,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uncontrolled consumption of clotting factors",
                    "choiceNumber": 5,
                    "correctTaken": 737,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "702",
                    "mediaDataId": 0,
                    "title": "Antiphospholipid syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 209,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 15852,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 440,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 4616,
            "questionIndex": 4616,
            "questionText": "<p>A 35-year-old woman with no past medical history is hospitalized with severe shortness of breath.&nbsp; She also has swelling and tenderness of her right calf.&nbsp; CT angiogram of the chest shows pulmonary embolism.&nbsp; Compression ultrasonography is consistent with right femoral vein thrombosis.&nbsp; The patient is started on anticoagulation therapy.&nbsp; On the sixth day of hospitalization, she develops right arm pain.&nbsp; Physical examination shows a cold right upper extremity with no palpable peripheral pulse.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"600\"><tbody><tr><td>Hematocrit</td><td>42%</td></tr><tr><td>Leukocytes</td><td>8,500/&micro;L</td></tr><tr><td>Platelets</td><td>76,000/&micro;L (246,000/&micro;L at presentation)</td></tr><tr><td>Prothrombin time</td><td>13 sec</td></tr><tr><td>Activated partial thromboplastin time (aPTT)</td><td>63 sec</td></tr></tbody></table></blockquote><p>Which of the following drugs was most likely used to treat this patient&#39;s deep venous thrombosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s markedly elevated aPTT is suggestive of unfractionated heparin use.&nbsp; The presentation of new-onset thrombocytopenia and arterial thrombosis in the setting of heparin use is due to heparin-induced thrombocytopenia (HIT).&nbsp; The 2 forms of HIT differ in onset, clinical course, and severity of disease.</p><p><strong>Type 1 HIT</strong> occurs due to a nonimmune direct effect of heparin on platelet activation and usually presents within the first 2 days of heparin exposure.&nbsp; The platelet count then normalizes with continued heparin therapy and there are no clinical consequences.</p><p><strong>Type 2 HIT</strong> is a more serious immune-mediated disorder due to <strong>antibodies to platelet factor 4 (PF4)</strong> complexed with heparin.&nbsp; This leads to platelet aggregation, thrombocytopenia, and thrombosis (both arterial and venous).&nbsp; Platelet counts usually drop <u>&gt;</u>50% from baseline, with a nadir of 30,000-60,000/&micro;L.&nbsp; Type 2 HIT usually presents <strong>5-10 days</strong> after the initiation of heparin therapy and may lead to life-threatening consequences (eg, limb ischemia, stroke).</p><p><strong>(Choice A)</strong>&nbsp; Enoxaparin typically does not prolong the activated partial thromboplastin time (it may in rare cases cause mild prolongation).&nbsp; However, the risk of HIT is lower with enoxaparin than with unfractionated heparin therapy.</p><p><strong>(Choices B and C)</strong>&nbsp; The risk of developing HIT is negligible with factor X-a inhibitors such as fondaparinux and rivaroxaban.</p><p><strong>(Choice E)</strong>&nbsp; Oral warfarin is typically co-administered with intravenous unfractionated heparin (or low-molecular-weight heparin) in the initial treatment of venous thromboembolism.&nbsp; It is not used alone due to initial hypercoagulable state from transient protein C depletion and risk of thrombosis and skin necrosis.&nbsp; Warfarin typically causes prothrombin time prolongation (normal in this patient) and does not affect platelet count.</p><p><strong>Educational objective:</strong><br>Heparin-induced thrombocytopenia should be suspected in patients receiving heparin anticoagulation who have thrombocytopenia, thrombosis (arterial or venous), or a &gt;50% drop in the platelet count from baseline 5-10 days after the initiation of treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7111,
            "topic": "Heparin induced thrombocytopenia",
            "titleId": 7111,
            "title": "Heparin induced thrombocytopenia",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Enoxaparin",
                    "choiceNumber": 1,
                    "correctTaken": 7035,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fondaparinux",
                    "choiceNumber": 2,
                    "correctTaken": 3031,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rivaroxaban",
                    "choiceNumber": 3,
                    "correctTaken": 5149,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Unfractionated heparin",
                    "choiceNumber": 4,
                    "correctTaken": 102016,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Warfarin",
                    "choiceNumber": 5,
                    "correctTaken": 8068,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1071,1293,true,-1,1*1430,1853,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24319250",
                    "mediaDataId": 0,
                    "title": "Heparin-induced thrombocytopenia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24319250",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 57,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 125299,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 384,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 2250,
            "questionIndex": 2250,
            "questionText": "<p>A 65-year-old man comes to the emergency department due to severe right leg pain and is found to have an acute thrombotic occlusion of the right popliteal artery.&nbsp; He has a history of hypertension, type 2 diabetes mellitus, and hyperlipidemia.&nbsp; The patient is admitted to the surgical floor and initiated on intravenous unfractionated heparin.&nbsp; The following morning, he undergoes surgical revascularization of the right leg.&nbsp; The patient&#39;s hospital course progresses well, but 5 days postoperatively his platelet count decreases from 240,000/mm<font size=\"2\"><sup>3</sup></font> on admission to 65,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; His vital signs are stable.&nbsp; The surgical wound is healing well.&nbsp; There are no rashes or pitting edema.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t79879\"><table class=\"table-default-style\" style=\"width:505px\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features of type 2 heparin-induced thrombocytopenia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical signs</strong></p></td><td><p>Suspected with heparin exposure &gt;5 days &amp; any of the following:</p><ul><li>Platelet count reduction &gt;50% from baseline</li><li>Arterial or venous thrombosis</li><li>Necrotic skin lesions at heparin injection sites</li><li>Acute systemic (anaphylactoid) reactions after heparin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic evaluation</strong></p></td><td><ul><li>Serotonin release assay: gold standard confirmatory test</li><li>Start treatment in suspected cases prior to confirmatory tests</li></ul></td></tr><tr><td><p align=\"center\"><strong>Therapy</strong></p></td><td><ul><li>Stop all heparin products</li><li>Start a direct thrombin inhibitor (eg, argatroban) or fondaparinux (synthetic pentasaccharide)</li></ul></td></tr></tbody></table></div></p><p>Type 2 <strong>heparin-induced thrombocytopenia</strong> (HIT) is a life-threatening complication of heparin therapy.&nbsp; A drop in the platelet count by <strong>&gt;50%</strong> or a new thrombus within <strong>5-10 days</strong> of initiating heparin should raise suspicion for HIT (HIT may manifest sooner in patients previously exposed to heparin).&nbsp; HIT is <strong>antibody mediated</strong> and causes a mild to moderate <strong>thrombocytopenia</strong> (rarely &lt;20,000/mm<font size=\"2\"><sup>3</sup></font>) with minimal bleeding risk.&nbsp; However, venous and arterial <strong>thrombotic risk</strong> is significant, as high as 50% in untreated HIT.</p><p>If HIT is suspected, all heparin products (including heparin flushes) should be <strong>discontinued immediately</strong>, and <strong>anticoagulation</strong> should be initiated with a nonheparin medication (eg, argatroban, fondaparinux).</p><p><strong>(Choices A, B, and C)</strong>&nbsp; Although the diagnosis of HIT is confirmed with a high titer immunoassay or a functional assay of the blood (eg, serotonin release assay), discontinuing heparin and initiating nonheparin anticoagulation should not be delayed for laboratory results due to the high risk of thrombus.&nbsp; Platelet counts typically normalize 2-7 days after stopping heparin; transfusions are not required unless the patient is overtly bleeding (which is uncommon in HIT).</p><p><strong>(Choice E)</strong>&nbsp; Warfarin is used for anticoagulation maintenance in patients with HIT but only after the patient has received another anticoagulant and the platelet count is &gt;150,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Initial treatment with warfarin is contraindicated in patients with HIT as it rapidly lowers protein C levels, which may transiently increase the risk of thrombus.</p><p><strong>(Choice F)</strong>&nbsp; All heparin products, including low molecular weight heparin, should be avoided in patients with HIT.</p><p><strong>Educational objective:</strong><br>Suspected heparin-induced thrombocytopenia requires immediate cessation of all forms of heparin and initiation of anticoagulation with an alternate agent (eg, argatroban, fondaparinux).&nbsp; Once the platelet count is &gt;150,000/mm<font size=\"2\"><sup>3</sup></font>, most patients can be switched safely to warfarin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7111,
            "topic": "Heparin induced thrombocytopenia",
            "titleId": 7111,
            "title": "Heparin induced thrombocytopenia",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "4",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Continue heparin and obtain a serotonin release assay",
                    "choiceNumber": 1,
                    "correctTaken": 884,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stop heparin and observe",
                    "choiceNumber": 2,
                    "correctTaken": 2722,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stop heparin and order a platelet transfusion",
                    "choiceNumber": 3,
                    "correctTaken": 1465,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stop heparin and start argatroban",
                    "choiceNumber": 4,
                    "correctTaken": 17839,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stop heparin and start warfarin",
                    "choiceNumber": 5,
                    "correctTaken": 1577,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Switch to low molecular weight heparin",
                    "choiceNumber": 6,
                    "correctTaken": 2720,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "245,348,true,-1,1*525,619,true,-1,1*2484,2576,true,-1,1*1011,1132,true,-1,1*1155,1241,true,-1,1*1996,2161,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22399304",
                    "mediaDataId": 0,
                    "title": "Heparin-induced thrombocytopenia: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22399304",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 75,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 27207,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 456,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 2208,
            "questionIndex": 2208,
            "questionText": "<p>A 53-year-old man comes to the office due to a 3-day history of right leg swelling and pain.&nbsp; He has had no chest pain or dyspnea.&nbsp; The patient describes himself as healthy, and his last visit to the doctor was 10 years ago.&nbsp; He has had no weight loss or abdominal pain.&nbsp; The patient smokes and has a 30-pack-year history.&nbsp; He has an active lifestyle and has not recently traveled.&nbsp; The patient&#39;s mother died of breast cancer, and his father has congestive heart failure.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 140/80 mm Hg, pulse is 70/min, and respirations are 14/min.&nbsp; Oxygen saturation is 97% on room air.&nbsp; Normal vesicular breath sounds and cardiac sounds are heard on chest auscultation.&nbsp; Abdominal examination is unremarkable.&nbsp; The right leg is swollen and tender up to midthigh.&nbsp; Results of complete blood cell count and coagulation studies are within normal limits.&nbsp; Duplex ultrasonography demonstrates incompressible popliteal and femoral veins, and anticoagulation is started immediately.&nbsp; Chest x-ray is unremarkable.&nbsp; Which of the following is most appropriate in evaluation of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has <strong>deep venous thrombosis</strong> (DVT) of the popliteal and femoral veins.&nbsp; Risk factors for venous thromboembolism (VTE) include <strong>inherited</strong> (eg, factor V Leiden, prothrombin gene mutation, protein C deficiency) and <strong>acquired</strong> (eg, immobilization, surgery, <strong>malignancy</strong>, medications) factors.&nbsp; Initial evaluation is directed at identifying major causes of VTE or factors that can increase the risks of anticoagulation therapy; evaluation should include careful history, physical examination, and limited diagnostic testing (eg, blood counts, serum chemistries, coagulation studies, fecal occult blood testing, chest x-ray).</p><p>In the absence of any clear provoking factors (eg, recent surgery, immobilization), patients with a first episode of VTE, such as this man, should be referred for <strong>age-appropriate cancer screening</strong> (eg, <strong>colonoscopy</strong>) to evaluate for malignancy as a potential risk factor for VTE.&nbsp; In addition, any suspicious symptoms of malignancy (eg, weight loss, unexplained pain) warrant consideration for more extensive cancer evaluation (eg, CT scan of the abdomen) <strong>(Choice B)</strong>.</p><p><strong>(Choice C)</strong>&nbsp; Because of this patient&#39;s smoking history, he should be offered screening for lung cancer with low-dose CT scan of the chest.&nbsp; However, he has a normal chest x-ray and no symptoms concerning for lung cancer (eg, hemoptysis, cough), so positron emission tomography of the chest would not be appropriate.</p><p><strong>(Choice D)</strong>&nbsp; Testing for an inherited thrombophilia (eg, factor V Leiden; deficiency of protein C, protein S, or antithrombin III) is generally considered only if the patient&#39;s history is suggestive of a genetic predisposition (eg, recurrent VTE; multiple or unusual sites of thrombosis; family history of VTE, particularly at a young age).</p><p><strong>(Choice E)</strong>&nbsp; Carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen are tumor markers generally used to trend disease progression in patients with diagnosed pancreatic and gastrointestinal tract cancer, respectively.&nbsp; They are not effective screening tests.</p><p><strong>Educational objective:</strong><br>In the absence of any clear provoking factors (eg, recent surgery, immobilization), patients with a first episode of venous thromboembolism should be referred for age-appropriate cancer screening (eg, colonoscopy) to evaluate for malignancy as a potential risk factor for this disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "1",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age-appropriate cancer screening",
                    "choiceNumber": 1,
                    "correctTaken": 7671,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen",
                    "choiceNumber": 2,
                    "correctTaken": 1679,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Positron emission tomography of the chest",
                    "choiceNumber": 3,
                    "correctTaken": 787,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Protein C, protein S, and antithrombin tests",
                    "choiceNumber": 4,
                    "correctTaken": 2879,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen tests",
                    "choiceNumber": 5,
                    "correctTaken": 406,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "458,655,true,-1,1*1447,1775,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "447",
                    "mediaDataId": 0,
                    "title": "Venous thromboembolism (VTE):  Deep venous thrombosis (DVT) and pulmonary embolism (PE)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26095467",
                    "mediaDataId": 0,
                    "title": "Screening for occult cancer in unprovoked venous thromboembolism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26095467",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 155,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 13422,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 650,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 2426,
            "questionIndex": 2426,
            "questionText": "<p>A 3-year-old boy is brought to the emergency department by his stepfather due to right knee swelling.&nbsp; The knee swelled immediately after the patient fell while playing outside.&nbsp; He is generally healthy and very active.&nbsp; His stepfather reports that last week while climbing on the living room couch, he fell onto the floor and developed a large bruise to his left hip.&nbsp; Temperature is 36.7 C (98.1 F).&nbsp; Examination shows an uncomfortable-appearing boy with significant swelling of the right knee.&nbsp; The patient has pain with knee movement and limited range of motion.&nbsp; An area of ecchymosis is seen on the left hip.&nbsp; There are also scattered ecchymoses to the anterior shins.&nbsp; The remainder of the physical examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp; &nbsp; Hemoglobin</td><td>13 g/dL</td></tr><tr><td>&nbsp; &nbsp; Platelets</td><td>187,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp; &nbsp; Leukocytes</td><td>8,500/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Radiograph of the right knee shows a large effusion but no fracture.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41222\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hemophilia A &amp; B</strong></p></td></tr><tr><td><p align=\"center\"><strong>Inheritance</strong></p></td><td><ul><li>X-linked recessive</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Delayed/prolonged bleeding after mild trauma<ul style=\"list-style-type:circle;\"><li>Hemarthrosis, intramuscular hematomas</li><li>Gastrointestinal or genitourinary tract bleeding</li><li>Intracranial hemorrhage</li></ul></li><li>Complications: hemophilic arthropathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>&uarr; Activated PTT</li><li>Normal platelet count &amp; PT</li><li>Absent or &darr; factor VIII (hemophilia A) or factor IX<br />(hemophilia B) activity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Factor replacement</li><li>Desmopressin for mild hemophilia A</li></ul></td></tr></tbody></table></div><p>This child&#39;s history of easy bruising and acute onset of joint effusion following minor trauma (suggestive of hemarthrosis) raise concern for <strong>hemophilia</strong>, a coagulation disorder.&nbsp; Hemophilia A and B, or deficiency of factor VIII and IX, respectively, are X-linked recessive disorders that typically affect boys.</p><p>The severity of symptoms depends on the degree of factor deficiency, ranging from spontaneous bleeding (eg, intracranial hemorrhage) to delayed postprocedure bleeding (eg, oozing from dental extraction site).&nbsp; <strong>Hemarthrosis</strong>, or joint hemorrhage, is common and typically presents following mild injury with pain and swelling in weight-bearing joints (eg, knees, ankles).&nbsp; Recurrent hemarthroses in the same joint can lead to chronic hemophilic arthropathy.</p><p>Initial screening tests for hemophilia include <strong>coagulation studies</strong> and a complete blood count.&nbsp; Hemophilia causes <strong>prolonged PTT</strong> due to absent factor VIII or IX but <strong>normal PT</strong>; platelet count is normal.</p><p><strong>(Choice A)</strong>&nbsp; Bone marrow evaluation is indicated for spontaneous bruising in patients with anemia, thrombocytopenia, and leukocytosis/leukopenia, which are findings suggestive of leukemia.&nbsp; This patient has normal cell counts, and bone marrow evaluation is contraindicated in severe hemophilia due to bleeding risk.</p><p><strong>(Choice C)</strong>&nbsp; A skeletal survey (full body x-ray) is indicated when <a href=\"1563\">nonaccidental trauma</a> is suspected.&nbsp; Red flags include an inconsistent history of bruises that are patterned (eg, belt buckle) or in unusual locations (eg, abdomen, buttocks).&nbsp; This patient has a knee injury from a witnessed fall and bruising on the shins, which are typical of normal toddler injuries.</p><p><strong>(Choice D)</strong>&nbsp; Reassurance and observation are appropriate for minor contusions or sprains.&nbsp; Hemarthrosis requires further evaluation and treatment to prevent recurrent bleeds.</p><p><strong>(Choice E)</strong>&nbsp; Coagulopathy may result from advanced liver disease, which impairs production of vitamin K&ndash;dependent clotting factors (II, VII, IX, X) and often causes thrombocytopenia.&nbsp; Coagulation studies should be obtained first, and if abnormal, further evaluation of the liver (eg, transaminases) should be conducted.</p><p><strong>(Choice F)</strong>&nbsp; Synovial fluid Gram stain and culture are indicated for septic arthritis, which typically presents with refusal to bear weight and signs of systemic inflammation (eg, fever, leukocytosis), which are not present in this patient.</p><p><strong>Educational objective:</strong><br>Hemarthrosis after minor trauma is suspicious for a bleeding disorder (eg, hemophilia), and coagulation studies should be obtained.&nbsp; Hemophilia presents with a prolonged PTT, normal PT, and normal platelet count.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16524,
            "topic": "Hemophilias",
            "titleId": 16524,
            "title": "Hemophilias",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone marrow evaluation",
                    "choiceNumber": 1,
                    "correctTaken": 83,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coagulation studies",
                    "choiceNumber": 2,
                    "correctTaken": 10928,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Complete skeletal survey",
                    "choiceNumber": 3,
                    "correctTaken": 2797,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and observation",
                    "choiceNumber": 4,
                    "correctTaken": 1948,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum transaminase levels",
                    "choiceNumber": 5,
                    "correctTaken": 21,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Synovial fluid Gram stain and culture",
                    "choiceNumber": 6,
                    "correctTaken": 601,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22187396",
                    "mediaDataId": 0,
                    "title": "Pediatric hemophilia:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22187396",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23530171",
                    "mediaDataId": 0,
                    "title": "Evaluating for suspected child abuse:  conditions that predispose to bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23530171",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 75,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 16378,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 501,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 4187,
            "questionIndex": 4187,
            "questionText": "<p>A 15-year-old boy with cystic fibrosis is brought to the emergency department for epistaxis.&nbsp; He first noticed intermittent nose bleeds a few days ago after a week of nasal congestion with low-grade fever.&nbsp; The bleeding worsened today and has been difficult to control.&nbsp; The patient has also had easy bruising for the past 2 months.&nbsp; He has not been taking his prescribed medications.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 108/72 mm Hg, pulse is 90/min, and respirations are 18/min.&nbsp; The patient is alert and cooperative.&nbsp; There is active bleeding from the left naris.&nbsp; The pupils are equal and reactive.&nbsp; Breath sounds are coarse bilaterally, and cardiac examination is unremarkable.&nbsp; The abdomen is soft and nontender with no organomegaly.&nbsp; Strength and sensations are 5/5.&nbsp; Reflexes are equal bilaterally, and gait appears normal.&nbsp; Skin examination shows diffuse bruises along the extremities.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T58363\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vitamin K deficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk<br>factors</strong></p></td><td><ul><li>Inadequate dietary intake (eg, malnutrition)</li><li>Disorders of fat malabsorption<ul style=\"list-style-type:circle;\"><li>Cystic fibrosis</li><li>Biliary atresia</li></ul></li></ul><ul><li>Disorders of intestinal inflammation<ul style=\"list-style-type:circle;\"><li>Celiac disease</li><li>Inflammatory bowel disease</li></ul></li><li>Decreased production by bacterial flora (eg, frequent antibiotic use)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Easy bruising</li><li>Mucosal bleeding</li><li>Gastrointestinal bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br>findings</strong></p></td><td><ul><li>&#8593; PT &amp; INR</li><li>If severely deficient, &#8593; PTT</li></ul></td></tr></tbody></table></div><p>This patient with <strong>cystic fibrosis</strong> (CF) has bruising and epistaxis likely due to deficiency of vitamin K, a fat-soluble vitamin.&nbsp; Patients with CF are at increased risk for <strong>vitamin K deficiency</strong> because defective chloride transport causes viscous exocrine secretions to block pancreatic ducts, leading to <strong>pancreatic insufficiency</strong>.&nbsp; Impaired secretion of pancreatic enzymes (eg, lipase) results in the <strong>malabsorption</strong> of fats and <strong>fat-soluble vitamins</strong> (ie, A, D, E, and K).&nbsp; In patients with CF, nonadherence to pancreatic enzyme replacement and fat-soluble vitamin supplementation, as seen here, increases the risk of bleeding diatheses.</p><p>Because vitamin K normally acts as an important cofactor in the <a href=\"35655\">hepatic activation</a> of coagulation <strong>factors II</strong>, <strong>VII</strong>, <strong>IX</strong>, and <strong>X</strong>, deficiency results in <strong>low</strong> levels of <strong>activated</strong> vitamin K&ndash;dependent <strong>coagulation factors</strong>.&nbsp; PT is prolonged due to deficiency of <a href=\"466\">activated factor VII</a>; activated PTT is typically normal but can be prolonged with severe deficiency.</p><p>Symptoms include <strong>easy bruising</strong> and mucosal bleeding (eg, <strong>epistaxis</strong>), as seen in this patient.&nbsp; Acute bleeding due to vitamin K deficiency is treated with vitamin K replacement.</p><p><strong>(Choice B)</strong>&nbsp; Increased coagulation factor consumption, as seen with disseminated intravascular coagulation, can cause mucosal bleeding but is triggered by an underlying condition such as sepsis, trauma, or malignancy, none of which are present in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Increased platelet sequestration occurs with hypersplenism, which is common with sickle cell disease and leukemia but not CF.&nbsp; In addition, patients with hypersplenism have an enlarged spleen, which is not seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Reduced activity of ADAMTS13, the enzyme that cleaves von Willebrand factor, describes the pathogenesis of thrombotic thrombocytopenic purpura (TTP), an acute and rapidly progressive disorder.&nbsp; Although TTP can cause acute bleeding, chronic bruising would not be expected.&nbsp; In addition, abdominal pain and neurologic symptoms (eg, confusion) are often present but are not seen here.</p><p><strong>(Choice E)</strong>&nbsp; Deficiency of vitamin C can cause easy bruising and bleeding, but because it is not a fat-soluble vitamin, patients with CF are not at risk for vitamin C malabsorption.</p><p><strong>Educational objective:</strong><br>Patients with cystic fibrosis are at risk for fat-soluble vitamin (ie, A, D, E, and K) deficiency due to fat malabsorption from pancreatic insufficiency.&nbsp; Vitamin K is an important cofactor in coagulation factor activation; deficiency causes easy bruising and mucosal bleeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 12891,
            "topic": "Cystic fibrosis",
            "titleId": 12891,
            "title": "Cystic fibrosis",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Absent coagulation factor activation",
                    "choiceNumber": 1,
                    "correctTaken": 8422,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased coagulation factor consumption",
                    "choiceNumber": 2,
                    "correctTaken": 1255,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased platelet sequestration",
                    "choiceNumber": 3,
                    "correctTaken": 1950,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduced von Willebrand factor cleaving enzyme activity",
                    "choiceNumber": 4,
                    "correctTaken": 2330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin C malabsorption",
                    "choiceNumber": 5,
                    "correctTaken": 2524,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "156,171,true,-1,1*209,250,true,-1,1*251,320,true,-1,1*416,455,true,-1,1*370,395,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27068495",
                    "mediaDataId": 0,
                    "title": "ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27068495",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26410287",
                    "mediaDataId": 0,
                    "title": "Routine use of daily oral vitamin K to treat infants with cystic fibrosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26410287",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 181,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 16481,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 513,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 4338,
            "questionIndex": 4338,
            "questionText": "<p>A 35-year-old man is brought to the emergency department by his roommate, who says that the patient has been acting strangely for 2 days.&nbsp; The patient has spent most of the time in his room and has not eaten much.&nbsp; He has not noted headaches, focal weakness, or sensory symptoms.&nbsp; Medical history is significant for untreated HIV and hepatitis C infections.&nbsp; Temperature is 37.9 C (100.2 F), blood pressure is 140/86 mm Hg, pulse is 96/min, and respirations are 16/min.&nbsp; Mild scleral icterus is present.&nbsp; The oropharynx is normal and there is no nuchal rigidity.&nbsp; Examination of the chest and abdomen is unremarkable.&nbsp; Neurologic examination shows no focal deficits.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Hemoglobin</td><td style=\"vertical-align:middle;\">7.6 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Mean corpuscular volume</td><td style=\"vertical-align:middle;\">85 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Reticulocytes</td><td style=\"vertical-align:middle;\">8.1%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Platelets</td><td style=\"vertical-align:middle;\">26,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Leukocytes</td><td style=\"vertical-align:middle;\">4,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Blood urea nitrogen</td><td style=\"vertical-align:middle;\">30 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Creatinine</td><td style=\"vertical-align:middle;\">2.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Calcium</td><td style=\"vertical-align:middle;\">9.4 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Glucose</td><td style=\"vertical-align:middle;\">98 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Total bilirubin</td><td style=\"vertical-align:middle;\">3.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Indirect bilirubin</td><td style=\"vertical-align:middle;\">2.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Alkaline phosphatase</td><td style=\"vertical-align:middle;\">108 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">62 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp; Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">64 U/L</td></tr></tbody></table><p>CT scan of the head with and without contrast reveals no abnormalities.&nbsp; Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32902\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Thrombotic thrombocytopenic purpura</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li><strong>&#8595;</strong> ADAMTS13 level &#8594; uncleaved vWF multimers &#8594; platelet<br>trapping &amp; activation</li><li>Acquired (autoantibody) or hereditary</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Hemolytic anemia (&#8593; LDH, &#8595; haptoglobin) with schistocytes</li><li>Thrombocytopenia (&#8593; bleeding time, normal PT/PTT)</li></ul><p>Sometimes with:</p><ul><li>Renal failure</li><li>Neurologic manifestations</li><li>Fever</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Plasma exchange</li><li>Glucocorticoids</li><li>Rituximab</li><li>Caplacizumab</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>LDH</strong> = lactate dehydrogenase; <strong>vWF</strong> = von Willebrand factor.</p></td></tr></tbody></table></div><p><strong>Thrombotic thrombocytopenic purpura</strong> (TTP) is marked by <strong>small vessel thrombi</strong> that consume platelets, shear red blood cells, and cause end organ damage (primarily renal and CNS).&nbsp; This patient has several manifestations of the classic TTP&nbsp;<strong>pentad</strong>, which includes:</p><ul><li>Thrombocytopenia.</li><li><strong>Microangiopathic hemolytic anemia</strong> (MAHA).</li><li>Renal insufficiency.</li><li>Neurologic changes (eg, acting &#x22;strangely&#x22;).</li><li>Fever (not always present).</li></ul><p>TTP is usually due to an acquired <strong>autoantibody</strong> to ADAMTS13, a protease that cleaves von Willebrand factor (vWF) off the endothelial surface.&nbsp; As ADAMTS13 levels fall (due to the antibody), vWF multimer&nbsp;accumulation on the endothelial wall traps&nbsp;platelets at areas of high shearing force (eg, small arterioles, capillaries), leading to thrombus&nbsp;formation.</p><p>Most cases arise in middle age and are idiopathic; however, chronic infections (eg, <strong>HIV</strong>), malignancy, or certain medications can increase the risk for TTP.&nbsp; Diagnosis is based on clinical and laboratory data.&nbsp; Thrombocytopenia (platelet count &lt;30,000/mm<font size=\"2\"><sup>3</sup></font>) and MAHA (eg, increased levels of indirect bilirubin, aspartate aminotransferase [AST], alanine aminotransferase [ALT], lactate dehydrogenase, and reticulocytes) should always raise suspicion.&nbsp; A&nbsp;<a href=\"5142\">peripheral blood smear</a> showing&nbsp;intravascular hemolysis (eg, <strong>schistocytes</strong>, helmet cells, triangle cells)&nbsp;supports the diagnosis</p><p>TTP must be <strong>treated urgently</strong> with <strong>plasma exchange</strong>.&nbsp; Patients should also receive high-dose <strong>glucocorticoids</strong> and <strong>rituximab</strong> to suppress autoantibody production&nbsp;by B cells.&nbsp; Caplacizumab (monoclonal antibody that blocks the vWF binding site for the ADAMTS13-autoantibody) is frequently added for severe disease.</p><p><strong>(Choice A)</strong>&nbsp; Bone marrow biopsy is useful in unknown causes of anemia and thrombocytopenia.&nbsp; This patient has evidence of intravascular hemolysis and end organ damage, making TTP most likely.</p><p><strong>(Choice B)</strong>&nbsp; Flow cytometry can evaluate for paroxysmal nocturnal hemoglobinuria, which can cause hemolysis but not neurologic changes; hemoglobinuria and dyspnea are common, and&nbsp;thrombocytopenia and renal failure are also less likely.&nbsp; Flow cytometry can assess CD4 cell count, which would be useful in this patient with HIV; however,&nbsp;urgent TTP management takes precedence.</p><p><strong>(Choices C and E)</strong>&nbsp; Cirrhosis (eg, from hepatitis C) may cause acute confusion (eg, encephalopathy).&nbsp; However, this patient&#39;s mild AST and ALT elevations, indirect hyperbilirubinemia, and significant anemia likely reflect intravascular hemolysis due to TTP, not intrinsic liver pathology requiring ultrasonography or liver biopsy.&nbsp; Indirect (vs direct) hyperbilirubinemia also makes gallbladder disease (evaluated by right upper quadrant ultrasonography) less likely.</p><p><strong>Educational objective:</strong><br>Thrombotic thrombocytopenic purpura should be suspected in patients with thrombocytopenia and intravascular hemolytic anemia.&nbsp; Neurologic changes and renal failure may be present at diagnosis.&nbsp; Peripheral blood smear will show intravascular hemolysis (eg, schistocytes).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8735,
            "topic": "Thrombotic thrombocytopenic purpura",
            "titleId": 8735,
            "title": "Thrombotic thrombocytopenic purpura",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone marrow biopsy",
                    "choiceNumber": 1,
                    "correctTaken": 1592,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flow cytometry of peripheral blood",
                    "choiceNumber": 2,
                    "correctTaken": 1703,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 965,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral blood smear",
                    "choiceNumber": 4,
                    "correctTaken": 8459,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Right upper quadrant ultrasonography",
                    "choiceNumber": 5,
                    "correctTaken": 2964,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "322,383,true,-1,1*395,449,true,-1,1*769,922,true,-1,1*1505,1532,true,-1,1*1547,1567,true,-1,1*1588,1651,true,-1,1*1338,1432,true,-1,1*1857,2164,true,-1,1*2367,2730,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "665",
                    "mediaDataId": 0,
                    "title": "Thrombotic microangiopathies: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 238,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 15683,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 900,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 3089,
            "questionIndex": 3089,
            "questionText": "<p>A 3-day-old boy is brought to the emergency department due to bruising.&nbsp; The patient was born at 39 weeks gestation via vaginal delivery at home, and this is his first medical evaluation.&nbsp; He is breastfed exclusively.&nbsp; Vital signs are within normal limits.&nbsp; Several ecchymoses are visible on the extremities.&nbsp; Physical examination is otherwise unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"width:217.55pt; vertical-align:middle;\">270,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"width:108pt; vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">PT</td><td style=\"width:217.55pt; vertical-align:middle;\">26 sec</td><td style=\"width:108pt; vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Activated PTT</td><td style=\"width:217.55pt; vertical-align:middle;\">42 sec</td><td style=\"width:108pt; vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Thrombin time</td><td style=\"width:217.55pt; vertical-align:middle;\">18 sec (normal: 15-20)</td><td style=\"width:108pt; vertical-align:middle;\"></td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t58280\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Infantile vitamin K&ndash;deficient bleeding</strong></p></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Pathophysiology</strong></p></td><td style=\"width: 70%;\"><ul><li>Low vitamin&nbsp;K stores (poor placental transfer, sterile gut, low content in breast milk)</li><li>Inefficient vitamin&nbsp;K use by immature liver</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Classically presents on day 2-7 of life*</li><li>Easy bruising</li><li>Umbilical, mucosal &amp; gastrointestinal bleeding</li><li>Intracranial hemorrhage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&uarr;&nbsp;PT</li><li>&uarr;&nbsp;PTT (if severe)</li><li>Normal platelet count</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Intramuscular vitamin&nbsp;K at birth</li></ul></td></tr><tr><td colspan=\"2\"><p>*Can occur up to age 6&nbsp;months.</p></td></tr></tbody></table></div><p>This neonate who has not received prior medical care has bruising and prolonged PT and PTT, findings concerning for <strong>vitamin K&ndash;deficient bleeding</strong> (VKDB).</p><p>Vitamin K is essential for enzymatic carboxylation and activation of coagulation factors II (prothrombin), VII, IX, and X.&nbsp; <strong>Newborns</strong> are vitamin K deficient due to poor placental transfer, lack of intestinal flora to synthesize vitamin K, and immature liver function (ie, poor vitamin K utilization).&nbsp; Therefore, <strong>intramuscular vitamin K</strong> is given at birth to <strong>prevent spontaneous bleeding</strong>.&nbsp; Neonates who <strong>do not receive</strong> this injection, such as this patient, are at <strong>highest risk</strong> of VKDB, particularly if exclusively breastfed because breast milk contains insufficient vitamin K.</p><p>Classic VKDB presents on <strong>day 2-7</strong> of life with <strong>easy bruising</strong>, <strong>mucosal bleeding</strong> (eg, epistaxis), <strong>gastrointestinal hemorrhage</strong>, and/or <strong>intracranial hemorrhage</strong>.&nbsp; Late-onset disease can occur up to age 6 months.&nbsp; Because of reduced coagulation factor carboxylation, laboratory evaluation shows <strong>prolonged PT</strong> and, in severe deficiency, <strong>prolonged PTT</strong>.&nbsp; The diagnosis is confirmed by the reversal of laboratory abnormalities with vitamin K administration.</p><p><strong>(Choice A)</strong>&nbsp; Afibrinogenemia is a rare, autosomal recessive bleeding disorder characterized by absent fibrinogen production.&nbsp; Severe bleeding classically develops at the site of the umbilical cord after birth.&nbsp; Like PT and PTT, thrombin time is prolonged.</p><p><strong>(Choice B)</strong>&nbsp; Disseminated intravascular coagulation typically presents with bleeding (eg, bruising, intravenous site oozing) due to consumption of platelets and clotting factors.&nbsp; Laboratory findings include prolonged PT and PTT and thrombocytopenia.&nbsp; This patient&#39;s platelet count is normal.</p><p><strong>(Choices C and D)</strong>&nbsp; Severe von Willebrand disease (characterized by impaired synthesis of von Willebrand factor) and factor VIII deficiency (hemophilia A) can present with easy bruising and bleeding in the neonatal period.&nbsp; Both conditions have a prolonged PTT but normal PT.</p><p><strong>(Choice E)</strong>&nbsp; Impaired platelet function can be caused by medications (eg, aspirin), metabolic conditions (eg, uremia, liver disease), or congenital disorders (eg, Glanzmann thrombasthenia).&nbsp; Patients have mucocutaneous bleeding and petechiae; PT, PTT, and platelet count are normal.</p><p><strong>Educational objective:</strong><br>Vitamin K&ndash;deficient bleeding classically presents with bleeding in newborns (day 2-7 of life) who did not receive intramuscular vitamin K, which is essential in the enzymatic carboxylation and activation of coagulation factors II (prothrombin), VII, IX, and X.&nbsp; Symptoms include easy bruising, mucosal bleeding, gastrointestinal bleeding, and/or intracranial hemorrhage; laboratory evaluation reveals prolonged PT with or without prolonged PTT.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9108,
            "topic": "Vitamin k deficiency",
            "titleId": 9108,
            "title": "Vitamin k deficiency",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "6",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Absent fibrinogen production",
                    "choiceNumber": 1,
                    "correctTaken": 562,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coagulation factor consumption",
                    "choiceNumber": 2,
                    "correctTaken": 770,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased von Willebrand factor synthesis",
                    "choiceNumber": 3,
                    "correctTaken": 1106,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Deficient factor VIII production",
                    "choiceNumber": 4,
                    "correctTaken": 1551,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired platelet function",
                    "choiceNumber": 5,
                    "correctTaken": 663,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduced coagulation factor carboxylation",
                    "choiceNumber": 6,
                    "correctTaken": 11812,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "85,216,true,-1,1*1572,1674,true,-1,1*1798,1929,true,-1,1*2507,2778,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "575",
                    "mediaDataId": 0,
                    "title": "Vitamin deficiencies and toxicities",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27109090",
                    "mediaDataId": 0,
                    "title": "Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systemic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27109090",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27050049",
                    "mediaDataId": 0,
                    "title": "Prevention of vitamin K deficiency bleeding in newborn infants: a position paper by the ESPGHAN committee on nutrition.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27050049",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 148,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16465,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 668,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 22252,
            "questionIndex": 106236,
            "questionText": "<p>A 16-year-old boy is evaluated for persistent epistaxis over the past 2 days.&nbsp; There is no personal or family history of excessive bleeding.&nbsp; The patient has a history of chronic glomerulonephritis and is on the waiting list for transplantation.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">9.5 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">86 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td style=\"vertical-align:middle;\">200,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">8,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">50 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td style=\"vertical-align:middle;\">4.4 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Coagulation studies</td></tr><tr><td style=\"padding-left: 2em;\">PT</td><td style=\"vertical-align:middle;\">12 sec</td></tr><tr><td style=\"padding-left: 2em;\">Activated PTT</td><td style=\"vertical-align:middle;\">23 sec</td></tr><tr><td style=\"padding-left: 2em;\">Fibrinogen</td><td style=\"vertical-align:middle;\">normal</td></tr></tbody></table><p>What is the best next step in diagnosis of this patient&#39;s bleeding disorder?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T82321\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Platelet dysfunction in chronic kidney disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Rising urea &#8594; upregulation of nitric oxide &#8594;<br>&#8595; platelet adhesion, activation &amp; aggregation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Easy bruising</li><li>Mucosal bleeding (eg, epistaxis, GI hemorrhage)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Normal platelet count (may be mildly low)</li><li>Normal coagulation studies</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Desmopressin (&#8593; vWF secretion from endothelial cells)<ul style=\"list-style-type:circle;\"><li>Only required if having bleeding symptoms<br>or upcoming procedure</li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GI</strong> = gastrointestinal; <strong>vWF</strong> = von Willebrand factor.</p></td></tr></tbody></table></div><p>Classic causes of prolonged bleeding (eg, persistent epistaxis) include platelet or coagulation disorders.&nbsp; In this case, the patient has a normal platelet count and normal coagulation studies (eg, PT, activated PTT) in addition to <strong>chronic kidney disease</strong> (CKD).&nbsp; Therefore, the most likely diagnosis is <strong>platelet dysfunction</strong>, a common cause of <strong>easy bruising</strong> and <strong>mucosal bleeding</strong> in those with CKD.</p><p>Patients with CKD have disruption of <a href=\"16355\">primary hemostasis</a>, including platelet&ndash;von Willebrand factor (vWF) interactions.&nbsp; As levels of urea (the end product of ammonia breakdown) rise, its precursors are shunted to a different pathway that leads to nitric oxide production.&nbsp; Inappropriately high nitric oxide results in <a href=\"53221\">decreased platelet adhesion, activation, and aggregation</a>.</p><p>In patients with CKD and bleeding tendencies, a diagnosis of platelet dysfunction can be established with a <strong>normal platelet count</strong> and <strong>normal coagulation studies</strong>.&nbsp; Symptomatic patients are typically treated with desmopressin (DDAVP), which stimulates the release of vWF and reduces bleeding time.</p><p><strong>(Choice A)</strong>&nbsp; Antiplatelet antibodies are associated with (but not routinely measured in) immune thrombocytopenia, which can cause persistent epistaxis.&nbsp; Other conditions associated with platelet antibodies and epistaxis include drug-induced thrombocytopenia and, rarely, heparin-induced thrombocytopenia (which is more likely to cause clotting).&nbsp; However, platelet count would be low (usually &lt;10,000/mm<font size=\"2\"><sup>3</sup></font> in patients with immune thrombocytopenia and mucosal bleeding).</p><p><strong>(Choice B)</strong>&nbsp; Unexplained cytopenias, particularly involving multiple cell lines, may warrant bone marrow biopsy to assess for an underlying cause (eg, aplastic crisis).&nbsp; This patient&#39;s normocytic anemia is characteristic of CKD due to reduced erythropoietin production, making bone marrow evaluation unnecessary.&nbsp; In addition, anemia would not cause persistent bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Factor VII deficiency is rare but may lead to mucosal bleeding.&nbsp; However, PT would be prolonged.</p><p><strong>(Choice E)</strong>&nbsp; Thrombin time (TT) reflects the last step of the clotting cascade (fibrinogen to fibrin conversion), which is mediated by thrombin; it is typically ordered if a prolonged PTT is suspected to be due to a fibrinogen disorder or to anticoagulant exposure.&nbsp; For example, TT is elevated in disseminated intravascular coagulation, which causes bleeding; unlike this case, patients typically have an acute risk factor (eg, sepsis, trauma), thrombocytopenia, and prolonged PT and PTT.</p><p><strong>Educational objective:</strong><br>Platelet dysfunction is common in patients with chronic kidney disease due to decreased platelet adhesion, activation, and aggregation.&nbsp; Patients often have easy bruising or mucosal bleeding, and platelet count and coagulation studies are typically normal.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 23485,
            "topic": "Platelet dysfunction",
            "titleId": 23485,
            "title": "Platelet dysfunction",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antiplatelet antibody measurement",
                    "choiceNumber": 1,
                    "correctTaken": 2676,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 521,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional testing",
                    "choiceNumber": 3,
                    "correctTaken": 9121,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum factor VII level",
                    "choiceNumber": 4,
                    "correctTaken": 1329,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum thrombin time",
                    "choiceNumber": 5,
                    "correctTaken": 2837,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "90,180,true,-1,1*360,477,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "553",
                    "mediaDataId": 0,
                    "title": "Chronic kidney disease: an overview",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15497100",
                    "mediaDataId": 0,
                    "title": "Platelet dysfunction in renal failure.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15497100",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16484,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1162,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 3596,
            "questionIndex": 3596,
            "questionText": "<p>A 45-year-old woman comes to the emergency department with left leg pain and swelling that has worsened over the last 2 days.&nbsp; The patient has no fevers, chills, dyspnea, or chest pain and has had no trauma to the left leg.&nbsp; Her medical history includes rheumatoid arthritis and gastroesophageal reflux disease, for which she takes low-dose methotrexate, folic acid, and omeprazole.&nbsp; The patient has smoked a pack of cigarettes daily for 10 years and does not consume alcohol.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 130/80 mm Hg, pulse is 70/min, and respirations are 14/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The left leg is swollen (&gt;4 cm) compared to the right and is warm and tender on palpation.&nbsp; Pitting edema is present.&nbsp; Her legs are shown in the image below.</p><p><img  draggable=\"false\" id=\"1328\" src=\"https://www.uworld.com/media/U10081.jpg\"  ></p><p>Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t64318\"><table class=\"table-default-style table-header-footer-style\" style=\"width:552px\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%\"><p align=\"center\"><strong>Modified Wells criteria for pretest probability<br>of deep venous thrombosis</strong></p></td></tr><tr><td style=\"width:25.0%\"><p align=\"center\"><strong>Score 1 point for each feature present</strong></p></td><td style=\"width:75.0%\"><ul><li>Previously documented DVT</li><li>Active cancer</li><li>Recent immobilization of the legs</li><li>Recently bedridden &gt;3 days</li><li>Localized tenderness along vein distribution</li><li>Swollen leg</li><li>Calf swelling &gt;3 cm compared to other leg</li><li>Pitting edema</li><li>Collateral superficial nonvaricose veins</li><li>Alternate diagnosis more likely (&#8722;2 points)</li></ul></td></tr><tr><td style=\"width:25.0%\"><p align=\"center\"><strong>Total score for clinical probability</strong></p></td><td style=\"width:75.0%\"><ul><li>0 points = Low probability</li><li>1 or 2 points = Moderate probability</li><li>&#8805;3 points = High probability</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:100.0%\"><p><strong>DVT</strong> = deep venous thrombosis.</p></td></tr></tbody></table></div><p>This patient with left leg pain and marked asymmetric swelling likely has a <strong>deep venous thrombosis (DVT)</strong>.&nbsp; Rheumatoid arthritis (RA) itself is a risk factor, regardless of whether or not it is associated with immobilization.&nbsp; Other common risk factors include family history of DVT, trauma, <strong>hypercoagulable state</strong> (eg, underlying malignancy), and medications (eg, oral contraceptives).</p><p>The diagnosis of DVT is based on history and physical examination findings combined with laboratory results and imaging.&nbsp; The modified <strong>Wells score</strong> is a widely used risk assessment tool for DVT.&nbsp; Patients with a score &#8805;2 (eg, pitting edema, calf swelling &gt;3 cm compared to the other leg) are more likely to have DVT.&nbsp; In such patients, <strong>compression ultrasonography</strong> is the preferred initial test as it can be performed quickly in most emergency departments.</p><p>Patients with clinical evidence of pulmonary embolus (eg, pleuritic chest pain, dyspnea, tachypnea, tachycardia) should be started on anticoagulation if there are no contraindications (eg, active bleeding)&nbsp;while undergoing diagnostic evaluation (eg, chest CT angiogram) <strong>(Choice C)</strong>.&nbsp; In contrast, patients with features of DVT only, as in this case, should have DVT confirmed by imaging prior to starting anticoagulation as anticoagulation itself has risks <strong>(Choice F)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Anticoagulation is the preferred treatment for patients with confirmed DVT.&nbsp; Aspirin is used in patients with peripheral artery disease, which can cause atypical leg pain (without swelling or warmth) that is often bilateral and exacerbated by exertion.</p><p><strong>(Choice B)</strong>&nbsp; Blood cultures and empiric antibiotic therapy would be appropriate in patients with <a href=\"625\">cellulitis</a>, but such patients would generally also have fever (or other systemic symptoms), extremity redness, and an elevated white blood cell count.&nbsp; Marked asymmetric swelling is also more suggestive of a DVT.</p><p><strong>(Choice E)</strong>&nbsp; In patients with low pretest probability based on the Wells score, a negative D-dimer is useful for excluding DVT.&nbsp; However, D-dimer levels are not specific for DVT, and an elevated level alone is not sufficient to establish the diagnosis.&nbsp; In patients with moderate or high pretest probability (as in this patient), compression ultrasonography is the best next step.</p><p><strong>Educational objective:</strong><br>Noninvasive evaluation with compression ultrasonography is recommended as an initial test in patients with moderate or high probability of deep venous thrombosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aspirin",
                    "choiceNumber": 1,
                    "correctTaken": 190,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Blood cultures followed by antibiotics",
                    "choiceNumber": 2,
                    "correctTaken": 610,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chest CT angiogram",
                    "choiceNumber": 3,
                    "correctTaken": 371,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Compression ultrasonography",
                    "choiceNumber": 4,
                    "correctTaken": 8756,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "D-dimer test",
                    "choiceNumber": 5,
                    "correctTaken": 2151,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Empiric anticoagulation",
                    "choiceNumber": 6,
                    "correctTaken": 3744,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "217,243,true,-1,1*301,356,true,-1,1*357,441,true,-1,1*244,288,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23157144",
                    "mediaDataId": 0,
                    "title": "Diagnosis of deep venous thrombosis and pulmonary embolism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23157144",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 139,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 15822,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 940,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 14309,
            "questionIndex": 15717,
            "questionText": "<p>A 69-year-old woman comes to the emergency department due to increasing abdominal pain for the past several hours that is worsened by cough or movement.&nbsp; She has had no nausea, vomiting, or diarrhea.&nbsp; For the past 2 days, the patient has had cough and wheezing due to an asthma exacerbation, for which she has been taking an oral glucocorticoid and using inhaled bronchodilators.&nbsp; Other medical conditions include atrial fibrillation for which she takes apixaban and diltiazem.&nbsp; Surgical history includes abdominal hysterectomy 15 years ago.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/60 mm Hg, pulse is 92/min, and respirations are 16/min.&nbsp; BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; There is mild expiratory wheezing bilaterally.&nbsp; Heart sounds are normal.&nbsp; Abdominal examination reveals a palpable mass with tenderness and guarding just lateral to the umbilicus on the left side.&nbsp; The mass does not cross the midline and does not change with movement of the lower extremities.&nbsp; Bowel sounds are normal in all quadrants.&nbsp; Leukocyte count is 12,000/mm<font size=\"2\"><sup>3</sup></font> and hemoglobin is 10.8 g/dL.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s abdominal symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T54293\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Rectus sheath hematoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Abdominal trauma, forceful abdominal contractions (eg, coughing)</li><li>Anticoagulation</li><li>Older age, female sex</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Acute-onset abdominal pain with palpable abdominal mass</li><li>Blood loss anemia, leukocytosis</li><li>&plusmn; Nausea, vomiting, fever</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Hemodynamically stable: serial monitoring of CBC, reverse anticoagulation and transfuse blood products when appropriate</li><li>Unstable: angiography with embolization, surgical ligation</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBC</strong> = complete blood count.</p></td></tr></tbody></table></div><p>This patient taking apixaban developed acute abdominal pain associated with a palpable abdominal mass and anemia, suggesting the development of a <strong>rectus sheath hematoma</strong> (RSH).</p><p>RSH typically occurs due to rupture of the <strong>inferior epigastric artery</strong>, which supplies blood to the lower aspect of the rectus abdominis muscle.&nbsp; The <a href=\"710\">rectus sheath</a>, which contains this muscle, does not extend posteriorly below the arcuate line; therefore, bleeding below this line (eg, lower aspect of rectus abdominis muscle) is relatively uncontained and can result in significant hemorrhage with hematoma formation.&nbsp; RSH is often seen with blunt trauma or <strong>forceful abdominal contractions</strong> (eg, severe <strong>coughing</strong>), particularly in patients receiving <strong>anticoagulation</strong> therapy.</p><p>Manifestations include <strong>acute abdominal pain</strong>, often associated with rebound or guarding, and a <strong>palpable abdominal wall mass</strong>.&nbsp; The mass does not cross the midline and does not change with movement of the lower extremities (Fothergill sign).&nbsp; Nausea, vomiting, and fever may also occur.&nbsp; Laboratory findings usually include <strong>anemia</strong> and <strong>leukocytosis</strong> (likely due to inflammation).&nbsp; Abdominal CT confirms the diagnosis.&nbsp; Hemodynamically stable patients are usually managed conservatively (eg, serial monitoring of CBC, reversal of anticoagulation when appropriate); however, those with significant bleeding or hemodynamic instability (eg, shock) may require angiography with embolization or surgery.</p><p><strong>(Choice A)</strong>&nbsp; Rectus abdominis diastasis (diastasis recti, abdominal muscle separation) refers to increased midline separation between the right and left rectus abdominis muscles (sometimes described as increased inter-rectus distance), usually due to weakening of the linea alba.&nbsp; It is typically seen in pregnant patients or those with obesity (ie, increased lateral strain on the rectus abdominis) and would not cause tenderness or a palpable mass.</p><p><strong>(Choice B)</strong>&nbsp; Diverticular abscess also causes leukocytosis and abdominal pain and may cause a palpable abdominal mass.&nbsp; However, fever and nausea/vomiting usually precede the development of the abscess.&nbsp; The onset is generally less acute, and anemia is unexpected.</p><p><strong>(Choice C)</strong>&nbsp; Ovarian torsion is associated with pain and a palpable mass; however, it causes severe pelvic (rather than periumbilical) pain and an adnexal mass.&nbsp; In addition, it would not cause anemia and is more common in women in their 20s and 30s.</p><p><strong>(Choice E)</strong>&nbsp; Sigmoid volvulus presents with abdominal pain and vomiting.&nbsp; However, onset is typically insidious (days) and is associated with severe, diffuse, abdominal pain and tympany on examination.&nbsp; Blood counts are usually normal unless perforation has occurred.</p><p><strong>Educational objective:</strong><br>Rectus sheath hematomas are characterized by acute abdominal pain with a palpable abdominal wall mass, often associated with anemia and leukocytosis.&nbsp; They usually occur due to rupture of the inferior epigastric artery from blunt trauma or forceful abdominal contractions (eg, severe coughing), particularly in those receiving anticoagulation therapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 23661,
            "topic": "Rectus sheath hematoma",
            "titleId": 23661,
            "title": "Rectus sheath hematoma",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abdominal muscle separation (diastasis recti)",
                    "choiceNumber": 1,
                    "correctTaken": 5179,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diverticular abscess",
                    "choiceNumber": 2,
                    "correctTaken": 1370,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian torsion",
                    "choiceNumber": 3,
                    "correctTaken": 1255,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rectus sheath hematoma",
                    "choiceNumber": 4,
                    "correctTaken": 7597,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sigmoid volvulus",
                    "choiceNumber": 5,
                    "correctTaken": 1117,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "312,490,true,-1,1*839,1112,true,-1,1*1391,1506,true,-1,1*1642,1679,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25529279",
                    "mediaDataId": 0,
                    "title": "Rectus sheath hematoma: a review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25529279",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 243,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 16518,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1151,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 15120,
            "questionIndex": 16544,
            "questionText": "<p>A 56-year-old man comes to the office due to pain, redness, and swelling in his right arm.&nbsp; The patient was recently diagnosed with unresectable lung cancer.&nbsp; He received the first cycle of chemotherapy 2 weeks ago through a right-sided peripherally inserted central catheter (PICC).&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 130/80 mm Hg, pulse is 78/min, and respirations are 14/min.&nbsp; Oxygen saturation is normal.&nbsp; Examination shows right arm swelling and mild erythema.&nbsp; Capillary refill is normal.&nbsp; No discharge is seen around the PICC line.&nbsp; The remainder of the examination is normal.&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t51064\"><div align=\"center\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Upper extremity deep venous thrombosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Central catheter or PICC line</li><li>Young, athletic males (spontaneous)</li><li>Thoracic outlet obstruction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Unilateral arm or forearm edema</li><li>Pain/heavy sensation</li><li>Erythema</li><li>Dilated subcutaneous collateral veins</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Doppler or duplex ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>3 months of anticoagulation</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>PICC</strong> = peripherally inserted central catheter.</p></td></tr></tbody></table></div></div><p>This patient&#39;s arm swelling, pain, and mild erythema developed in the setting of a <strong>peripherally inserted central catheter</strong> (PICC), raising strong suspicion for <strong>upper extremity deep venous thrombosis</strong> (DVT).&nbsp; All upper extremity central catheters (eg, internal jugular, subclavian) are associated with increased risk of DVT due to endothelial trauma during insertion and improper positioning of the catheter tip; the risk of DVT is somewhat higher with PICCs because they travel long distances through narrow peripheral veins (often occupying &gt;50% of total vein caliber).&nbsp; Hospitalized patients, particularly those with a hypercoagulable state (eg, <strong>malignancy</strong>), are most likely to develop PICC-related DVT.</p><p>Upper extremity DVT is most common within 7-14 days of PICC insertion.&nbsp; The primary manifestation is <strong>arm or forearm swelling</strong>.&nbsp; Pain and mild erythema may also occur.&nbsp; In contrast to PICC infection, patients with DVT usually have a normal appearing catheter insertion site (eg, no purulence).&nbsp; The diagnosis is made with compression or <strong>duplex ultrasonography</strong>, which visualizes the subclavian, axillary, and brachiocephalic veins.&nbsp; Although upper extremity DVT is associated with a relatively low risk of pulmonary embolism (~6%), treatment with <strong>3 months of anticoagulation</strong> is recommended.&nbsp; The PICC line can often remain in place.</p><p><strong>(Choice A)</strong>&nbsp; Chest MRI can be used to diagnose superior vena cava (SVC) syndrome, which is often caused by lung malignancy.&nbsp; The SVC is not well visualized with ultrasound, although indirect findings (eg, waveforms) can suggest SVC occlusion.&nbsp; Although SVC syndrome is associated with increased risk of DVT, patients usually have dyspnea, chest pain, and/or face or neck swelling.</p><p><strong>(Choice C)</strong>&nbsp; Echocardiography is used to evaluate for structural defects of the heart.&nbsp; It is not routinely used in the evaluation of upper extremity DVT.&nbsp; Although PICC lines can be associated with bacteremia and resultant endocarditis, this diagnosis is unlikely in a patient who is afebrile and does not have a murmur.</p><p><strong>(Choice D)</strong>&nbsp; This patient with no fever or catheter site purulence&nbsp;is less likely to have infection.&nbsp; He should undergo duplex ultrasound to evaluate for DVT prior to consideration of empiric antibiotics for cellulitis.</p><p><strong>(Choice E)</strong>&nbsp; Superficial phlebitis can be treated with warm compresses and NSAIDs.&nbsp; It is generally caused by peripheral, not central, venous access and marked by redness along the peripheral vein.&nbsp; Arm swelling in the setting of PICC is far more likely to indicate DVT.</p><p><strong>Educational objective:</strong><br>Peripherally inserted central catheters increase the risk of upper extremity deep venous thrombosis.&nbsp; The risk is greatest in hospitalized patients, particularly those with malignancy or other hypercoagulable state.&nbsp; Manifestations include arm swelling, erythema, and pain.&nbsp; The diagnosis is made with duplex ultrasonography.&nbsp; Treatment with 3 months of anticoagulation is required.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chest MRI",
                    "choiceNumber": 1,
                    "correctTaken": 744,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Duplex ultrasonography",
                    "choiceNumber": 2,
                    "correctTaken": 9265,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 3,
                    "correctTaken": 199,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Empiric antibiotics",
                    "choiceNumber": 4,
                    "correctTaken": 2072,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Warm compresses and NSAIDs",
                    "choiceNumber": 5,
                    "correctTaken": 4151,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2686,2943,true,-1,1*1712,1753,true,-1,1*626,830,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16431,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 686,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 4647,
            "questionIndex": 4647,
            "questionText": "<p>A 32-year-old man comes to the emergency department due to a day of worsening pain and swelling in his right leg.&nbsp; He has no fever, chest pain, or shortness of breath.&nbsp; The patient was hospitalized 2 weeks ago for right lower extremity deep vein thrombosis after a minor sports injury; he was discharged on warfarin.&nbsp; When he left the hospital, his INR was 2.2 (goal:&nbsp; 2-3).&nbsp; The patient has been taking warfarin daily; however, due to a busy work schedule, his dietary intake has been variable and last week he missed his clinic appointment for anticoagulation monitoring.&nbsp; He has no other medical problems.&nbsp; Blood pressure is 120/70 mm Hg, pulse is 70/min, and respirations are 14/min.&nbsp; Examination shows moderate pretibial edema in the right leg.&nbsp; Today, his INR is 1.3.&nbsp; Platelet count, creatinine, and liver function tests are within normal limits.&nbsp; Venous Doppler ultrasound shows a right popliteal vein thrombus that extends into the femoral vein and is worse than on previous ultrasound.&nbsp; What is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31154\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Treatment of acute deep vein thrombosis/pulmonary embolism</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Oral factor Xa inhibitors</strong></p></td><td><p align=\"center\"><strong>Warfarin</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mechanism<br />of action</strong></p></td><td><p align=\"center\">Direct factor Xa inhibition</p></td><td><p align=\"center\">Vitamin K antagonism</p></td></tr><tr><td><p align=\"center\"><strong>Therapeutic onset</strong></p></td><td><p align=\"center\">2-4 hr</p></td><td><p align=\"center\">5-7 days</p></td></tr><tr><td><p align=\"center\"><strong>Overlap needed?</strong></p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">Yes, overlap with UFH<br />or LMWH for ~5&nbsp;days</p></td></tr><tr><td><p align=\"center\"><strong>Laboratory monitoring</strong></p></td><td><p align=\"center\">No</p></td><td><p align=\"center\">PT/INR</p></td></tr><tr><td colspan=\"3\"><p><strong>LMWH</strong> = low molecular weight heparin; <strong>UFH</strong> = unfractionated heparin.</p></td></tr></tbody></table></div><p>This patient was recently diagnosed with <strong>deep vein thrombosis (DVT)</strong>.&nbsp; He has been compliant with taking his warfarin, but his schedule has prevented proper anticoagulation monitoring; his DVT has now progressed in the setting of a subtherapeutic INR.&nbsp; The risk of pulmonary embolism (PE) is higher with proximal (eg, femoral vein, iliac vein) than distal (eg, below the knee) DVT; therefore, he needs immediate anticoagulation.</p><p>Oral <a href=\"672\">direct factor Xa inhibitors</a> (eg, <strong>rivaroxaban</strong>, apixaban) are as effective as warfarin in the treatment of <strong>acute DVT or PE</strong> and do not increase the risk of bleeding complications.&nbsp; These drugs have the advantage of rapid onset of action, <strong>no requirement for laboratory (eg, INR) monitoring</strong>, and <strong>no requirement for overlap therapy</strong> with heparin.&nbsp; Therefore, these agents are becoming preferred for the treatment of acute DVT and PE.&nbsp; These drugs are an especially good option in patients who have difficulty with the dietary restrictions or frequent INR monitoring required with warfarin.</p><p><strong>(Choice A)</strong>&nbsp; In this patient with a worsening DVT and an INR of &lt;2.0, it is not appropriate to increase the warfarin dose without overlapping with heparin anticoagulation.&nbsp; In addition, if this patient remains on warfarin, it is likely that his diet and schedule will continue to cause issues with maintaining a therapeutic INR.</p><p><strong>(Choice B)</strong>&nbsp; Thrombolytic therapy is typically reserved for hemodynamically unstable patients with PE.&nbsp; Less commonly, it is used for massive proximal DVT associated with significant symptomatic swelling and/or limb ischemia.&nbsp; It is not indicated in this patient with moderate pretibial edema and absence of hypotension and tachycardia.</p><p><strong>(Choice C)</strong>&nbsp; Anticoagulation failure (eg, recurrent or extending thromboembolism while fully anticoagulated) or anticoagulation contraindication (eg, active bleeding) are indications for inferior vena cava filter placement.&nbsp; This patient is not considered to have anticoagulation failure as his INR is grossly subtherapeutic (he is not fully anticoagulated).</p><p><strong>(Choice E)</strong>&nbsp; Aspirin is inadequate for the treatment of acute DVT.</p><p><strong>Educational objective:</strong><br>Oral direct factor Xa inhibitors (eg, rivaroxaban, apixaban) have similar efficacy to warfarin in the treatment of acute venous thromboembolism and do not increase the risk of bleeding complications.&nbsp; These drugs do not require laboratory monitoring or overlap therapy with heparin and are becoming preferred agents for the treatment of acute venous thromboembolism.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Increase warfarin dose and follow up in 3 days",
                    "choiceNumber": 1,
                    "correctTaken": 1397,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate thrombolytic therapy",
                    "choiceNumber": 2,
                    "correctTaken": 4490,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Place inferior vena cava filter",
                    "choiceNumber": 3,
                    "correctTaken": 3349,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Replace warfarin with rivaroxaban",
                    "choiceNumber": 4,
                    "correctTaken": 6231,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start low-dose aspirin",
                    "choiceNumber": 5,
                    "correctTaken": 280,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1415,1731,true,-1,1*2079,2291,true,-1,1*1743,2067,true,-1,1*212,218,true,-1,1*219,227,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24053656",
                    "mediaDataId": 0,
                    "title": "Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24053656",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23808982",
                    "mediaDataId": 0,
                    "title": "Oral apixaban for the treatment of acute venous thromboembolism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23808982",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 143,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 15747,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 818,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 14164,
            "questionIndex": 15567,
            "questionText": "<p>A 17-year-old boy with chronic immune thrombocytopenia (ITP) comes to the clinic for follow-up.&nbsp; The patient was initially diagnosed with ITP over a year ago when he developed prolonged epistaxis after colliding with another player during a soccer game.&nbsp; This past school year the patient has been unable to participate in sports due to frequent episodes of mucosal bleeding after mild trauma warranting pharmacologic intervention.&nbsp; He has received treatment with multiple medications, including intravenous immunoglobulin and prednisone.&nbsp; His response to treatment has been transient, with platelet counts that have decreased rapidly to the 10,000/mm<font size=\"2\"><sup>3</sup></font> range at follow-up visits.&nbsp; Physical examination shows diffuse petechiae and a few areas of ecchymosis along the thighs but is otherwise normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>Hemoglobin</td><td>13.0 g/dL</td></tr><tr><td>Platelets</td><td>10,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td>57%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Eosinophils</td><td>3%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td>33%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td>7%</td></tr><tr><td>ABO blood group antigen</td><td>O</td></tr><tr><td>Rh(D) antigen</td><td>negative</td></tr><tr><td>Direct antibody testing (Coombs)</td><td>negative</td></tr></tbody></table><p>Workup for autoimmune disorders and chronic viral infections is negative.&nbsp; Bone marrow evaluation reveals a normocellular marrow with slightly increased megakaryocytes.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41094\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Immune thrombocytopenia </strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Platelet autoantibodies</li><li>Preceding viral infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Petechiae, ecchymosis</li><li>Mucosal bleeding (eg, epistaxis, hematuria)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Isolated thrombocytopenia &lt;100,000/mm<sup>3</sup></li><li>Few platelets (size normal to large) on peripheral smear</li></ul></td></tr><tr><td>&nbsp;<p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Children<ul style=\"list-style-type:circle;\"><li>Observe if cutaneous symptoms only</li><li>Glucocorticoids, IVIG, or anti-D if bleeding</li></ul></li><li>Adults<ul style=\"list-style-type:circle;\"><li>Observation if cutaneous symptoms AND platelets &ge;30,000/mm<sup>3</sup></li><li>Glucocorticoids, IVIG, or anti-D if bleeding or platelets &lt;30,000/mm<sup>3</sup></li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.25in;\"><strong>IVIG</strong> = intravenous immunoglobulin.</p></td></tr></tbody></table></div><p>Immune thrombocytopenia (ITP) is an autoimmune disorder in which IgG antibodies form against platelet membrane proteins, resulting in isolated thrombocytopenia.&nbsp; Most cases of ITP self-resolve within 3 months; however, some patients continue to have <strong>platelets &lt;100,000/mm<font size=\"2\"><sup>3</sup></font></strong> for <strong>&gt;1 year</strong>, which is known as <strong>chronic ITP</strong>.&nbsp; Adolescents with mild initial presentation and no preceding viral trigger are more likely to develop chronic ITP.</p><p>Chronic ITP evaluation includes bone marrow examination and blood tests for infection (eg, HIV, hepatitis C, cytomegalovirus) and autoimmune disorders (eg, systemic lupus erythematosus, thyroid disease).&nbsp; If laboratory evaluation is negative, management is similar to acute ITP.&nbsp; This includes observation alone if asymptomatic, or a combination of <strong>glucocorticoids</strong>, anti-D immune globulin (if Rh-positive and Coombs-negative), and/or <strong>intravenous immunoglobulin</strong> for bleeding episodes.</p><p>This patient has bleeding and thrombocytopenia requiring repeated pharmacologic interventions and should be considered for second-line therapies (eg, rituximab, thrombopoietin receptor agonists) or <strong>splenectomy</strong>.&nbsp; Although not without risk (eg, sepsis, thrombosis), splenectomy removes the source of platelet destruction and is often curative in patients with ITP.</p><p><strong>(Choice A)</strong>&nbsp; Anti-D immune globulin is a potential first-line therapy for ITP in patients with the Rh antigen.&nbsp; Anti-D binding to Rh(D)-positive erythrocytes is thought to&nbsp;saturate Fc receptors on macrophages within the reticuloendothelial system (RES), thereby limiting the ability of the RES to clear platelets.&nbsp; This patient is Rh(D) negative.</p><p><strong>(Choice B)</strong>&nbsp; Desmopressin promotes release of von Willebrand factor and&nbsp;is used for the treatment of von Willebrand disease (vWD); it is not helpful in patients with ITP.&nbsp; VWD does not typically cause significant thrombocytopenia.</p><p><strong>(Choice C)</strong>&nbsp; Epoetin alfa stimulates red blood cell production for patients with anemia, not thrombocytopenia.</p><p><strong>(Choice D)</strong>&nbsp; Granulocyte colony-stimulating factor increases granulocyte production and is used to treat neutropenia, not seen in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Platelet transfusions are reserved for life-threatening hemorrhage in patients with ITP because antibody production destroys the transfused platelets.&nbsp; In contrast, this patient&#39;s bleeding is limited to mucocutaneous.</p><p><strong>Educational objective:</strong><br>Patients with chronic immune thrombocytopenia have platelets &lt;100,000/mm<font size=\"2\"><sup>3</sup></font> for &gt;1 year.&nbsp; Splenectomy is an option for those with persistent bleeding and thrombocytopenia despite repeated pharmacologic interventions (eg, glucocorticoids, anti-D, intravenous immunoglobulin).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16575,
            "topic": "ITP",
            "titleId": 16575,
            "title": "ITP",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anti-D immune globulin",
                    "choiceNumber": 1,
                    "correctTaken": 742,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Desmopressin",
                    "choiceNumber": 2,
                    "correctTaken": 750,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epoetin alfa",
                    "choiceNumber": 3,
                    "correctTaken": 384,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Granulocyte colony-stimulating factor",
                    "choiceNumber": 4,
                    "correctTaken": 1498,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Scheduled platelet transfusion",
                    "choiceNumber": 5,
                    "correctTaken": 5003,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenectomy",
                    "choiceNumber": 6,
                    "correctTaken": 8047,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1878,2211,true,-1,1*218,256,true,-1,1*747,1018,true,-1,1*1105,1223,true,-1,1*1503,1714,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23550040",
                    "mediaDataId": 0,
                    "title": "Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23550040",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27741009",
                    "mediaDataId": 0,
                    "title": "Reemergence of splenectomy for ITP second-line treatment?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27741009",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23664519",
                    "mediaDataId": 0,
                    "title": "Chronic immune thrombocytopenia in children: who needs splenectomy?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23664519",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 150,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16424,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1043,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 4339,
            "questionIndex": 4339,
            "questionText": "<p>A 45-year-old, previously healthy man is brought to the emergency department due to headache and confusion for 2 days.&nbsp; He has no focal weakness or sensory symptoms.&nbsp; The patient has no significant medical history and takes no medications.&nbsp; He does not use tobacco, alcohol, or recreational drugs.&nbsp; Temperature is 37.9 C (100.2 F), blood pressure is 140/86 mm Hg, pulse is 96/min, and respirations are 16/min.&nbsp; Mild icterus is present.&nbsp; The neck is supple and with no rigidity.&nbsp; Cardiopulmonary and abdominal examinations are normal.&nbsp; Neurologic examination shows no focal deficits.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">8.4 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td style=\"vertical-align:middle;\">44,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">5,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">30 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td style=\"vertical-align:middle;\">2.2 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Calcium</td><td style=\"vertical-align:middle;\">10 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Glucose</td><td style=\"vertical-align:middle;\">98 mg/dL</td></tr></tbody></table><p>Peripheral blood smear shows many fragmented red blood cells.&nbsp; PT is normal.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32902\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Thrombotic thrombocytopenic purpura</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li><strong>&#8595;</strong> ADAMTS13 level &#8594; uncleaved vWF multimers &#8594; platelet<br>trapping &amp; activation</li><li>Acquired (autoantibody) or hereditary</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Hemolytic anemia (&#8593; LDH, &#8595; haptoglobin) with schistocytes</li><li>Thrombocytopenia (&#8593; bleeding time, normal PT/PTT)</li></ul><p>Sometimes with:</p><ul><li>Renal failure</li><li>Neurologic manifestations</li><li>Fever</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Plasma exchange</li><li>Glucocorticoids</li><li>Rituximab</li><li>Caplacizumab</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>LDH</strong> = lactate dehydrogenase; <strong>vWF</strong> = von Willebrand factor.</p></td></tr></tbody></table></div><p>This patient likely has <strong>thrombotic thrombocytopenic purpura</strong> (TTP), a life-threatening thrombotic microangiopathy that classically causes a <strong>pentad</strong> of manifestations:</p><ul><li>Thrombocytopenia</li><li>Microangiopathic hemolytic anemia (MAHA)</li><li>Renal insufficiency</li><li>Neurologic changes (eg, headache, confusion, coma, stroke)</li><li>Fever</li></ul><p>However, most patients <strong>do not have all 5</strong> manifestations at the time of diagnosis.&nbsp; Cases are most common in previously healthy individuals in middle age who are female, black, pregnant, or obese.</p><p>Immune TTP is caused by <strong>autoantibodies</strong> against the plasma protease <strong>ADAMTS13</strong>.&nbsp; Low levels of ADAMTS13 lead to the accumulation of long chains of von Willebrand factor on the endothelial wall, which traps platelets and generates thrombi in areas of high shearing force (eg, arterioles, capillaries).&nbsp; Patients with TTP will have MAHA (eg,&nbsp;<strong>schistocytes</strong>) on peripheral blood smear; <strong>coagulation studies</strong> are generally <strong>normal</strong> (in contrast to those with disseminated intravascular coagulation).&nbsp; Although purpura often occurs in the setting of severe thrombocytopenia, it is not always present in patients with TTP and is not required for the diagnosis.</p><p>TTP is life threatening and must be treated with emergency <strong>plasma exchange</strong> (PEX), which removes the patient&#39;s plasma and replaces it with donor plasma.&nbsp; This replenishes ADAMTS13 and removes the autoantibodies.&nbsp; Without emergency PEX, mortality is approximately 90%.</p><p>TTP is closely related to hemolytic uremic syndrome (HUS).&nbsp; Both cause MAHA and thrombocytopenia.&nbsp; Unlike TTP, HUS is typically associated with <em>Escherichia coli</em> O157:H7 infection and is primarily a disorder of the renal system; neurologic findings and fever are uncommon.</p><p><strong>(Choice A)</strong>&nbsp; Cryoprecipitate contains clotting factors, fibrinogen, and von Willebrand factor.&nbsp; It is often used in patients with DIC.&nbsp; This patient&#39;s PT is normal, making DIC unlikely.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s renal insufficiency is mild.&nbsp; Hemodialysis would not be required.&nbsp; In contrast to PEX, hemodialysis does not eliminate the autoantibodies against ADAMTS13 or replenish ADAMTS13.</p><p><strong>(Choice C)</strong>&nbsp; This patient has headache and confusion but no focal neurologic deficits.&nbsp; If there were concern for intracranial bleeding (given thrombocytopenia), a noncontrast CT scan of the head could be ordered.&nbsp; MRI of the brain is expensive and time consuming and would not be a useful next step.</p><p><strong>(Choices D and H)</strong>&nbsp; Red blood cell transfusions are considered for life-threatening bleeding or a hemoglobin level &lt;7 g/dL (and possibly higher in patients with coronary artery disease).</p><p><strong>(Choice F)</strong>&nbsp; Nothing in this patient&#39;s clinical and laboratory findings suggests he has severe bleeding.&nbsp; Platelets should not be transfused in TTP unless an invasive procedure or significant bleeding occurs.</p><p><strong>(Choice G)</strong>&nbsp; Urine drug screens are often useful in patients with confusion.&nbsp; However, given this patient&#39;s anemia, thrombocytopenia, and evidence of intravascular hemolysis, TTP is likely.&nbsp; Emergency PEX is necessary.</p><p><strong>Educational objective:</strong><br>Thrombotic thrombocytopenic purpura (TTP) is caused by autoantibodies to the plasma protease ADAMTS13 and is marked by microangiopathic hemolytic anemia and thrombocytopenia.&nbsp; TTP is life threatening and requires emergency treatment with plasma exchange.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8735,
            "topic": "Thrombotic thrombocytopenic purpura",
            "titleId": 8735,
            "title": "Thrombotic thrombocytopenic purpura",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cryoprecipitate infusion",
                    "choiceNumber": 1,
                    "correctTaken": 804,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemodialysis",
                    "choiceNumber": 2,
                    "correctTaken": 1758,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the brain",
                    "choiceNumber": 3,
                    "correctTaken": 624,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Packed red blood cell transfusion",
                    "choiceNumber": 4,
                    "correctTaken": 985,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma exchange",
                    "choiceNumber": 5,
                    "correctTaken": 7439,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Platelet transfusion",
                    "choiceNumber": 6,
                    "correctTaken": 1972,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urine drug screen",
                    "choiceNumber": 7,
                    "correctTaken": 748,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Whole blood transfusion",
                    "choiceNumber": 8,
                    "correctTaken": 1389,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2209,2381,true,-1,1*1499,1657,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "665",
                    "mediaDataId": 0,
                    "title": "Thrombotic microangiopathies: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 188,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 15719,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 870,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 15113,
            "questionIndex": 16537,
            "questionText": "<p>A 35-year-old woman undergoes core needle biopsy for a suspicious, asymptomatic thyroid nodule that was discovered during a routine physical examination.&nbsp; TSH is normal.&nbsp; After the procedure, the patient develops an expanding hematoma at the biopsy site.&nbsp; She has no personal or family history of bleeding or easy bruising.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient developed a hematoma after core needle biopsy for an asymptomatic thyroid nodule.&nbsp; She has no personal or family history of easy bleeding or bruising, making vitamin deficiency and most hereditary bleeding disorders unlikely.&nbsp; Therefore, despite a core needle biopsy being a fairly low-risk procedure, the most likely explanation for the hematoma is <strong>insufficient hemostasis</strong> following tissue injury from the biopsy.</p><p><strong>(Choice A)</strong>&nbsp; Platelet dysfunction can be seen in patients who take antiplatelet agents (eg, aspirin) or have certain comorbid conditions (eg, liver disease, uremia).&nbsp; Von Willebrand disease can affect platelet function.&nbsp; This otherwise healthy individual (with no family history of bleeding) is unlikely to have platelet dysfunction.&nbsp; Furthermore, most cases would manifest immediately with oozing at the biopsy site.</p><p><strong>(Choice B)</strong>&nbsp; Factor VIII deficiency is seen in hemophilia A, which usually presents in childhood with bruising and mucocutaneus or joint bleeding.&nbsp; Because it is transmitted in an X-linked recessive fashion, male patients are affected; a female patient with no history of bleeding is unlikely to have factor VIII deficiency.</p><p><strong>(Choice D)</strong>&nbsp; Clinically significant thrombocytopenia (eg, primary immune thrombocytopenia) usually manifests with a history of bruising and mucocutaneous bleeding.</p><p><strong>(Choices E and F)</strong>&nbsp; Although vitamin C deficiency (scurvy) can increase the risk of bleeding due to blood vessel fragility, and vitamin K deficiency can increase the risk of bleeding due to coagulation factor (eg, factor II, VII, IX, X) deficiency, this patient&#39;s lack of mucocutaneous bruising or bleeding makes these conditions unlikely.&nbsp; In addition, healthy individuals who consume a relatively normal diet are at very low risk for vitamin deficiency.</p><p><strong>Educational objective:</strong><br>Insufficient hemostasis is the most common cause of postoperative hematoma in patients with no personal or family history of easy bleeding or bruising.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9145,
            "topic": "Von willebrand disease",
            "titleId": 9145,
            "title": "Von willebrand disease",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Dysfunctional platelets",
                    "choiceNumber": 1,
                    "correctTaken": 2001,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factor VIII deficiency",
                    "choiceNumber": 2,
                    "correctTaken": 822,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insufficient hemostasis",
                    "choiceNumber": 3,
                    "correctTaken": 10593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thrombocytopenia",
                    "choiceNumber": 4,
                    "correctTaken": 1280,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin C deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 298,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin K deficiency",
                    "choiceNumber": 6,
                    "correctTaken": 1631,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 261,
            "othersAvgTimeSpent": 45,
            "notes": null,
            "peopleTaken": 16625,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 401,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 15024,
            "questionIndex": 16448,
            "questionText": "<p>A 56-year-old man comes to the emergency department with right leg swelling.&nbsp; He noticed the swelling yesterday and has not had injury to that leg or a recent fall.&nbsp; The patient has no chronic medical conditions and takes no medications.&nbsp; On review of systems, he endorses frequent nosebleeds and occasional gum bleeding, which began recently.&nbsp; He has also had persistent, nagging epigastric and back pain.&nbsp; The patient has lost 4.5 kg (10 lb) over the past 3 months despite no change in diet or activities.&nbsp; He has smoked a pack of cigarettes daily for 30 years.&nbsp; The patient does not use alcohol or illicit drugs.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 110/80 mm Hg, pulse is 96/min, and respirations are 16/min.&nbsp; Chest examination is unremarkable.&nbsp; Mild epigastric tenderness is present.&nbsp; There is moderate, asymmetric right lower extremity edema.&nbsp; Peripheral pulses are full and symmetric.&nbsp; Further evaluation is most likely to reveal which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50751\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Acute vs chronic disseminated intravascular coagulation (DIC)</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Acute DIC</strong></p></td><td><p align=\"center\"><strong>Chronic DIC</strong></p></td></tr><tr><td><p align=\"center\"><strong>Common etiologies</strong></p></td><td><p>Sepsis</p><p>Severe trauma</p><p>Obstetric complications</p></td><td><p>Malignancy (eg, pancreatic)</p></td></tr><tr><td><p align=\"center\"><strong>Coagulation studies</strong></p></td><td><p>Prolonged</p></td><td><p>Often normal</p></td></tr><tr><td><p align=\"center\"><strong>Platelets</strong></p></td><td><p>Low</p></td><td><p>Often normal</p></td></tr><tr><td><p align=\"center\"><strong>Fibrinogen</strong></p></td><td><p>Low</p></td><td><p>Often normal</p></td></tr><tr><td><p align=\"center\"><strong>D-dimer</strong></p></td><td><p>High</p></td><td><p>High</p></td></tr><tr><td><p align=\"center\"><strong>Bleeding risk</strong></p></td><td><p>Very high</p></td><td><p>Mildly increased</p></td></tr><tr><td><p align=\"center\"><strong>Thromboembolism risk</strong></p></td><td><p>Mildly increased</p></td><td><p>Very high</p></td></tr></tbody></table></div><p>In this patient with asymmetric leg swelling suggestive of deep venous thrombosis (DVT), several features are concerning for <strong>chronic disseminated intravascular coagulation</strong> (DIC) in the setting of cancer.&nbsp; His long history of smoking combined with unintentional weight loss and nagging epigastric and back pain raises suspicion for <strong>pancreatic cancer</strong>.&nbsp; Mucin-producing tumors (eg, pancreatic, gastric, ovarian, breast) often secrete tissue factor into the blood, which <strong>intermittently</strong> triggers the coagulation cascade and can lead to chronic DIC, a <strong>consumptive coagulopathy</strong>.</p><p>As with other consumptive coagulopathies, the risk of arterial or <strong>venous thrombosis</strong> (eg, <strong>DVT</strong>) is significantly increased in patients with chronic DIC; in addition, periodic <strong>mucocutaneous bleeding</strong> (eg, gums, nose) can occur, as seen in this patient.&nbsp; However, because patients with chronic DIC are usually able to compensate for intermittent coagulation and fibrinolysis via increased production of coagulation factors, platelets, and fibrinogen, they may be asymptomatic and frequently have normal platelet counts and coagulation times.</p><p>In contrast to chronic DIC, acute DIC usually arises in the setting of sustained procoagulant exposure (eg, lipopolysaccharide in sepsis) and is marked by massive activation of the coagulation cascade, with rapid consumption of platelets, coagulation factors, and fibrinogen.&nbsp; Most cases present with acute bleeding rather than thrombosis.</p><p><strong>(Choice A)</strong>&nbsp; Antiphospholipid antibodies increase the risk of venous thromboembolism and fetal loss.&nbsp; Bleeding risk is not generally increased.&nbsp; In addition, antiphospholipid antibodies are most often associated with systemic lupus erythematosus, not pancreatic cancer.</p><p><strong>(Choice C)</strong>&nbsp; Cryoglobulinemia, a small- to medium-sized vessel vasculitis caused by the precipitation of circulating antibodies, is most common in the setting of infection (eg, hepatitis C), monoclonal gammopathy (eg, multiple myeloma), or connective tissue disease.&nbsp; Patients generally have palpable purpura, weakness, renal insufficiency, and arthritis/arthralgias.&nbsp; Thrombosis and bleeding are atypical, and the condition is not typically linked to pancreatic cancer.</p><p><strong>(Choice D)</strong>&nbsp; Factor V Leiden is a disorder marked by an inherited resistance to activated protein C.&nbsp; Because protein C is an anticoagulant, patients are at increased risk for thromboembolism.&nbsp; However, bleeding risk is not increased, and the condition is not associated with pancreatic cancer.</p><p><strong>(Choice E)</strong>&nbsp; Thromboangiitis obliterans is a small- and medium-sized vessel vasculitis of the extremities that typically occurs in young patients who smoke.&nbsp; It generally causes distal extremity ischemia, digit ulcers, and/or digit gangrene.&nbsp; This older patient with epigastric pain, unintentional weight loss, and evidence of both bleeding and thrombosis is more likely to have chronic DIC due to cancer.</p><p><strong>Educational objective:</strong><br>Chronic disseminated intravascular coagulation is common in patients with mucin-producing tumors (eg, pancreatic cancer) due to periodic release of tissue factor into the bloodstream, which triggers low-grade coagulation and fibrinolysis.&nbsp; Patients frequently have normal platelet counts and coagulation times but are at increased risk for venous and arterial thrombosis and, to a lesser extent, mucocutaneous bleeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16440,
            "topic": "DIC",
            "titleId": 16440,
            "title": "DIC",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antiphospholipid antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 824,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Consumptive coagulopathy",
                    "choiceNumber": 2,
                    "correctTaken": 6010,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cryoglobulinemia",
                    "choiceNumber": 3,
                    "correctTaken": 2144,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inherited activated protein C resistance",
                    "choiceNumber": 4,
                    "correctTaken": 989,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thromboangiitis obliterans",
                    "choiceNumber": 5,
                    "correctTaken": 2809,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "336,410,true,-1,1*322,335,true,-1,1*312,321,true,-1,1*762,982,true,-1,1*2289,2393,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 153,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 12776,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1808,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 18530,
            "questionIndex": 20001,
            "questionText": "<p>A 22-year-old man is brought to the emergency department by ambulance after sustaining a gunshot wound to the abdomen during a home invasion.&nbsp; The event occurred 45 minutes prior to arrival.&nbsp; Because of hypotension, paramedics administered 1 L of normal saline en route to the emergency department.&nbsp; On arrival, blood pressure is 98/62 mm Hg, pulse is 120/min, and respirations are 22/min.&nbsp; The patient is awake and moaning in pain.&nbsp; The lungs are clear to auscultation bilaterally, and heart sounds are normal.&nbsp; One bullet wound is noted in the left upper quadrant.&nbsp; The abdomen is tender and distended.&nbsp; The patient is moving all his extremities, but they are cool and clammy.&nbsp; Focused Assessment with Sonography for Trauma examination shows free fluid in the abdomen.&nbsp; Continuation of additional normal saline fluid boluses in this patient would likely result in which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with penetrating abdominal trauma has signs of <strong>hemorrhagic shock</strong> (eg, hypotension, tachycardia, cool extremities) and, likely, <strong>ongoing hemorrhage</strong> (eg, free intraperitoneal fluid on Focused Assessment with Sonograph for Trauma).&nbsp; Such patients once received early, aggressive crystalloid (eg, normal saline) resuscitation to restore intravascular volume and normal blood pressure.&nbsp; Now, <strong>balanced resuscitation</strong> (aka, damage-control resuscitation) is used; it includes the following measures:</p><ul><li><p><strong>Limiting</strong> use of <strong>crystalloids</strong> (eg, &#8804;1 L), which dilute existing coagulation (eg, clotting) factors and platelets, thereby increasing coagulopathy</p></li><li><p><strong>Replacing</strong> lost <strong>intravascular volume</strong> with <strong>blood products</strong> (rather than crystalloids), transfused in a ratio similar to that of whole blood (eg, 1:1:1 ratio of packed red blood cells/plasma/platelets)</p></li><li><p>Permitting hypotension (ie, <strong>permissive hypotension</strong>) to limit ongoing hemorrhage and/or prevent clot disruption and rebleeding</p></li></ul><p>With balanced resuscitation, blood products are administered only as needed to maintain a blood pressure (eg, mean arterial pressure ~65 mm Hg) sufficient for tissue perfusion, until definitive <strong>hemorrhage control</strong> (eg, surgical intervention) can be achieved.</p><p>In addition to coagulopathy, aggressive crystalloid resuscitation has been associated with the following detrimental effects:</p><ul><li><p>Hypothermia:&nbsp; Room temperature fluids are cooler than body temperature and can cause hypothermia (which worsens coagulopathy), especially when administered in large volumes <strong>(Choice B)</strong>.</p></li><li><p>Acidosis:&nbsp; Large volumes of rapidly administered normal saline can cause non&ndash;anion gap hyperchloremic metabolic acidosis (vs alkalosis), which can further worsen the performance of coagulation factors <strong>(Choice D)</strong>.</p></li><li><p>Increased mortality:&nbsp; Overuse of crystalloids worsens the &#x22;lethal triad&#x22; (hypothermia, acidosis, coagulopathy) already present in severely injured trauma patients, increasing the risk for mortality.</p></li></ul><p><strong>(Choice A)</strong>&nbsp; The trauma-induced inflammatory response can cause capillary leakage and diffuse pulmonary edema, sometimes resulting in acute respiratory distress syndrome (ARDS).&nbsp; Crystalloids have been shown to cause a dose-dependent increase (vs decrease) in ARDS; they have a lower oncotic pressure than blood and can leak more easily into the pulmonary interstitium.</p><p><strong>Educational objective:</strong><br>Large-volume crystalloid resuscitation increases coagulopathy, hypothermia, and mortality in trauma patients.&nbsp; Balanced resuscitation, which restricts crystalloid use and uses blood products to maintain a blood pressure just sufficient for tissue perfusion (ie, permissive hypotension) until hemorrhage is controlled, can decrease these adverse effects.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19726,
            "topic": "Hypovolemic shock",
            "titleId": 19726,
            "title": "Hypovolemic shock",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased risk for acute respiratory distress syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 1735,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased risk for hypothermia",
                    "choiceNumber": 2,
                    "correctTaken": 2737,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased risk for coagulopathy",
                    "choiceNumber": 3,
                    "correctTaken": 7879,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased risk for metabolic alkalosis",
                    "choiceNumber": 4,
                    "correctTaken": 5119,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1113,1180,true,-1,1*1648,1788,true,-1,1*905,1004,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28958369",
                    "mediaDataId": 0,
                    "title": "Balanced resuscitation in trauma management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28958369",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29132583",
                    "mediaDataId": 0,
                    "title": "The evolving science of trauma resuscitation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29132583",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27894494",
                    "mediaDataId": 0,
                    "title": "Optimal fluid therapy for traumatic hemorrhagic shock.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27894494",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 116,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 17470,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 553,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 15285,
            "questionIndex": 16710,
            "questionText": "<p>A 24-year-old woman at 10 weeks gestation comes to the office for evaluation of thrombocytopenia.&nbsp; She was found to have a platelet count of 90,000/mm<font size=\"2\"><sup>3</sup></font> at her initial prenatal visit last week.&nbsp; The patient has no known history of a blood disorder; she had episodes of epistaxis during childhood but none since and has never had other bleeding issues.&nbsp; Prior to her pregnancy, her menses occurred monthly and lasted 4-5 days with light vaginal bleeding.&nbsp; The patient has no other medical conditions and takes no medications.&nbsp; She drank alcohol occasionally but stopped after a positive home pregnancy test.&nbsp; There is no significant family history of blood disorders or cancer.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no enlarged lymph nodes or hepatosplenomegaly.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Repeat platelet count is 98,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Peripheral blood smear is shown in the <a href=\"25996\">exhibit</a>.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"25997\" src=\"https://www.uworld.com/media/L25803.png\" ></p><p>This patient&nbsp;has <strong>mild thrombocytopenia</strong> with no associated symptoms (eg, bruising, mucocutaneous bleeding), no personal/family history of bleeding diathesis, and no abnormal physical examination findings.&nbsp; Peripheral blood smear reveals large clumps of platelets. &nbsp;This presentation raises suspicion for <strong>pseudothrombocytopenia</strong>.</p><p>Pseudothrombocytopenia is a <strong>laboratory error</strong> caused by platelet aggregation <em>in vitro</em>.&nbsp; Most cases are due to incompletely mixed blood samples or the presence of serum antibodies to ethylenediaminetetraacetic acid (EDTA), an anticoagulant used in hematologic testing.&nbsp; The error is generally identified when a patient with mild thrombocytopenia has <strong>peripheral blood smear</strong> evidence of <strong>large clumps of platelets</strong>.&nbsp; Drawing blood samples in tubes with a non-EDTA anticoagulant (eg, heparin, sodium citrate) normalizes the automated platelet count and confirms the diagnosis.&nbsp; Because patients with pseudothrombocytopenia do not have true thrombocytopenia, they do not require intervention or monitoring.</p><p><strong>(Choice A)</strong>&nbsp; Gestational thrombocytopenia is the most common cause of thrombocytopenia during pregnancy.&nbsp; It is generally mild and does not cause maternal or fetal morbidity.&nbsp; However, gestational thrombocytopenia usually arises in the second half of the pregnancy (not at 10 weeks), and peripheral blood smear would reveal a paucity of platelets (not platelet clumping).</p><p><strong>(Choice B)</strong>&nbsp; Glanzmann thrombasthenia is an autosomal recessive disorder associated with impaired platelet aggregation.&nbsp; Patients generally have a history of mucocutaneous bleeding, normal platelet counts, and no platelet clumping on peripheral blood smear.</p><p><strong>(Choice C)</strong>&nbsp; Idiopathic thrombocytopenic purpura, which is approximately tenfold more common in pregnant women than in the general population, usually presents with mild thrombocytopenia.&nbsp; Patients are often asymptomatic and have no history of bleeding disorder.&nbsp; However, peripheral blood smear would show a paucity of platelets, not platelet clumping.</p><p><strong>(Choice E)</strong>&nbsp; Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency can occasionally cause mild thrombocytopenia and leukopenia.&nbsp; However, peripheral blood smear usually shows hypersegmented neutrophils and <a href=\"25998\">macrocytic anemia</a>; platelet clumping would not be seen.</p><p><strong>(Choice F)</strong>&nbsp; Von Willebrand disease is the most common inherited bleeding disorder.&nbsp; It is marked by a defect in platelet aggregation due to a deficiency of von Willebrand factor.&nbsp; Most cases are asymptomatic, and patients have normal platelet counts and peripheral smears.</p><p><strong>Educational objective:</strong><br>Pseudothrombocytopenia is a laboratory error characterized by platelet aggregation <em>in vitro</em>.&nbsp; It is generally confirmed when peripheral smear reveals large clumps of platelets.&nbsp; Patients do not require additional evaluation or follow-up and are not at risk for bleeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16644,
            "topic": "Thrombocytopenia",
            "titleId": 16644,
            "title": "Thrombocytopenia",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gestational thrombocytopenia",
                    "choiceNumber": 1,
                    "correctTaken": 4004,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glanzmann thrombasthenia",
                    "choiceNumber": 2,
                    "correctTaken": 1920,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Idiopathic thrombocytopenic purpura",
                    "choiceNumber": 3,
                    "correctTaken": 2416,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pseudothrombocytopenia",
                    "choiceNumber": 4,
                    "correctTaken": 6718,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 213,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Von Willebrand disease",
                    "choiceNumber": 6,
                    "correctTaken": 528,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "359,625,true,-1,1*1241,1428,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 171,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 15799,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 945,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 17322,
            "questionIndex": 18776,
            "questionText": "<p>A 36-year-old woman comes to the urgent care clinic due to worsening right lower extremity pain and swelling for the past several days.&nbsp; The patient has a history of injection drug use.&nbsp; She also exchanges sex for drugs and is inconsistent with condom use.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 126/76 mm Hg, pulse is 86/min, and respirations are 13/min.&nbsp; Oxygen saturation is 98% on room air.&nbsp; On physical examination, edema, erythema, and warmth of the right leg are noted with increased calf and thigh diameters.&nbsp; There are injection marks in the right groin.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T64318\"><table class=\"table-default-style table-header-footer-style\" style=\"width:552px\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%\"><p align=\"center\"><strong>Modified Wells criteria for pretest probability<br>of deep venous thrombosis</strong></p></td></tr><tr><td style=\"width:25.0%\"><p align=\"center\"><strong>Score 1 point for each feature present</strong></p></td><td style=\"width:75.0%\"><ul><li>Previously documented DVT</li><li>Active cancer</li><li>Recent immobilization of the legs</li><li>Recently bedridden &gt;3 days</li><li>Localized tenderness along vein distribution</li><li>Swollen leg</li><li>Calf swelling &gt;3 cm compared to other leg</li><li>Pitting edema</li><li>Collateral superficial nonvaricose veins</li><li>Alternate diagnosis more likely (&#8722;2 points)</li></ul></td></tr><tr><td style=\"width:25.0%\"><p align=\"center\"><strong>Total score for clinical probability</strong></p></td><td style=\"width:75.0%\"><ul><li>0 points = Low probability</li><li>1 or 2 points = Moderate probability</li><li>&#8805;3 points = High probability</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:100.0%\"><p><strong>DVT</strong> = deep venous thrombosis.</p></td></tr></tbody></table></div><p>This patient with a history of injection drug use has right leg edema, erythema, and warmth.&nbsp; Although these symptoms often occur in a localized manner in injection drug users due to skin and soft tissue infection, the presence of symptoms in the entire leg, increased thigh and calf diameters, and injection marks in the right groin raises strong suspicion for acute iliofemoral <strong>deep venous thrombosis</strong> (DVT).</p><p>Common risk factors for first DVT include prolonged immobility or hospitalization, recent major surgery, obesity, malignancy, oral contraceptive/hormone replacement use, and pregnancy.&nbsp; However, patients who <strong>inject drugs</strong> into the <strong>femoral vein</strong> also are at high risk for DVT due to iliofemoral venous wall trauma, chemical irritation, and/or infection.</p><p>Manifestations of lower extremity DVT generally include <strong>unilateral leg swelling</strong>, <strong>pain</strong>, and <strong>warmth</strong>; physical examination often reveals dilated superficial veins and <strong>increased diameter of the calf or thigh</strong> when compared to the unaffected leg.&nbsp; Initial evaluation typically includes D-dimer (in those with low or moderate pretest probability) and/or lower extremity Doppler ultrasound examination (in those with high pretest probability).</p><p><strong>(Choice A)</strong>&nbsp; Acute lymphangitis is a common complication of injection drug use due to inoculation of skin flora into subcutaneous tissue.&nbsp; However, this condition is generally marked by tender red streaks up the lymphatic channels with painful, swollen, erythematous regional lymphadenitis.&nbsp; The presence of diffuse right leg symptoms and increased calf or thigh diameter enlargement makes DVT far more likely.</p><p><strong>(Choice C)</strong>&nbsp; Chronic lymphatic filariasis often results in limb lymphedema due to long-standing lymphatic inflammation.&nbsp; However, most cases occur in sub-Saharan Africa, Southeast Asia, the Caribbean, and the Indian subcontinent.&nbsp; In addition, this patient with injection marks in the right groin is far more likely to have acute DVT due to iliofemoral vein injury.</p><p><strong>(Choice D)</strong>&nbsp; Lymphogranuloma venereum is a tropical and subtropical disease caused by serovars of <em>Chlamydia trachomatis</em>; it is marked by genital ulcers and inguinal lymphadenitis.</p><p><strong>(Choice E)</strong>&nbsp; Necrotizing myositis is a rare condition generally marked by severe systemic toxicity (eg, high fever, hypotension, toxic appearance) and rapidly progressive skin changes (eg, discoloration, gangrene).&nbsp; This patient&#39;s normal vital signs and slow-onset symptoms make this highly unlikely.</p><p><strong>Educational objective:</strong><br>Patients who inject drugs into the femoral vein can develop iliofemoral deep venous thrombosis.&nbsp; This disorder is typically marked by unilateral leg edema, warmth, and erythema with evidence of dilated superficial veins and increased calf/thigh diameter on examination.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15915,
            "topic": "Venous thromboembolism",
            "titleId": 15915,
            "title": "Venous thromboembolism",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute lymphangitis",
                    "choiceNumber": 1,
                    "correctTaken": 5345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Deep venous thrombosis",
                    "choiceNumber": 2,
                    "correctTaken": 8337,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lymphatic filariasis",
                    "choiceNumber": 3,
                    "correctTaken": 816,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lymphogranuloma venereum",
                    "choiceNumber": 4,
                    "correctTaken": 1059,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Necrotizing myositis",
                    "choiceNumber": 5,
                    "correctTaken": 1542,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1206,1362,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 51,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 17099,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 541,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 23185,
            "questionIndex": 107347,
            "questionText": "<p>A 7-year-old girl is brought to the emergency department due to leg pain.&nbsp; Two weeks ago, the mother noticed the child walking with a slight limp after playing in the backyard.&nbsp; The limp has worsened, and today the patient refuses to walk.&nbsp; Her energy level has decreased, but the mother attributed this to a poor diet.&nbsp; The patient has autism and limits her diet to only a few items, mainly chocolate milk and crackers.&nbsp; Vaccinations are up to date.&nbsp; Temperature is 98.6 F (37 C).&nbsp; Examination shows scattered erythematous, red macules that do not blanche on bilateral lower extremities.&nbsp; There is tenderness in the thighs with palpation.&nbsp; The patient does not want to move either leg and cries when attempting to stand.&nbsp; Examination of the oropharynx shows inflammation with edema and bleeding along the gums.&nbsp; The neck is supple, and there is no lymphadenopathy.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; The abdomen is soft without organomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">8.7 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Mean corpuscular volume (MCV)</td><td style=\"vertical-align:middle;\">70 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Reticulocytes</td><td style=\"vertical-align:middle;\">1%</td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td style=\"vertical-align:middle;\">250,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">6,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Coagulation studies</td></tr><tr><td style=\"padding-left: 2em;\">Prothrombin time (PT)</td><td style=\"vertical-align:middle;\">12 sec</td></tr><tr><td style=\"padding-left: 2em;\">Activated partial thromboplastin time (PTT)</td><td style=\"vertical-align:middle;\">30 sec</td></tr></tbody></table><p>Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t37344\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vitamin C deficiency (scurvy)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Insufficient dietary intake (lack of citrus fruits/vegetables)<ul style=\"list-style-type:circle;\"><li>Chronic alcohol/substance use</li><li>Severe malnutrition (eg, anorexia, restricted diet)</li></ul></li><li>Impaired collagen production</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Cutaneous:<ul style=\"list-style-type:circle;\"><li>Coiled hair, perifollicular hemorrhages</li><li>Petechiae, ecchymoses</li><li>Impaired wound healing</li></ul></li><li>Mucosal: gingivitis with bleeding</li><li>Musculoskeletal (eg, periosteal hemorrhage): arthralgia, limp</li><li>Constitutional: malaise, depression, vasomotor instability</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Anemia (normocytic or microcytic)</li><li>Normal platelet count &amp; coagulation studies</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Oral/injectable vitamin C (improvement within days to weeks)</li><li>Toxicity (eg, abdominal pain, diarrhea) with excessive supplementation</li></ul></td></tr></tbody></table></div><p>This patient with a severely <strong>limited diet</strong> has leg pain, petechiae, and gingivitis, findings concerning for <strong>vitamin C deficiency (scurvy)</strong>.&nbsp; This condition is rare in resource-rich countries but can occur in patients who are malnourished; children with autism, as in this case, may have self-restrictive diets that lack vitamin C&ndash;rich foods (eg, vegetables, citrus fruits), increasing the risk of deficiency.</p><p>Vitamin C is a cofactor for the hydroxylation of proline and lysine, which is essential for collagen cross-linking.&nbsp; <strong>Impaired collagen synthesis</strong> compromises tensile strength, particularly in the skin and vascular walls, resulting in <a href=\"54786\">perifollicular hemorrhages</a>, hemorrhagic gingivitis, <strong>petechiae</strong>, and ecchymoses.&nbsp; Intramuscular or <strong>subperiosteal hemorrhages</strong> can occur, especially in the lower extremities due to gravity-dependent hydrostatic pressure within fragile capillaries.&nbsp; This results in <strong>pain</strong> and <strong>difficulty with ambulation</strong>, which may be the presenting symptoms in children, as seen here.&nbsp; Generalized malaise is also common.</p><p>The diagnosis can be confirmed by a <strong>low ascorbic acid level</strong>.&nbsp; Laboratory evaluation may also reveal anemia due to blood loss within tissues (normocytic) or associated iron deficiency (microcytic, as in this case), the latter of which occurs in part because vitamin C normally enhances iron absorption in the small intestine.</p><p><strong>(Choice A)</strong>&nbsp; Acute rheumatic fever (immune sequela of group A <em>Streptococcus</em> pharyngitis) may present with rash and arthritis.&nbsp; Unlike in this patient, the rash is <a href=\"40866\">annular and nonblanching (erythema marginatum)</a>.&nbsp; Moreover, this child has no additional manifestations (eg, fever, subcutaneous nodules, chorea).</p><p><strong>(Choices C and E)</strong>&nbsp; Bone pain, petechiae, and anemia may be signs of leukemia; evaluation includes an LDH level (marker of cell turnover) and bone marrow biopsy.&nbsp; However, the pain is due to bone marrow infiltration and would cause multiple cytopenias (not isolated anemia), and petechiae is caused by thrombocytopenia, not seen here.&nbsp; Moreover, lymphadenopathy and hepatosplenomegaly are typical and absent in this case.</p><p><strong>(Choice D)</strong>&nbsp; Arthritis and anemia may be symptoms of inflammatory bowel disease, but this diagnosis is less likely in a patient without gastrointestinal symptoms (eg, diarrhea, abdominal pain).&nbsp; In addition, findings can include oral ulcers, not gingivitis, and <a href=\"13117\">subcutaneous nodules (erythema nodosum)</a>, rather than petechiae.</p><p><strong>(Choice F)</strong>&nbsp; Vitamin K deficiency may cause petechiae, but hemorrhage causing musculoskeletal symptoms is not typical.&nbsp; Moreover, PT with or without PTT would be elevated.</p><p><strong>Educational objective:</strong><br>Vitamin C deficiency (scurvy) may occur in patients who are malnourished (eg, severely restricted diet).&nbsp; Impaired collagen synthesis results in fragile vascular walls, causing petechiae/ecchymoses, gingival bleeding, and musculoskeletal hemorrhage (eg, leg pain, limp).&nbsp; A low ascorbic acid level confirms the diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 20899,
            "topic": "Vitamin C deficiency",
            "titleId": 20899,
            "title": "Vitamin C deficiency",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antistreptolysin O titer",
                    "choiceNumber": 1,
                    "correctTaken": 639,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ascorbic acid level",
                    "choiceNumber": 2,
                    "correctTaken": 9057,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow evaluation",
                    "choiceNumber": 3,
                    "correctTaken": 1948,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Colonoscopy",
                    "choiceNumber": 4,
                    "correctTaken": 273,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LDH level",
                    "choiceNumber": 5,
                    "correctTaken": 716,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin K level",
                    "choiceNumber": 6,
                    "correctTaken": 1232,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "392,453,true,-1,1*533,566,true,-1,1*1473,1635,true,-1,1*1853,2116,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "575",
                    "mediaDataId": 0,
                    "title": "Vitamin deficiencies and toxicities",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 76,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 13865,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 707,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 4416,
            "questionIndex": 4416,
            "questionText": "<p>A 25-year-old African American woman comes to the office after experiencing increasingly heavy menstrual cycles for 3 months.&nbsp; The patient has also noticed that her gums frequently bleed when she brushes her teeth.&nbsp; Review of systems is positive for ongoing pain and stiffness in her hands and wrists that is partially responsive to ibuprofen.&nbsp; She is not taking any medications and has no known medical conditions.&nbsp; The patient is afebrile, blood pressure is 149/79 mm Hg, and pulse is 87/min.&nbsp; A nonpainful oral ulcer is present.&nbsp; Multiple petechiae are present on the upper arms and shins.&nbsp; The wrists and hands are tender to palpation and demonstrate reduced range of motion.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">10.8 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">40,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">2,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Serum creatinine</td><td style=\"vertical-align:middle;\">1.7 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of thrombocytopenia in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T53175\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Hematologic manifestations of SLE</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Common mechanisms</strong></p></td><td><p align=\"center\"><strong>Uncommon mechanisms</strong></p></td></tr><tr><td><p align=\"center\"><strong>Anemia</strong></p></td><td><ul><li>Anemia of chronic disease</li><li>SLE nephritis</li><li>Iron deficiency anemia (gastrointestinal loss)</li><li>Immune hemolytic anemia</li></ul></td><td><ul><li>Medications</li><li>MAHA</li><li>Aplastic anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Leukopenia</strong></p></td><td><ul><li>Immune-mediated destruction</li></ul></td><td><ul><li>Medications</li><li>Bone marrow dysfunction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Thrombocytopenia</strong></p></td><td><ul><li>Immune-mediated destruction</li></ul></td><td><ul><li>Medications</li><li>TTP (&#8593; consumption)</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>MAHA</strong> = microangiopathic autoimmune hemolytic anemia; <strong>SLE</strong> = systemic lupus erythematosus; <strong>TTP</strong> = thrombotic thrombocytopenic purpura.</p></td></tr></tbody></table></div><p>This patient&#39;s presentation (joint pains, oral ulcer, hypertension, pancytopenia, impaired renal function) suggests possible <a href=\"1256\">systemic lupus erythematosus (SLE)</a>, a systemic autoimmune disorder.&nbsp; Her severe thrombocytopenia (platelet count &lt;50,000/mm<font size=\"2\"><sup>3</sup></font>), manifesting with common associated features of bleeding gums and heavy menstrual periods, is likely due to SLE.&nbsp; In the United States, SLE occurs most commonly in African American, Hispanic, and Asian women.&nbsp; <strong>Hematologic abnormalities</strong> occur in over half of SLE patients and include:</p><ul><li>Anemia, resulting from immune destruction, but also from coexisting renal disease or chronic inflammation</li><li>Leukopenia (eg, neutropenia), often immune-mediated and correlating with disease activity</li><li>Thrombocytopenia, most commonly due to immune thrombocytopenic purpura (ITP)</li></ul><p>The presence of <strong>autoantibodies</strong> is the primary mechanism underlying the most common cytopenias in SLE.&nbsp; <strong>Thrombocytopenia</strong> is most often caused by <strong>antiplatelet antibodies</strong>, which trigger <strong>increased destruction</strong> of platelets via immunoglobulin binding in peripheral blood vessels and subsequent macrophage phagocytosis.&nbsp; Less commonly, thrombocytopenia can occur in SLE-associated hypercoagulable states in which platelets are consumed within thrombi (eg, thrombotic thrombocytopenic purpura, associated with <a href=\"27033\">schistocytes</a>; disseminated intravascular coagulation, which can occur in antiphospholipid antibody syndrome).</p><p><strong>(Choice A)</strong>&nbsp; Although splenic sequestration of immunoglobulin-bound platelets may occur downstream, the primary initiating mechanism for platelet destruction in SLE occurs in peripheral blood vessels via the abnormal formation of immune complexes.&nbsp; In contrast, aberrant splenic sequestration occurs in conditions that increase portal pressure and splenic congestion, such as liver disease, hepatic vein thrombosis, or sickle cell anemia. Typically, the thrombocytopenia associated with these conditions is mild (60,000-150,000/mm<font size=\"2\"><sup>3</sup></font>).</p><p><strong>(Choices B and D)</strong>&nbsp; Malignant invasion of bone marrow, seen in leukemias and lymphomas, may cause pancytopenia.&nbsp; Similarly, pancytopenia can be caused by ineffective hematopoiesis resulting from primary bone marrow disorders (eg, myelodysplastic syndrome, aplastic anemia).&nbsp; However, these conditions are unlikely to explain this patient&#39;s new kidney disease, hypertension, nonpainful oral ulcer, and arthralgias.</p><p><strong>(Choice C)</strong>&nbsp; Dilutional thrombocytopenia can occur following massive transfusion of packed red blood cells or large-volume intravenous fluid resuscitation, in which plasma volume is increased disproportionately to platelet count.&nbsp; This patient has no history of either procedure.</p><p><strong>Educational objective:</strong><br>Pancytopenia (decreased red blood cells, white blood cells, and platelets) is common in patients with systemic lupus erythematosus.&nbsp; It usually indicates concurrent peripheral, immune-mediated destruction of all 3 cell lines.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19642,
            "topic": "SLE",
            "titleId": 19642,
            "title": "SLE",
            "topicAttributeId": 330658,
            "topicAttribute": "Platelet disorders",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aberrant splenic sequestration",
                    "choiceNumber": 1,
                    "correctTaken": 2449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow invasion by malignancy",
                    "choiceNumber": 2,
                    "correctTaken": 1879,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dilutional cytopenia",
                    "choiceNumber": 3,
                    "correctTaken": 152,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ineffective hematopoiesis",
                    "choiceNumber": 4,
                    "correctTaken": 3123,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral destruction",
                    "choiceNumber": 5,
                    "correctTaken": 5966,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "8130682",
                    "mediaDataId": 0,
                    "title": "Hematological manifestations of systemic lupus erythematosus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/8130682",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 74,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 13570,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 7,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}